KOL | Erika RM von MutiusComprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, ... |
के लिए फिर से शुरू Erika RM von Mutius
| Year | |
|---|---|
| 2022 | Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, Munich, Germany; Institute of Asthma and Allergy Prevention (IAP), Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Institute for Asthma and Allergy Prevention, Helmholtz Centre Munich, 85764 Neuherberg, Germany |
| 2021 | Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany |
| 2020 | German Center for Lung Research, CPC-M From the Institute of Asthma and Allergy Prevention, Helmholtz Centre Munich, Munich, and the Asthma and Airway Disease Research Center, University of Arizona, Tucson. |
| 2019 | Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Institute for Asthma and Allergy Prevention, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany Dr von Hauner Children's Hospital, Ludwig Maximilian University German Center for Lung Research (DZL) |
| 2018 | Member of the German Centre for Lung Research, Munich, Germany Direktorin, Institut für Asthma und Allergieprävention Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstraße 1, 85764 Neuherberg |
| 2017 | Children Hospital and Children Polyclinic in the Dr. von Haunersches Children Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, 80337 Munich, Germany Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL) |
Erika RM von Mutius: आँकड़ों को प्रभावित करें
रिपोर्ट चलाएं
| Concept | World rank |
|---|---|
| strongest predictor atopy | #1 |
| childrens bedrooms cowsheds | #1 |
| lca feeding patterns | #1 |
| farm exposure asthma | #1 |
| farm milk meat | #1 |
| transient wheeze asthma | #1 |
| allergic diseases protective | #1 |
| girls late onset | #1 |
| insight asthma | #1 |
| order covariates | #1 |
| psychosocial characteristics children | #1 |
| food items year | #1 |
| children automobiles child | #1 |
| protective farm environment | #1 |
| sod3 sod3 snps | #1 |
| farmers children | #1 |
| traditional farms | #1 |
| preschool children predictor | #1 |
| functionality network differences | #1 |
| richness farming | #1 |
| jobs asthma risk | #1 |
| w12 ddhay fever | #1 |
| ranks performance | #1 |
| countries pasture study | #1 |
| asthma questionnaire responses | #1 |
| higher specificity asthma | #1 |
| mite exposure risk | #1 |
| ige seasonal allergens | #1 |
| parental questionnaires | #1 |
| network differences groups | #1 |
| interaction npsr1 polymorphisms | #1 |
| amish hutterite | #1 |
| spt atopic dermatitis | #1 |
| otus bacterial diversity | #1 |
| yogurt diversity | #1 |
| review hygiene hypothesis | #1 |
| serum ige levels | #1 |
| farms farm homes | #1 |
| school age early | #1 |
| 12 months doctor | #1 |
| yogurt year | #1 |
| east germany leipzig | #1 |
| incident wheezing | #1 |
| immune receptors birth | #1 |
| 3 mm spt | #1 |
| farm environments asthma | #1 |
| muramic acid concentration | #1 |
| sum indicators | #1 |
| bacterial exposures | #1 |
| animal farms substances | #1 |
| positive sensitization egg | #1 |
| abundances 6 otus | #1 |
| 15ans | #1 |
| asthma bronchial response | #1 |
| atopic dermatitis adolescence | #1 |
| 95 grass pollen | #1 |
| allergy symptoms childhood | #1 |
| peptidoglycan ppg birth | #1 |
| ml1 cohort studies | #1 |
| ema protective farm | #1 |
| farmers anthroposophic families | #1 |
| protection yogurt | #1 |
| occurrence generations | #1 |
| asthma atopic disease | #1 |
| infancy case status | #1 |
| farming environments | #1 |
| gpra polymorphisms | #1 |
| maturation gut microbiome | #1 |
| wholeto | #1 |
| hlx1 polymorphisms | #1 |
| lukas2 lca | #1 |
| dermatitis symptoms | #1 |
| farm reduced prevalence | #1 |
| germany prevalence differences | #1 |
| prehireonset | #1 |
| 6 years subtypes | #1 |
| protective allergic diseases | #1 |
| determinants airway responsiveness | #1 |
| maternal farm exposure | #1 |
| food sensitization egg | #1 |
| allergic allergic dermatitis | #1 |
| environmental allergens variety | #1 |
| concomitant bhr 95 | #1 |
| transcription factors hlx1 | #1 |
| 18 months protective | #1 |
| amish hutterite children | #1 |
| wheeze asthma questions | #1 |
| parasitic infections predictor | #1 |
| crp early age | #1 |
| 105 years richness | #1 |
| bacterial signals atopy | #1 |
| turkish children asthma | #1 |
| ilcs neonatal mice | #1 |
| immune activation populations | #1 |
| feeding cattle cowsheds | #1 |
| allergies | #1 |
| prehireonset odds ratio | #1 |
| allergies personal cleanliness | #1 |
| asthma bacteria | #1 |
| groups rural areas | #1 |
| aa ifih1 expression | #1 |
| 95 asthma | #1 |
| samples farm dwellings | #1 |
| mrna expression year | #1 |
| t1432c | #1 |
| allergies addition | #1 |
| prevalence environmental factors | #1 |
| model bronchial hyperreactivity | #1 |
| respiratory symptoms childhood | #1 |
| relation late introduction | #1 |
| hrqol protective | #1 |
| bamse npsr1 | #1 |
| hypopharynx moraxella | #1 |
| adolescent agriculture | #1 |
| wheeze farmers children | #1 |
| positive sensitization | #1 |
| 12 months crowding | #1 |
| increased diversity food | #1 |
| work overload work | #1 |
| asthma symptoms adulthood | #1 |
| development preschool wheezing | #1 |
| farm exposure exposure | #1 |
| protection allergic diseases | #1 |
| anthropometric data overweight | #1 |
| sige cutoff | #1 |
| asthma aor | #1 |
| allergy exposures | #1 |
| menarche hormonal contraceptives | #1 |
| transient wheezing age | #1 |
| male poland quality | #1 |
| insight environmental factors | #1 |
| fpr2 aa | #1 |
| 5–13‐year | #1 |
| menarche allergic | #1 |
| symptoms gender ratio | #1 |
| atopic dermatitis jobs | #1 |
| indicators total quantity | #1 |
| farm childhood asthma | #1 |
| aa hcs | #1 |
| egg aor | #1 |
| hypersensitivity infections | #1 |
| allergoprotective capacity | #1 |
| allergy cohort methods | #1 |
| allergies existing cohort | #1 |
| ige levels exposure | #1 |
| associations airwayrelated symptoms | #1 |
| dgge asthma | #1 |
| treg marker genes | #1 |
| cowsheds peak | #1 |
| allergies atopic dermatitis | #1 |
| vehicle traffic asthma | #1 |
| newonset allergic rhinitis | #1 |
| gsdma expression secretion | #1 |
| incident wheezing association | #1 |
| dresden munich | #1 |
| west germany overweight | #1 |
| secretion life | #1 |
| farm exposure asthmatics | #1 |
| atopic embryonic allergic | #1 |
| atopy allergen specificity | #1 |
| anthroposophic lifestyle features | #1 |
| living farm | #1 |
| farming environment development | #1 |
| regulatory responses protection | #1 |
| diagnosed fever 95 | #1 |
| fever atopic sensitization | #1 |
| cord blood offspring | #1 |
| allergic rhinitis type | #1 |
| children farm children | #1 |
| infant design | #1 |
| tregs age | #1 |
| sige spt | #1 |
| life fungi humans | #1 |
| lca male phenotype | #1 |
| association atopic sensitization | #1 |
| rhinoconjunctivitis participation | #1 |
| covariates potential confounding | #1 |
| lpastimulation | #1 |
| asthma concomitant asthma | #1 |
| heattreated milk samples | #1 |
| no2 allergic sensitisation | #1 |
| asthma genetic effects | #1 |
| ilt4 cb | #1 |
| influential factors health | #1 |
| homes farm dwellings | #1 |
| atopic sensitization | #1 |
| asthma austria allergic | #1 |
| cutoff 3 mm | #1 |
| inhaled steroids dresden | #1 |
| endotoxin level production | #1 |
| children indoor mould | #1 |
| prognosis early wheeze | #1 |
| childhood asthma fever | #1 |
| study questionnaire responses | #1 |
| unhygienic contact | #1 |
| questionnaires childhood | #1 |
| actinomycetes cowsheds | #1 |
| analyses provocation time | #1 |
| prevent allergic diseases | #1 |
| polymorphisms tbx21 | #1 |
| bmi allergic dermatitis | #1 |
| kitchen moisture damage | #1 |
| current wheeze benzene | #1 |
| predictor immune activation | #1 |
| cd4creil13 | #1 |
| ddhay fever 95 | #1 |
| rhinitis predictor | #1 |
| animal sheds barns | #1 |
| rnastabilizing solution | #1 |
| allergen exposure life | #1 |
| newborn interleukin17 leukocytes | #1 |
| farm studies | #1 |
| factor school behavior | #1 |
| transmaternal asthma protection | #1 |
| asthma german children | #1 |
| crude measure exposure | #1 |
| occupational disinfectants asthma | #1 |
| farm children bavaria | #1 |
| atopic dermatitis farm | #1 |
| children unification | #1 |
| igg nglycosylation populations | #1 |
| 20 fall volume | #1 |
| adolescent agriculture dust | #1 |
| npsr1 tnc | #1 |
| mice atopic sensitization | #1 |
| 95 late introduction | #1 |
| domestic child child | #1 |
| allergies endotoxin | #1 |
| phase international | #1 |
| microbial exposure sum | #1 |
| tregs life | #1 |
| atopy interactions | #1 |
| visible mold homes | #1 |
| microorganisms animal sheds | #1 |
| increased food diversity | #1 |
| life antibiotic exposure | #1 |
| aetiology early years | #1 |
| infant inflammation crp | #1 |
| snps wheeze | #1 |
| aetiology atopic disease | #1 |
| farming children | #1 |
| farm rural children | #1 |
| th2 th1 gsdma | #1 |
| aa increased atp2a3 | #1 |
| asthma dresden | #1 |
| igg4 ige expression | #1 |
| farming exposure childhood | #1 |
| actinomycetes peak | #1 |
| 95 atopic sensitization | #1 |
| participants solar | #1 |
| association farm | #1 |
| males pierced ears | #1 |
| feeding patterns risk | #1 |
| grass pollen 95 | #1 |
| south bavarian population | #1 |
| complementary food year | #1 |
| package functionality | #1 |
| lower atopy asthma | #1 |
| juvenile crohn disease | #1 |
| asthma symptoms community | #1 |
| environmental exposures asthma | #1 |
| wheezing atopic sensitization | #1 |
| endotoxin levels stables | #1 |
| prediction farm children | #1 |
| farm milk asthma | #1 |
| lukas2 birth cohorts | #1 |
| allergic germany | #1 |
| cowsheds cattle | #1 |
| immune responses birth | #1 |
| munich dresden | #1 |
| hyperreactivity expiratory volume | #1 |
| farm wheeze phenotypes | #1 |
| parsifal‐study | #1 |
| tbx21 hlx1 | #1 |
| participation rates phase | #1 |
| development allergies | #1 |
| tcells foxp3 | #1 |
| 13 microbial influences | #1 |
| ilcs inception | #1 |
| pasture cohort | #1 |
| personal cleanliness | #1 |
| expression 17q21 | #1 |
| loft farm milk | #1 |
| higher hscrp values | #1 |
| otus farming | #1 |
| tbx21 | #1 |
| offspring atopic mothers | #1 |
| stable dust extract | #1 |
| endotoxin allergy | #1 |
| wheeze environmental determinants | #1 |
| censored immunological | #1 |
| exposure muramic | #1 |
| ppg lpa ppg | #1 |
| rora susceptibility gene | #1 |
| jobs potential confounders | #1 |
| children predominant hyperreactivity | #1 |
| provocation time | #1 |
| new onset wheeze | #1 |
| asthma 105 years | #1 |
| dust parameters development | #1 |
| breastfeeding length | #1 |
| girls allergic rhinitis | #1 |
| puberty infant | #1 |
| no2 traffic counts | #1 |
| personal cleanliness risk | #1 |
| farm exposure igg4 | #1 |
| 18 95 incidence | #1 |
| excessive sige production | #1 |
| farm living | #1 |
| lpa ppg stimulation | #1 |
| atopy microbial influences | #1 |
| late introduction solids | #1 |
| expiratory volume lca | #1 |
| farming allergies | #1 |
| school university life | #1 |
| 035 iu sige | #1 |
| pcr sscp method | #1 |
| alliance asthma | #1 |
| epidemiologic phenotype | #1 |
| farm nonfarm children | #1 |
| infant genetic polymorphism | #1 |
| asthmatics innate leukocytes | #1 |
| asthma west germany | #1 |
| 6 types cheese | #1 |
| allergies viral infections | #1 |
| nickel allergy asthma | #1 |
| health services exposure | #1 |
| 28 dust samples | #1 |
| 1120 german schoolchildren | #1 |
| computing microbial associations | #1 |
| early life insight | #1 |
| allergic illnesses | #1 |
| barns farm dwellings | #1 |
| features anthroposophic lifestyle | #1 |
| maternal atopy tregs | #1 |
| network construction comparison | #1 |
| gel variations gels | #1 |
| seasonal rural | #1 |
| employment new onset | #1 |
| allergen exposure associations | #1 |
| psychosocial characteristics asthma | #1 |
| agreement spts | #1 |
| auc spt | #1 |
| wheeze active smoking | #1 |
| childhood allergy children | #1 |
| asthma risk pasture | #1 |
| immunity innate infant | #1 |
| swinesheds | #1 |
| isolated cd4cd25hi tregs | #1 |
| overweight marked differences | #1 |
| paediatric origins | #1 |
| pollen dairy farms | #1 |
| repeated episodes fever | #1 |
| 2nd followup challenges | #1 |
| farm fungi humans | #1 |
| prenatal animal | #1 |
| immunity newborn mothers | #1 |
| occurrence allergy | #1 |
| protective childhood | #1 |
| indoor microbiota development | #1 |
| farm children microorganisms | #1 |
| farm animal exposure | #1 |
| protective exposures | #1 |
| score total quantity | #1 |
| “atopic march | #1 |
| genetic interaction npsr1 | #1 |
| germany dresden | #1 |
| nct02496468 | #1 |
| atopic dermatitis increase | #1 |
| 17q21 polymorphisms ormdl3 | #1 |
| incidence indoor allergens | #1 |
| wheezerelated latent classes | #1 |
| allergic asthmatics asthmatics | #1 |
| 95 hormonal contraceptives | #1 |
| exposure farming environment | #1 |
| birth tbx21 | #1 |
| allergic rhinitis childhood | #1 |
| farming protective farm | #1 |
| 57 911yearold children | #1 |
| gene expression ilt4 | #1 |
| 26 farms bavaria | #1 |
| predominant hyperreactivity subsample | #1 |
| cla content plasma | #1 |
| initial cohort pattern | #1 |
| asthma risk class | #1 |
| age dust microbiota | #1 |
| regular farm animal | #1 |
| egg positive sensitization | #1 |
| airborne moulds actinomycetes | #1 |
| clinical examinations challenges | #1 |
| male parents receptors | #1 |
| introduction yogurt | #1 |
| endotoxin levels samples | #1 |
| risk gene asthma | #1 |
| protection hygiene hypothesis | #1 |
| association incident rhinoconjunctivitis | #1 |
| allergic sensitization latex | #1 |
| moderate‐to‐adequate | #1 |
| gpra gene | #1 |
| children alliance asthma | #1 |
| isaac phase data | #1 |
| immune responsiveness life | #1 |
| lower atopic sensitization | #1 |
| data netcomi | #1 |
| childhood gondii seropositivity | #1 |
| rora asthma susceptibility | #1 |
| allergy prevention studies | #1 |
| development asthma | #1 |
| asthma protective | #1 |
| coupled receptor polymorphisms | #1 |
| feeding overweight | #1 |
| living environment children | #1 |
| phenotype health variables | #1 |
| fever milk consumption | #1 |
| genetic association tnc | #1 |
| neonatal immune mechanisms | #1 |
| multicenter cohort prevalence | #1 |
| bacterial exposures associations | #1 |
| mold problems children | #1 |
| 812 children | #1 |
| asthma consumption | #1 |
| allergies childhood phase | #1 |
| late introduction egg | #1 |
| preschool dermatitis questionnaires | #1 |
| food diversity year | #1 |
| lukas2 umc | #1 |
| followup solar iii | #1 |
| spts specific ige | #1 |
| wheezing invertedu shape | #1 |
| yogurt cows milk | #1 |
| pollen concentration feeding | #1 |
| protective mechanisms asthma | #1 |
| menarche allergic rhinitis | #1 |
| unprocessed farm milk | #1 |
| hygiene hypothesis endotoxin | #1 |
| protective effects asthma | #1 |
| il4ra association | #1 |
| analyses isaac phase | #1 |
| domestic asthma child | #1 |
| igg1 galactosylation levels | #1 |
| diversity protective effects | #1 |
| asthmaprotective farm | #1 |
| supplementation milk cla | #1 |
| associations dna fingerprinting | #1 |
| ormdl3 gsdma expression | #1 |
| asthmatics asthma phenotypes | #1 |
| children preschool conjunctivitis | #1 |
| studies microbial exposures | #1 |
| children 7 yrs | #1 |
| maternal atopy secretion | #1 |
| lumbricoides crude measure | #1 |
| pet contact infancy | #1 |
| pasture study spt | #1 |
| bronchial hyperreactivity age | #1 |
| persistence allergic rhinitis | #1 |
| wheezing fever | #1 |
| aa immunity receptors | #1 |
| development atopic sensitisation | #1 |
| pasture lukas2 | #1 |
| derp1lpa | #1 |
| rs11071559 | #1 |
| followup work discontent | #1 |
| protective farming | #1 |
| maternal farming activities | #1 |
| associations indoor mould | #1 |
| childhood dampness | #1 |
| 30 amish | #1 |
| acrossolar study | #1 |
| association haplotype studies | #1 |
| farm milk exposure | #1 |
| common infections infants | #1 |
| coexpression igg1 | #1 |
| diversity consumed types | #1 |
| peak airborne moulds | #1 |
| environmental exposures protection | #1 |
| observing children | #1 |
| reduced risk allergy | #1 |
| tubes rnastabilizing solution | #1 |
| allergic diseases hrqol | #1 |
| specific exposures cows | #1 |
| cough soot | #1 |
| increased risks rhinoconjunctivitis | #1 |
| aor farm exposures | #1 |
| allergies protective pet | #1 |
| factors th1 | #1 |
| pets associations | #1 |
| exposure farm | #1 |
| 3785 adolescents | #1 |
| recurrent unremitting wheeze | #1 |
| prenatal animal contact | #1 |
| npsr1 messenger receptors | #1 |
| 95 puberty | #1 |
| preschool children rhinitis | #1 |
| agriculture asthma | #1 |
| fever atopic | #1 |
| exposure protective | #1 |
| lumbricoides farmers children | #1 |
| cattle childrens bedrooms | #1 |
| 95 allergen | #1 |
| ilt4 cord blood | #1 |
| 457 iu | #1 |
| protective asthma | #1 |
| atopic sensitization development | #1 |
| allergic diseases cutoff | #1 |
| preschool wheezing aor | #1 |
| airborne fungi actinomycetes | #1 |
| microbial exposure endotoxin | #1 |
| children leipzig | #1 |
| atopic smokers baseline | #1 |
| gabriel study | #1 |
| wheeze bronchial | #1 |
| life protective | #1 |
| netcomi network | #1 |
| antipyretics reduced risk | #1 |
| 115 iu | #1 |
| latent classes populations | #1 |
| carriers hlx1 | #1 |
| tnc risk gene | #1 |
| advanced surveys | #1 |
| children atopic sensitization | #1 |
| child environmental pollutants | #1 |
| str bhr | #1 |
| messenger surveys | #1 |
| asthmatics hc | #1 |
| wheeze farm living | #1 |
| study prehireonset | #1 |
| farmrelated exposures | #1 |
| model hyperreactivity | #1 |
| asthma farm children | #1 |
| farm dwellings homes | #1 |
| asthma arabinogalactan | #1 |
| bhr fall | #1 |
| protective factors strategies | #1 |
| tbx21 hlx1 snps | #1 |
| gabriel advanced surveys | #1 |
| common inhalants | #1 |
| exposure farm children | #1 |
| dairying environment pollen | #1 |
| age bacterial endotoxin | #1 |
| risk mite sensitization | #1 |
| farm milk consumption | #1 |
| endotoxin exposure association | #1 |
| predictor igg1 galactosylation | #1 |
| solar cohort | #1 |
| jia domestic arthritis | #1 |
| wheeze classes | #1 |
| crowding dry cough | #1 |
| wheezing 3rd year | #1 |
| asthma microbiome analysis | #1 |
| alpine farms | #1 |
| dresden east germany | #1 |
| farm lung function | #1 |
| farm animals cats | #1 |
| children early phenotypes | #1 |
| cd4cd25hi tcells | #1 |
| farm fever | #1 |
| pasture study tubes | #1 |
| associations maternal sensitization | #1 |
| 95 nonatopic asthma | #1 |
| allergic rhinitis predictor | #1 |
| milk asthma | #1 |
| persistence adolescence | #1 |
| authors grass arabinogalactans | #1 |
| hc aa | #1 |
| epidemiologic phenotypes | #1 |
| recurrence atopic dermatitis | #1 |
| farm lifestyles | #1 |
| lower prevalence asthma | #1 |
| aa nonallergic asthma | #1 |
| arabinogalactan cde | #1 |
| unpasteurized cows milk | #1 |
| traditional upbringing | #1 |
| food allergy yogurt | #1 |
| class pasture | #1 |
| asthmatic farm children | #1 |
| unbalanced meat consumption | #1 |
| increased expression ormdl3 | #1 |
| bhr asthma child | #1 |
| protective cheese consumption | #1 |
| soot benzene | #1 |
| allergies cohort studies | #1 |
| animal contact infancy | #1 |
| eczema regions | #1 |
| microorganisms farms | #1 |
| rural allergy endotoxin | #1 |
| farming nasal samples | #1 |
| hlx1 snps cbmcs | #1 |
| associations transient sensitization | #1 |
| tregs asthmatics | #1 |
| farm homes homes | #1 |
| spts agreement | #1 |
| boys fever | #1 |
| prediction quality snps | #1 |
| parents allergies | #1 |
| phase isaac programme | #1 |
| 9 bronchodilators | #1 |
| rora snps | #1 |
| mite sensitization aor | #1 |
| risk hutterite children | #1 |
| consumption asthma | #1 |
| children isaac asthma | #1 |
| epidemiological evidence consumption | #1 |
| copd sod3 | #1 |
| atopic sensitization early | #1 |
| skin tests spt | #1 |
| prenatal farm | #1 |
| health influential factors | #1 |
| asthma interactions | #1 |
| potential confounders jobs | #1 |
| followup farm living | #1 |
| followup solar | #1 |
| innate immunity receptors | #1 |
| spink5 kazal type | #1 |
| oropharyngeal microbiota children | #1 |
| allergyprotective potential | #1 |
| chapter 16 epidemiology | #1 |
| childhood protective | #1 |
| crobiome data | #1 |
| farm dairy products | #1 |
| stepwise procedure risk | #1 |
| blood ormdl3 | #1 |
| farm allergic rhinitis | #1 |
| health urbanrural differences | #1 |
| stepwise procedure gene | #1 |
| 1 year occurrence | #1 |
| environmental factors sensitization | #1 |
| exposures pieces | #1 |
| patients neutrophil inflammation | #1 |
| 95 asthmatic children | #1 |
| cumulative incidence finland | #1 |
| asthma wisc | #1 |
| farm animals childhood | #1 |
| 420lys | #1 |
| hlx1 polymorphisms influence | #1 |
| subsample predominant obstruction | #1 |
| farm specific exposures | #1 |
| rs2738751 | #1 |
| 45yearold children protection | #1 |
| cleanliness matter | #1 |
| humans hypopharynx moraxella | #1 |
| annual concentrations benzene | #1 |
| childhood design | #1 |
| dermatitis depending | #1 |
| tregs cd4cd25hi | #1 |
| selection bias responders | #1 |
| infant adolescent aging | #1 |
| development allergic illnesses | #1 |
| provocation time bhr | #1 |
| symptoms school age | #1 |
| failure☆ | #1 |
| transient wheeze age | #1 |
| interaction rora | #1 |
| hrqol farm children | #1 |
| lca clinical phenotypes | #1 |
| cowsheds childrens bedrooms | #1 |
| wheezing w12 | #1 |
| fever farm | #1 |
| allergic rhinitis menarche | #1 |
| npsr1 interaction | #1 |
| regulatory triggering receptor | #1 |
| estonia environmental differences | #1 |
| tnc asthma | #1 |
| dgge health outcomes | #1 |
| fever spt cutoff | #1 |
| fever blood samples | #1 |
| npsr1 rora | #1 |
| allergies early phenotypes | #1 |
| allergic rhinitis jia | #1 |
| cla allergoprotective capacity | #1 |
| th2related genes | #1 |
| 1133 children | #1 |
| tnc npsr1 | #1 |
| incident wheezing asthma | #1 |
| dairy products protective | #1 |
| german peers | #1 |
| 5 years aor | #1 |
| pets crowding | #1 |
| increased risk rhinoconjunctivitis | #1 |
| identified polymorphisms asthma | #1 |
| children beta 2agonists | #1 |
| milkassociated cla | #1 |
| methods 2nd followup | #1 |
| allergies generations | #1 |
| male saline solution | #1 |
| farm protects | #1 |
| usage preventive measures | #1 |
| allergic diseases questionnaires | #1 |
| diseases farm | #1 |
| “hygiene hypothesis | #1 |
| comparison microbiome data | #1 |
| increased prevalence cough | #1 |
| accuracy regression approach | #1 |
| maschildren | #1 |
| mold problems kitchen | #1 |
| cde source | #1 |
| treatment 9 bronchodilators | #1 |
| association farm milk | #1 |
| respiratory sounds immunity | #1 |
| animal sheds 28 | #1 |
| grass arabinogalactan mice | #1 |
| rora neuropeptide receptor | #1 |
| pets farm animals | #1 |
| allergy‐protective effects | #1 |
| phenotypes atopic sensitization | #1 |
| contact farm | #1 |
| dampness childhood | #1 |
| 1120 children | #1 |
| regression approach order | #1 |
| atopic eczema 95 | #1 |
| atopy rural subjects | #1 |
| asthma bacterial diversity | #1 |
| anti‐asthmatic drugs | #1 |
| alpine farm environments | #1 |
| consumption farm milk | #1 |
| life inversely | #1 |
| histamine challenges age | #1 |
| infections hygiene hypothesis | #1 |
| sige association | #1 |
| protective farm asthma | #1 |
| atopic sensitisation fever | #1 |
| ormdl3 gasdermin | #1 |
| non‐farm children | #1 |
| overweight munich | #1 |
| leur relation | #1 |
| otitis fever | #1 |
| bactoscan | #1 |
| children rural allergy | #1 |
| children farmers | #1 |
| current asthma age | #1 |
| clec4e aa | #1 |
| bronchial obstruction hyperreactivity | #1 |
| external microbial | #1 |
| followup solar cohort | #1 |
| germany breast feeding | #1 |
| acrossolar | #1 |
| protection asthma | #1 |
| fever atopic dermatitis | #1 |
| exposure gstm1 deficiency | #1 |
| ddhay fever children | #1 |
| lpastimulation cord blood | #1 |
| atopy farm | #1 |
| current asthma soot | #1 |
| allergies cohort | #1 |
| asthma rhinoconjunctivitis eczema | #1 |
| sige sensitizations symptoms | #1 |
| west germany munich | #1 |
| unremitting wheeze | #1 |
| allergy protective | #1 |
| life chronic asthma | #1 |
| protective diversity | #1 |
| life maternal atopy | #1 |
| methods solar cohort | #1 |
| infant contact animals | #1 |
| asthma richness | #1 |
| gasdermin gsdma | #1 |
| bronchial response wheeze | #1 |
| associations pet contact | #1 |
| rs11079788 | #1 |
| evidence allergy prevention | #1 |
| sensitised children wheeze | #1 |
| questionnaire responses asthma | #1 |
| school children germany | #1 |
| polysaccharides cde | #1 |
| 035 iu specificity | #1 |
| interaction npsr1 protein | #1 |
| interquartile range asthma | #1 |
| work overload school | #1 |
| epigenetic regulation mechanism | #1 |
| validity food questionnaire | #1 |
| wheeze sensitisation | #1 |
| managing wheezing | #1 |
| mattress dust association | #1 |
| overweight dresden | #1 |
| benzene current wheeze | #1 |
| coding region il4ra | #1 |
| barns samples | #1 |
| newborn leukocytes surveys | #1 |
| new microscope | #1 |
| il13cd4 cells ilcs | #1 |
| solids development | #1 |
| 17q21 polymorphisms | #1 |
| germany allergic | #1 |
| diversity microbial exposure | #1 |
| anthroposophic families validity | #1 |
| identification immune phenotypes | #1 |
| classical definitions lca | #1 |
| mold immune responsiveness | #1 |
| solar 2nd followup | #1 |
| gabriel advanced study | #1 |
| unprocessed cow | #1 |
| doctor allergic rhinitis | #1 |
| obstruktive atemwegserkrankungen | #1 |
| allergyrisk factors | #1 |
| atopic sensitization birth | #1 |
| phenotypes atopic | #1 |
| atopic dermatitis onset | #1 |
| amish environment | #1 |
| children amish farms | #1 |
| helminths protective | #1 |
| wheezing male respiratory | #1 |
| allergoprotective | #1 |
| association occupational disinfectants | #1 |
| immune stimulation life | #1 |
| lca pasture | #1 |
| asthma rora | #1 |
| predominant obstruction | #1 |
| 048 95 95 | #1 |
| tenascin neuropeptide receptor | #1 |
| microbiome data package | #1 |
| current contact asthma | #1 |
| wheeze farming exposure | #1 |
| tregs maternal atopy | #1 |
| quantitative confirmation associations | #1 |
| allergies year | #1 |
| development childhood asthma | #1 |
| 1 ppg stimulation | #1 |
| study rural environment | #1 |
| pierced ears association | #1 |
| late onset menarche | #1 |
| atopic diseases association | #1 |
| 95 agmr | #1 |
| pattern atopic sensitization | #1 |
| work ilc2s | #1 |
| ascaris lumbricoides exposure | #1 |
| farming environment protective | #1 |
| ddhay fever | #1 |
| asthma turkish | #1 |
| source arabinogalactan | #1 |
| hyperreaktivität | #1 |
| adolescent aging asthma | #1 |
| preventive measures counselling | #1 |
| protective effects exposure | #1 |
| farm animals asthma | #1 |
| sensitisation early | #1 |
| hrqol rural farm | #1 |
| polymorphisms lps recognition | #1 |
| antipyretics increased risk | #1 |
| early phenotypes age | #1 |
| farm children hrqol | #1 |
| environments asthma | #1 |
| unifying computational tool | #1 |
| phase stratified sample | #1 |
| age asthma child | #1 |
| th2related genes cytokines | #1 |
| maternal farm | #1 |
| topic puberty rhinitis | #1 |
| edta tubes countries | #1 |
| selfreported nickel allergy | #1 |
| increased atp2a3 fpr2 | #1 |
| marked differences prevalence | #1 |
| children severe atopy | #1 |
| netcomi functionality | #1 |
| netcomi | #1 |
| cowshed dust cde | #1 |
| farm farm children | #1 |
| south bavarian | #1 |
| 168fold | #1 |
| lps recognition development | #1 |
| heating children | #1 |
| prevalence atopic sensitisation | #1 |
| gene expression ormdl3 | #1 |
| linens child dust | #1 |
| gsdma phytohemagglutinin | #1 |
| shop milk | #1 |
| spink5 420lys | #1 |
| atopic embryonic | #1 |
| living area risk | #1 |
| tregs foxp3 demethylation | #1 |
| consumption allergic | #1 |
| patients treg cells | #1 |
| kazal type spink5 | #1 |
| childhood asthma age | #1 |
| hyperreactive children | #1 |
| cε germline transcript | #1 |
| single taxa groups | #1 |
| damage systemic inflammation | #1 |
| cowsheds farm animals | #1 |
| asthmatic children result | #1 |
| allergen exposure age | #1 |
| adolescence bronchial hyperreactivity | #1 |
| treatment childhood asthma | #1 |
| persistence earlylife exposures | #1 |
| aor interquartile range | #1 |
| asthma toll | #1 |
| 95 atopic eczema | #1 |
| infancy jia | #1 |
| ilcs administration | #1 |
| asthma puberty | #1 |
| early age risk | #1 |
| children amish children | #1 |
| igg4 coexpression | #1 |
| richness asthma | #1 |
| lpastimulation carriers | #1 |
| microbes epigenetic mechanisms | #1 |
| moisture mold exposure | #1 |
| bronchial hyperreactivity adolescence | #1 |
| allergies respiratory infections | #1 |
| throat microbiota | #1 |
| exposure mattress dust | #1 |
| demethylation foxp3 demethylation | #1 |
| logistic models npsr1 | #1 |
| 1314 newborn infants | #1 |
| solar iii | #1 |
| city air pollution | #1 |
| childhood asthma allergies | #1 |
| association ilt4 | #1 |
| rural children w12 | #1 |
| atopic disease bias | #1 |
| dampness bronchial hyperreactivity | #1 |
| maternal farming | #1 |
| gpra polymorphisms asthma | #1 |
| farm asthma | #1 |
| ahr acinetobacter lwoffii | #1 |
| menarche hormonal | #1 |
| 95 endotoxin exposure | #1 |
| seasonal allergens | #1 |
| study parsifal | #1 |
| microbial exposure asthma | #1 |
| asthma food sensitization | #1 |
| association farm contact | #1 |
| dzl | #1 |
| wheezing children wheezing | #1 |
| environmental differences finland | #1 |
| bacterial groups prevalence | #1 |
| persistence bronchial hyperreactivity | #1 |
| paper online questionnaires | #1 |
| mold subclinical inflammation | #1 |
| east germany allergic | #1 |
| protection childhood asthma | #1 |
| farming environment role | #1 |
| groups netcomi | #1 |
| changing gender ratio | #1 |
| agents reduced risk | #1 |
| 9 10yold children | #1 |
| incident wheezing women | #1 |
| children acrossolar cohort | #1 |
| role th2 immunity | #1 |
| work overload followup | #1 |
| kitchen living area | #1 |
| children diabimmune study | #1 |
| phenotypes lca | #1 |
| stepwise protocol phase | #1 |
| asthma german | #1 |
| bronchial hyperreactivity childhood | #1 |
| 5–13‐year school children | #1 |
| antibiotics allergies | #1 |
| year environmental exposures | #1 |
| association spink5 420lys | #1 |
| europe protection | #1 |
| phytohemagglutinin ormdl3 | #1 |
| atopic sensitization aor | #1 |
| yoghurt asthma risk | #1 |
| associations hscrp values | #1 |
| network construction netcomi | #1 |
| asthma symptoms adolescence | #1 |
| allergies topic surveys | #1 |
| perinatal influences | #1 |
| asthma tregs | #1 |
| antiasthma drugs children | #1 |
| helminth parasites exposure | #1 |
| aa clec4e | #1 |
| farmingrelated exposures | #1 |
| asthma concomitant bhr | #1 |
| rhinoconjunctivitis sex | #1 |
| 7 yrs determinants | #1 |
| mrna expression tregs | #1 |
| protective effects diversity | #1 |
| solar study | #1 |
| h4 acetylation offspring | #1 |
| adolescents jobs | #1 |
| farms wheeze | #1 |
| physiciandiagnosed asthma groups | #1 |
| lps foxp3 demethylation | #1 |
| analysis step package | #1 |
| single microbial markers | #1 |
| age increased diversity | #1 |
| repeated infections life | #1 |
| 624 children | #1 |
| kitchen visible mold | #1 |
| igg1 galactosylation predictor | #1 |
| bhr str | #1 |
| moisture damage kitchen | #1 |
| farmers nonfarmers children | #1 |
| protective atopic sensitization | #1 |
| fpr2 clec4e | #1 |
| crohns disease atopy | #1 |
| environments pasture | #1 |
| protective 6 years | #1 |
| 911 yrs | #1 |
| cd4cd25hi isolated cells | #1 |
| girls mechanism | #1 |
| farm environments farms | #1 |
| asthma allergies | #1 |
| farm cowsheds | #1 |
| asthma risk lca | #1 |
| grass arabinogalactan | #1 |
| farm living symptoms | #1 |
| gsdma expression | #1 |
| bronchial hyperreactivity wheezing | #1 |
| munich leipzig | #1 |
| data fetal growth | #1 |
| neonatal mice ahr | #1 |
| childhood bronchial hyperreactivity | #1 |
| 17q21 locus method | #1 |
| farm milk | #1 |
| igein | #1 |
| foxp3 demethylation tregs | #1 |
| bifidobacterium breastfed infants | #1 |
| cohorte pasture | #1 |
| muramic acid wheezing | #1 |
| solids relation | #1 |
| environmental microbial | #1 |
| asthma diversity | #1 |
| farming asthma | #1 |
| farming environments asthma | #1 |
| harmful workplace exposure | #1 |
| infants karelia | #1 |
| normal censored | #1 |
| early development wheeze | #1 |
| pasture cohort lca | #1 |
| environmental exposure age | #1 |
| stepwise protocol bhr | #1 |
| indoor bacterial microbiota | #1 |
| pierced ears asthma | #1 |
| microbial exposure patterns | #1 |
| 17q21 risk | #1 |
| farm indoor | #1 |
| west germany allergic | #1 |
| children road traffic | #1 |
| generations birth cohort | #1 |
| stimulation 45yearold children | #1 |
| tempo method | #1 |
| cleanliness dust parameters | #1 |
| unprocessed cows milk | #1 |
| agreement association | #1 |
| 5 years predictor | #1 |
| influential factors phenotype | #1 |
| cbmcs ormdl3 | #1 |
| tolllike receptor farmers | #1 |
| allergic rhinitis puberty | #1 |
| risk tcell phenotypes | #1 |
| domestic cats child | #1 |
| gene expression ilt3 | #1 |
| tobit regression ranks | #1 |
| foxp3 cd4cd25hi | #1 |
| rs7164773 | #1 |
| farm dwellings children | #1 |
| worldwide asthma epidemic | #1 |
| asthma indoor exposure | #1 |
| leipzig munich | #1 |
| subtypes atopic dermatitis | #1 |
| 585883 | #1 |
| countries isaac phase | #1 |
| asthma turkish children | #1 |
| predictive models incidence | #1 |
| actinomycetes alpine farms | #1 |
| netcomi network construction | #1 |
| regular farm | #1 |
| asthma asthma bacteria | #1 |
| development atopic diseases | #2 |
| bronchial hyperresponsiveness allergic | #2 |
| lifelong farm exposure | #2 |
| arg130gln polymorphism linkage | #2 |
| allergen levels socks | #2 |
| cd4cd25hi foxp3 | #2 |
| munich participants | #2 |
| exposure life | #2 |
| fev1 fdr | #2 |
| amish hutterite homes | #2 |
| ages current paracetamol | #2 |
| data maternal weight | #2 |
| traditional farm | #2 |
| studies farms | #2 |
| farm milk pregnancy | #2 |
| pha farming mothers | #2 |
| interval156 | #2 |
| dust samples levels | #2 |
| animal sheds pregnancy | #2 |
| protein rhinitis allergic | #2 |
| prenatal farm exposure | #2 |
| collected dust indoor | #2 |
| dairying eczema | #2 |
| life increased risk | #2 |
| strachan | #2 |
| cd14 maternal exposures | #2 |
| allele specific ige | #2 |
| t2inflammation | #2 |
| rhinitis adolescents | #2 |
| lower atopy | #2 |
| asthmaassociated aor | #2 |
| rora asthma | #2 |
| beta1 endotoxin | #2 |
| doctors diagnosis aor | #2 |
| nocturnal asthma severity | #2 |
| low sensitization rates | #2 |
| maternal immunity gondii | #2 |
| adaptor protein rhinitis | #2 |
| socks alk samples | #2 |
| serum levels c4ma3 | #2 |
| followup university | #2 |
| peptidoglycan ppg | #2 |
| eczema conjunctivitis eczema | #2 |
| bronchial hyperresponsiveness children | #2 |
| exposure farmers children | #2 |
| hc ca2 | #2 |
| fdr clinical response | #2 |
| symptom control pa | #2 |
| alk samples | #2 |
| highdna | #2 |
| healthcare precision medicine | #2 |
| neu5gc role | #2 |
| association atopic children | #2 |
| influences development | #2 |
| nocturnal symptoms spirometry | #2 |
| farms reference | #2 |
| dresden higher greenness | #2 |
| phase prevalence rates | #2 |
| asthma symptoms fever | #2 |
| sensitized patients order | #2 |
| ga²len harmonization | #2 |
| atopic dermatitis childhood | #2 |
| farming families allergies | #2 |
| early immune maturation | #2 |
| neu5gc exposure | #2 |
| antit2 biological therapy | #2 |
| inflammatory diseases allergy | #2 |
| associations atopy | #2 |
| frequency nocturnal symptoms | #2 |
| antibiotic asthma risk | #2 |
| maternal contact protective | #2 |
| asthma cohort | #2 |
| sensitization patterns inhalant | #2 |
| atopic sensitization 14 | #2 |
| symptom control bmi | #2 |
| il4 gene | #2 |
| children bronchial obstruction | #2 |
| role helminths | #2 |
| isaac atopic eczema | #2 |
| messenger receptors tenascin | #2 |
| ifnγ levels snps | #2 |
| nonfarming mothers lipid | #2 |
| association allergic diseases | #2 |
| eczema farmers children | #2 |
| microbial exposure risk | #2 |
| fev1 score associations | #2 |
| allergic rhinitis adolescence | #2 |
| atopic eczema causation | #2 |
| th17 lineage markers | #2 |
| 95 school level | #2 |
| human microbiota asthma | #2 |
| dander artemisia | #2 |
| children bronchial hyperresponsiveness | #2 |
| lipid ppg | #2 |
| geneenvironment interactions asthma | #2 |
| 95 protective factors | #2 |
| life rural children | #2 |
| cd14 1721 | #2 |
| 14 260 | #2 |
| il13 gene linkage | #2 |
| card4 21596 | #2 |
| atopic eczema phenotypes | #2 |
| allergies cd14 expression | #2 |
| positive maternal record | #2 |
| farming exposure | #2 |
| asthma meeting | #2 |
| current interpretation | #2 |
| environmental microorganisms | #2 |
| increase worldwide | #2 |
| th2 cytokines ilc2s | #2 |
| sod3 transcript | #2 |
| exposures farm | #2 |
| increased risk employment | #2 |
| higher greenness quartile | #2 |
| allergic diseases allergies | #2 |
| doctors diagnosed asthma | #2 |
| nonfarming families | #2 |
| parent asthma | #2 |
| breathomics asthma | #2 |
| asthma adolescence | #2 |
| 19th century allergic | #2 |
| gmcsf ifnγ levels | #2 |
| fieldworkers absolute levels | #2 |
| school level 95 | #2 |
| card4 association | #2 |
| consumption farm | #2 |
| test inhalent | #2 |
| coaacetate | #2 |
| expression innate | #2 |
| current paracetamol 95 | #2 |
| influence cord | #2 |
| allergic disorders children | #2 |
| agmr 95 | #2 |
| eczema farm exposures | #2 |
| farming mothers ppg | #2 |
| excessive edna production | #2 |
| difference endotoxin levels | #2 |
| severity spirometric measures | #2 |
| developing allergies | #2 |
| children dresden | #2 |
| subsample children | #2 |
| asthma parsifal | #2 |
| adult arm alliance | #2 |
| agriculture allergens | #2 |
| tbx21 gene | #2 |
| specificity lca | #2 |
| pha maternal farming | #2 |
| pa interrelations | #2 |
| standardized procedure centres | #2 |
| phase isaac | #2 |
| ages strongest associations | #2 |
| farming environment mother | #2 |
| consumption unprocessed | #2 |
| childhood obesoty | #2 |
| university baseline | #2 |
| association opposite direction | #2 |
| positive spt sige | #2 |
| polymorphisms il13 gene | #2 |
| farmers asthma symptoms | #2 |
| bronchial challenge children | #2 |
| children farm | #2 |
| bhr individual level | #2 |
| associations lessaffluent countries | #2 |
| farm children | #2 |
| protection allergy | #2 |
| nonfarm children | #2 |
| igg4 ige levels | #2 |
| age allergic rhinitis | #2 |
| childhood symptoms relapse | #2 |
| cd14 1721 association | #2 |
| highrisk predictors | #2 |
| atopy early life | #2 |
| milk cd14 | #2 |
| study design participation | #2 |
| atopic smokers | #2 |
| wheeze bronchial hyperresponsiveness | #2 |
| atopic developing countries | #2 |
| affluent countries centers | #2 |
| participants dresden | #2 |
| exposure farming | #2 |
| 645 children | #2 |
| improvements fdr score | #2 |
| protect development | #2 |
| newonset asthma symptoms | #2 |
| causation environmental associations | #2 |
| polymorphisms card4 | #2 |
| affluent countries | #2 |
| gels bands | #2 |
| children nonfarm homes | #2 |
| atopic diseases subjects | #2 |
| lipid lpa | #2 |
| eczema allergic dermatitis | #2 |
| childhood phase | #2 |
| nocturnal asthma life | #2 |
| microbial exposure study | #2 |
| endotoxin allergen exposure | #2 |
| pha th17 lineage | #2 |
| affluent countries eczema | #2 |
| time breastfed children | #2 |
| followup ndvi | #2 |
| quartile work discontent | #2 |
| antiidiotypic aspergillosis | #2 |
| improvements fdr | #2 |
| life current symptoms | #2 |
| c4ma3 asthma | #2 |
| asthma phenotypes negative | #2 |
| study participants fieldworkers | #2 |
| farmlike indoor microbiota | #2 |
| age asthma cohort | #2 |
| values edna concentrations | #2 |
| premature respiratory | #2 |
| eczema lessaffluent countries | #2 |
| lessaffluent countries | #2 |
| children affluent countries | #2 |
| foxp3 demethylation | #2 |
| asthma child dermatitis | #2 |
| immune responses function | #2 |
| fever west germany | #2 |
| eczema affluent | #2 |
| prediction asthma | #2 |
| bm190th | #2 |
| 047 95 gg | #2 |
| leipzig halle | #2 |
| tregs demethylation | #2 |
| microbial agents association | #2 |
| allergic asthma degradation | #2 |
| exposure environmental microorganisms | #2 |
| asthma crp | #2 |
| lessaffluent countries adolescents | #2 |
| onset male recurrence | #2 |
| probability incidence | #2 |
| fieldworkers dust collection | #2 |
| alternaria animals animals | #2 |
| atopic sensitization upregulation | #2 |
| new onset wheezing | #2 |
| levels alk samples | #2 |
| asthma symptoms eczema | #2 |
| indoor bacterial | #2 |
| asthma protection | #2 |
| associations hscrp levels | #2 |
| allele card4 21596 | #2 |
| snps il4 gene | #2 |
| asthmaassociated | #2 |
| microbial influences | #2 |
| pattern missing values | #2 |
| germany asthma | #2 |
| artemisia olive pollen | #2 |
| paracetamol fever | #2 |
| asthma hygiene hypothesis | #2 |
| immunoglobulin nod1 | #2 |
| alk samples fieldworkers | #2 |
| ppg pha | #2 |
| asthma symptoms children | #2 |
| siblings atopic children | #2 |
| tirana mumbai | #2 |
| atopic dermatitis wheeze | #2 |
| dust endotoxin allele | #2 |
| role maternal exposures | #2 |
| asthma control pa | #2 |
| cd14 genotypes asthma | #2 |
| environmental microbial exposure | #2 |
| living farms | #2 |
| consumption unpasteurized milk | #2 |
| cases objective measurements | #2 |
| relapse newonset | #2 |
| individual level bhr | #2 |
| current exposure cats | #2 |
| dendritic cells dust | #2 |
| il4 il13 pathway | #2 |
| 95 047 95 | #2 |
| th17 markers | #2 |
| allele cd14 1721 | #2 |
| early life prevalence | #2 |
| grass pollen dander | #2 |
| allergies genetic variation | #2 |
| study participants levels | #2 |
| 17q21 | #2 |
| cd14 1721 children | #2 |
| bronchial hyperresponsiveness exposure | #2 |
| wheeze 12 | #2 |
| ors affluent countries | #2 |
| relation dust endotoxin | #2 |
| increase parent | #2 |
| allergic tolllike receptor | #2 |
| bronchitis east germany | #2 |
| affluent countries associations | #2 |
| histamine challenges | #2 |
| pregnancy specific ige | #2 |
| fev1 fdr fdr | #2 |
| adult farmers role | #2 |
| frequency nocturnal asthma | #2 |
| farmers children children | #2 |
| multivariate analyses haying | #2 |
| environmental exposures mother | #2 |
| genetic variation card4 | #2 |
| severe exacerbations feno | #2 |
| socks dust | #2 |
| higher foxp3 | #2 |
| card4 protein rhinitis | #2 |
| snps inflammatory diseases | #2 |
| fieldworkers house dust | #2 |
| bhr tirana | #2 |
| processed cow | #2 |
| order sensitized patients | #2 |
| wheeze bronchial responsiveness | #2 |
| current symptoms asthmaassociated | #2 |
| imposed social isolation | #2 |
| work discontent | #2 |
| opposite direction children | #2 |
| childhood lca | #2 |
| environmental microorganisms children | #2 |
| life pvalues | #2 |
| farm animals symptoms | #2 |
| card4 21596 children | #2 |
| viable listeria spp | #2 |
| immunoglobulin analyses children | #2 |
| bhr west germany | #2 |
| cd4 cells offspring | #2 |
| immunoglobulin life | #2 |
| farming environment allergies | #2 |
| sputum extracellular | #2 |
| rna russia | #2 |
| hutterite farm children | #2 |
| eczema symptom prevalence | #2 |
| measles vaccination infection | #2 |
| allergies farming status | #2 |
| domestic child dust | #2 |
| nonfarm homes children | #2 |
| alliance ages | #2 |
| c4ma3 biomarker | #2 |
| parsifal study phenotypes | #2 |
| farming families | #2 |
| alk samples levels | #2 |
| isaac prevalence rates | #2 |
| negative volatile organic | #2 |
| antiige therapy response | #2 |
| asthma observed | #2 |
| tregs cord blood | #2 |
| south bavaria | #2 |
| demethylation foxp3 | #2 |
| farming anthroposophic | #2 |
| aa hc | #2 |
| bacteriological properties | #2 |
| olive pollen dander | #2 |
| interactions asthma | #2 |
| halle west germany | #2 |
| cats eczema | #2 |
| statistical analysis performance | #2 |
| animal exposure levels | #2 |
| farming nonfarming families | #2 |
| farmers child cross | #2 |
| amish farms | #2 |
| patients childhood symptoms | #2 |
| exposure lifestyle factors | #2 |
| questionnaires physical examination | #3 |
| atopic dermatitis aor | #3 |
| paf seasonal allergens | #3 |
| 9 mmp9 mmp9 | #3 |
| fever aor | #3 |
| network construction | #3 |
| forward initiative | #3 |
| populations illness surveys | #3 |
| asthma bordetella | #3 |
| c746t | #3 |
| allergic disequilibrium rhinitis | #3 |
| german children munich | #3 |
| g1258a | #3 |
| atopy dresden | #3 |
| asthma genetic severity | #3 |
| characteristics respiratory | #3 |
| 1q31 locus dennd1b | #3 |
| asthma snp rs2786098 | #3 |
| mmp9 variants risk | #3 |
| auc asthma | #3 |
| eczema international study | #3 |
| t12888c | #3 |
| asthma 1431c | #3 |
| munich polymorphism | #3 |
| atopic female germany | #3 |
| dennd1b asthma | #3 |
| today1 | #3 |
| paf sensitisation | #3 |
| hlx1 gene development | #3 |
| progeny asthma | #3 |
| food year | #3 |
| germany west german | #3 |
| life allergic diseases | #3 |
| endotoxin levels asthma | #3 |
| food correction | #3 |
| markers fetal growth | #3 |
| amino acid cx3cr1 | #3 |
| 53152 | #3 |
| bhr haplotypes humans | #3 |
| prevalence asthma | #3 |
| c39134a | #3 |
| sensitisation affluent countries | #3 |
| eczema isaac phase | #3 |
| dresden odds ratio | #3 |
| female fetus immunity | #3 |
| pcdh1 polymorphisms associations | #3 |
| farm contact | #3 |
| prenatal asthma protection | #3 |
| individual level questionnaires | #3 |
| farming farm | #3 |
| asthma farming environment | #3 |
| hygiene hypothesis | #3 |
| cx3cr1 polymorphisms polymorphism | #3 |
| rare tlr2 mutations | #3 |
| associations pcdh1 | #3 |
| protocadherin‐1 | #3 |
| vivo expression irf1 | #3 |
| role asthma prevalence | #3 |
| parent prevalence | #3 |
| wheeze allergy | #3 |
| population german | #3 |
| rural dwellings | #3 |
| f78 | #3 |
| organic waste storage | #3 |
| culture techniques study | #3 |
| current asthma rhinoconjunctivitis | #3 |
| 1q31 locus | #3 |
| protection contre | #3 |
| anthroposophic children | #3 |
| overweight germany | #3 |
| allergy a20 induction | #3 |
| eczema col29a1 | #3 |
| endotoxin milk | #3 |
| col29a1 polymorphisms | #3 |
| environmental dusts | #3 |
| col29a1 expression eczema | #3 |
| col29a1 genetic variants | #3 |
| rhinoconjunctivitis conjunctivitis | #3 |
| occurrence rhinitis | #3 |
| allergyprotective | #3 |
| 45yearold children | #3 |
| atopic mothers | #3 |
| onset asthma child | #3 |
| children bronchial hyperreactivity | #3 |
| asthma subphenotypes | #3 |
| il15 il15 associations | #3 |
| allergic asthmatics aa | #3 |
| children negative spts | #3 |
| asthma tolllike receptors | #3 |
| bias asthma bias | #3 |
| role adam33 polymorphisms | #3 |
| asthma protection progeny | #3 |
| asthma identified | #3 |
| animal sheds | #3 |
| conjunctivitis paf | #3 |
| t3085 | #3 |
| col29a1 polymorphisms susceptibility | #3 |
| c1407t | #3 |
| stat1 gene variations | #3 |
| nonatopic asthma 95ci | #3 |
| 1431c | #3 |
| substances protection | #3 |
| regular contact | #3 |
| hlx1 gene variants | #3 |
| genetic variation crth2 | #3 |
| rural areas europe | #3 |
| biomaterial collection | #3 |
| rhinoconjunctivitis paf | #3 |
| role atopic sensitization | #3 |
| adam33 polymorphisms asthma | #3 |
| sod3 variants | #3 |
| atopic sensitisation | #3 |
| polymorphisms hlx1 gene | #3 |
| jobrelated chronic stress | #3 |
| growing farm | #3 |
| severity moisture damage | #3 |
| polymorphisms gm csf | #3 |
| domestic asthma | #3 |
| prenatal protection | #3 |
| 1431c specific ige | #3 |
| ile117thr | #3 |
| il5 c746t | #3 |
| arabinogalactan isolated | #3 |
| asthma major | #3 |
| il15 gene asthma | #3 |
| c2892 | #3 |
| united kingdom albania | #3 |
| eczema strong association | #3 |
| duration prevalence | #3 |
| crude measure | #3 |
| cd14 association | #3 |
| experimental asthma progeny | #3 |
| breastfeeding overweight | #3 |
| cx3cr1 polymorphisms atopy | #3 |
| —study | #3 |
| farm animals farm | #3 |
| tlr2 polymorphisms | #3 |
| allergic diseases children | #3 |
| gni measurements | #3 |
| eosinophil pathway | #3 |
| farm dust endotoxin | #3 |
| doctors diagnosis | #3 |
| risk nonatopic asthma | #3 |
| bavaria obesity | #3 |
| protein rhinitis | #3 |
| hlx1 gene | #3 |
| protection development | #3 |
| endotoxin dust samples | #3 |
| dogs exposure | #3 |
| il5 c746 allergic | #3 |
| stat6 haplotype | #3 |
| eczema farmers | #3 |
| role neu5gc | #3 |
| locus dennd1b | #3 |
| col29a1 eczema | #3 |
| cowshed dust | #3 |
| farm dwellings | #3 |
| stat6 gene regulation | #3 |
| allergic phenotype polymorphism | #3 |
| persistent flexural eczema | #3 |
| lukas2 birth | #3 |
| il5 il5 c746 | #3 |
| pcdh1 asthma | #3 |
| crth2 influences development | #3 |
| children isaac phase | #3 |
| puberty risk factors | #3 |
| cohort alliance | #3 |
| col29a1 polymorphisms eczema | #3 |
| cytokine cluster bhr | #3 |
| disequilibrium rhinitis allergic | #3 |
| allergy protection | #3 |
| ppg expression | #3 |
| rhinitis increased risk | #3 |
| microorganisms dust | #3 |
| blood allergen | #3 |
| moraxella colonization | #3 |
| seasonal allergens atopy | #3 |
| tlr2 receptor function | #3 |
| paracetamol risk | #3 |
| dennd1b chromosome | #3 |
| young adult europe | #3 |
| allergic inflammation polymorphisms | #3 |
| hygiene hypothesis development | #3 |
| wheezing neutrophils | #3 |
| children african ancestry | #3 |
| maternal tlr | #3 |
| throat microbiota asthma | #3 |
| eosinophils matrix metalloproteinase | #3 |
| work work overload | #3 |
| col29a1 variants eczema | #3 |
| blatella | #3 |
| atopic diseases mutations | #3 |
| albania antibody specificity | #3 |
| increased treg cells | #3 |
| bhr pcdh1 polymorphisms | #3 |
| allergic phenotypes correction | #3 |
| european ancestry asthma | #3 |
| asthma pcdh1 | #3 |
| il15 associations | #3 |
| bacterial diversity asthma | #3 |
| eosinophil pathway genes | #3 |
| farms asthma | #3 |
| adam33 snps | #3 |
| cowshed dust extract | #3 |
| pcr sscp analysis | #3 |
| rhinoconjunctivitis atopic eczema | #3 |
| individual level centers | #3 |
| domestic arthritis | #3 |
| european science foundation | #3 |
| il15 gene variants | #3 |
| asthma atopic sensitization | #3 |
| bdnf polymorphisms asthma | #3 |
| monocytes lps stimulation | #3 |
| perennial allergens paf | #3 |
| atopic asthma effects | #3 |
| phase international study | #3 |
| prenatal protection asthma | #3 |
| dcs a20 induction | #3 |
| prevalence allergies | #3 |
| children farming | #3 |
| tlr2 amino acid | #3 |
| irf1 interferon expression | #3 |
| susceptibility col29a1 expression | #3 |
| treatment asthma phenotypes | #3 |
| life development | #3 |
| crosssectional population | #3 |
| nf kappa polymorphism | #3 |
| 95ci nonatopic asthma | #3 |
| gni rho | #3 |
| 3099 children | #3 |
| sige asthma | #3 |
| lwoffii f78 | #3 |
| 1000 enfants | #3 |
| paf allergic | #3 |
| ferme | #3 |
| farming status | #3 |
| countries endotoxin levels | #3 |
| mmp9 variants mmp9 | #3 |
| microbiota farm | #3 |
| asthma genetic association | #3 |
| responses innate | #3 |
| asthma amino acid | #3 |
| childhood asthma community | #3 |
| asthma cattle | #3 |
| asthma endotoxin levels | #3 |
| samples 1q31 locus | #3 |
| mmp9 influence development | #3 |
| 280met | #3 |
| sod3 extracellular matrix | #3 |
| effects single snps | #3 |
| affluent countries atopy | #3 |
| isaac polymorphisms | #3 |
| exposure helminths | #3 |
| putative functional role | #3 |
| protective farm | #3 |
| age 7–10 years | #3 |
| rare tlr2 | #4 |
| asthma 3 | #4 |
| cats pregnancy | #4 |
| birthcohort study | #4 |
| children maternal overweight | #4 |
| fever 17 | #4 |
| bacillus licheniformis spores | #4 |
| crp blood leukocytes | #4 |
| antibiotics antipyretics | #4 |
| genes il4r | #4 |
| dietary habits children | #4 |
| 5 13 years | #4 |
| parental allergic rhinitis | #4 |
| secretory receptors allergic | #4 |
| questionnaires eczema | #4 |
| dust personal | #4 |
| cough bronchitis | #4 |
| allergic diseases humans | #4 |
| indoor pollen | #4 |
| rs2786098 | #4 |
| high‐sensitivity c‐reactive protein | #4 |
| lukas2 | #4 |
| adult lung disease | #4 |
| environmental dust samples | #4 |
| environmental factors development | #4 |
| glu420lys | #4 |
| life childhood | #4 |
| study centers phase | #4 |
| cd4cd25hi tregs | #4 |
| 95 gene expression | #4 |
| allergic dermatitis allergic | #4 |
| gabriel advanced | #4 |
| allergies children | #4 |
| il4r tlr4 | #4 |
| prevalence random | #4 |
| german children bavaria | #4 |
| feeding prevalence | #4 |
| exposure cats | #4 |
| genetic rhinitis allergic | #4 |
| development atopic | #4 |
| wheezing onset | #4 |
| anthroposophic families | #4 |
| sas genetics | #4 |
| neonatal window | #4 |
| common sensitizations | #4 |
| heating prevalence | #4 |
| incident sensitization | #4 |
| tlr2 mutations | #4 |
| h20like homeobox | #4 |
| aetiology asthma | #4 |
| asthma auc | #4 |
| children farms | #4 |
| asthma symptoms association | #4 |
| particle boluses | #4 |
| pro27ser | #4 |
| parent odds ratio | #4 |
| cowsheds | #4 |
| promoter region arg130gln | #4 |
| participants fieldworkers | #4 |
| questionnaires populations | #4 |
| fever eczema | #4 |
| spt sige | #4 |
| development atopic sensitization | #4 |
| predictors visits | #4 |
| asthma current symptoms | #4 |
| eczema flg mutations | #4 |
| children munich | #4 |
| occupational allergy risks | #4 |
| late phenotype | #4 |
| agreement spt | #4 |
| asthma atopic diseases | #4 |
| asthma phenotype children | #4 |
| microbial compounds | #4 |
| increase eczema prevalence | #4 |
| atopic dermatitis birth | #4 |
| immunity receptors | #4 |
| groups taxa | #4 |
| gene expression receptors | #4 |
| children mattresses | #4 |
| benzene no2 | #4 |
| fatty acids allergic | #4 |
| childhood asthma | #4 |
| n2267 | #4 |
| fever year | #4 |
| genotypes cd14 | #4 |
| t2high asthma | #4 |
| ige levels associations | #4 |
| a20 induction | #4 |
| alliance cohort | #4 |
| mother role | #4 |
| asthma induction | #4 |
| risk factor symptoms | #4 |
| minimum battery | #4 |
| lower risk allergy | #4 |
| fetal growth asthma | #4 |
| col29a1 gene | #4 |
| current asthma bhr | #4 |
| flexural eczema | #4 |
| allergy international study | #4 |
| wheeze bhr | #4 |
| birth atopic dermatitis | #4 |
| prenatal asthma | #4 |
| asthma medication exposure | #4 |
| stables farm milk | #4 |
| microbes asthma | #4 |
| ilc2s human asthma | #4 |
| permanovas | #4 |
| east germany bhr | #4 |
| allergic ecuador eczema | #4 |
| nonfarming | #4 |
| adolescents duration | #4 |
| early life basis | #4 |
| initial data analysis | #4 |
| asthma hygiene | #4 |
| licheniformis spores | #4 |
| col29a1 expression | #4 |
| sounds rhinitis | #4 |
| cromolyns | #4 |
| candidate genes wheeze | #4 |
| phase 2 allergies | #4 |
| allergic il5 | #4 |
| lifetime prevalence asthma | #4 |
| tolllike receptors receptor | #4 |
| current symptoms asthma | #4 |
| occurrence atopic dermatitis | #4 |
| childhood protect | #4 |
| cord blood lipid | #4 |
| predictor wheezing | #4 |
| asthma snps | #4 |
| 99th dahlem conference | #4 |
| questionnaires adolescent eczema | #4 |
| human genetic nod1 | #4 |
| stable dust | #4 |
| exposure microbial | #4 |
| asthma symptoms adults | #4 |
| cheese consumption | #4 |
| inhalant patients | #4 |
| c746 | #4 |
| factors wheeze | #4 |
| doctors diagnosis asthma | #4 |
| lrti asthma | #4 |
| risk atopic dermatitis | #4 |
| leisure time activity | #4 |
| genetic nod1 | #4 |
| endotoxin relation | #4 |
| farm environment development | #4 |
| wheeze ige levels | #4 |
| eczema questionnaires adolescent | #4 |
| cx3cr1 polymorphisms | #4 |
| early identification atopy | #4 |
| infections early | #4 |
| flexural eczema strength | #5 |
| participation behaviour | #5 |
| linkage development | #5 |
| 2q14 | #5 |
| ige regulation | #5 |
| 2nd followup | #5 |
| west german children | #5 |
| pattern sensitization | #5 |
| jf1 msf | #5 |
| processing intensity | #5 |
| young adults methods | #5 |
| il13cd4 cells | #5 |
| trigger factors asthma | #5 |
| cd14 gene expression | #5 |
| genetic variants tbx21 | #5 |
| tbx21 combination | #5 |
| communitybased random sample | #5 |
| mmp9 influence | #5 |
| neu5gc mice | #5 |
| agriculture animals | #5 |
| nonfarmers children | #5 |
| c2892t | #5 |
| cats risk factor | #5 |
| tnc nps | #5 |
| milk exposure | #5 |
| atopic dermatitis age | #5 |
| mechanism environmental factors | #5 |
| combination hlx1 polymorphisms | #5 |
| ornonaffluent | #5 |
| atopic eczema allergic | #5 |
| duration jobs | #5 |
| tests bronchitis | #5 |
| nod1 variation | #5 |
| timing exposures | #5 |
| dresden | #5 |
| allergic rhinitis wheeze | #5 |
| cd4cd25hi | #5 |
| cow milk samples | #5 |
| farming mothers | #5 |
| 26 farms | #5 |
| moulds actinomycetes | #5 |
| milk consumption age | #5 |
| popular terms | #5 |
| 14452 | #5 |
| atopy flexural eczema | #5 |
| moisture mold problems | #5 |
| taxa groups | #5 |
| genetic asthma | #5 |
| visits predictors | #5 |
| rhinitis increase | #5 |
| combination hlx1 variants | #5 |
| n1046 | #5 |
| sensitization atopic | #5 |
| receptors innate immunity | #5 |
| rs3771300 | #5 |
| influence ige | #5 |
| asthma endotoxins | #5 |
| thr280met | #5 |
| puberty menarche | #5 |
| eczema relation | #5 |
| childhood isaac phase | #5 |
| hlx1 variants | #5 |
| incident wheeze | #5 |
| atopy airway hyperresponsiveness | #5 |
| allergen 95 | #5 |
| environmental dust | #5 |
| disinfectants asthma | #5 |
| tbx21 polymorphisms development | #5 |
| ormdl3 gsdma | #5 |
| tbx21 gene variants | #5 |
| pregnancy year | #5 |
| ors atopy | #5 |
| allergic diseases exposure | #5 |
| asthma medication 95 | #5 |
| asthma child dust | #5 |
| verlaufsformen | #5 |
| life questionnaires switzerland | #5 |
| milk odds | #5 |
| severe atopy | #5 |
| phänotypen | #5 |
| helsinki alert | #5 |
| atopic sensitization asthma | #5 |
| airway responsiveness age | #5 |
| lung health disease | #5 |
| delayed manifestation | #5 |
| dogs symptoms | #5 |
| cowshed | #5 |
| children validity | #5 |
| ors positive association | #5 |
| 95 populationattributable risk | #5 |
| hlx1 polymorphisms development | #5 |
| female germany allergic | #5 |
| current symptoms rhinoconjunctivitis | #5 |
| adulthood asthma | #5 |
| endotoxin protection | #5 |
| il13cd4 | #5 |
| children current wheeze | #5 |
| associations wheeze | #5 |
| consumption 4 years | #5 |
| exposure rhinitis | #5 |
| rural subjects | #5 |
| subtypes risk | #5 |
| hyperreactivity child | #5 |
| wisconsin infant | #5 |
| allergystudy | #5 |
| asthma girls | #5 |
| risk atopic | #5 |
| parental reports asthma | #5 |
| inverse association overweight | #5 |
| tbx21 promoter activity | #5 |
| 95 reverse causation | #5 |
| asthma allergic sensitisation | #6 |
| childhood aa | #6 |
| abschnitten | #6 |
| german nationality | #6 |
| rhinoconjunctivitis eczema | #6 |
| 16q12 region | #6 |
| progression asthma | #6 |
| microorganisms samples | #6 |
| allergic diseases | #6 |
| dogs environmental exposure | #6 |
| children farming environment | #6 |
| prevent allergic | #6 |
| 7 years association | #6 |
| steiner schools | #6 |
| parsifal | #6 |
| cold air challenge | #6 |
| fever atopy | #6 |
| lifestyle factors symptoms | #6 |
| natural atopic dermatitis | #6 |
| 939 children | #6 |
| childhood asthma genes | #6 |
| eating environmental | #6 |
| european dairy farms | #6 |
| sscp method | #6 |
| longitudinal populations | #6 |
| tripeptidylpeptidases subunit p40 | #6 |
| susceptibility gene asthma | #6 |
| current contact | #6 |
| pierced ears | #6 |
| lowgrade inflammation hscrp | #6 |
| fever wheezing | #6 |
| new locus time | #6 |
| tlr1 tlr10 | #6 |
| farm nonfarm | #6 |
| 17q12q21 earlier onset | #6 |
| primary preventive strategies | #6 |
| atemwegserkrankungen | #6 |
| 11094 | #6 |
| 14 genes tripeptidylpeptidases | #6 |
| children positive spt | #6 |
| protection allergies | #6 |
| responders frequency | #6 |
| sounds surveys | #6 |
| oropharyngeal microbiota | #6 |
| yearly interviews | #6 |
| rora npsr1 | #6 |
| distinct underlying mechanisms | #6 |
| pair deubiquitinating enzyme | #6 |
| nonaffluent | #6 |
| devenues | #6 |
| central europe asthma | #6 |
| tests asthma | #6 |
| asthma austria | #6 |
| food allergy 95 | #6 |
| asthma context | #6 |
| il33 17q12q21 | #6 |
| comprehensive questionnaires | #6 |
| deubiquitinating enzyme tao | #6 |
| allergic epistasis | #6 |
| nd132656 | #6 |
| central europe interactions | #6 |
| overweight data | #6 |
| allergic immunologic receptors | #6 |
| genetic variants time | #6 |
| lung barrier | #6 |
| children east germany | #6 |
| data 7 years | #6 |
| allergens needed | #6 |
| rhinoconjunctivitis atopic | #6 |
| dipeptidyl peptidases tripeptidylpeptidases | #6 |
| allergoprotective properties | #6 |
| study rarer snps | #6 |
| countries albania | #6 |
| no2 current asthma | #6 |
| asthma transition | #6 |
| inversely asthma | #6 |
| interactions farm exposures | #6 |
| polymorphisms stat6 gene | #6 |
| asthma genotypes | #6 |
| bolus dispersion | #6 |
| complete screening | #6 |
| dust collection | #6 |
| sensitisation exposure | #6 |
| childhood asthma phenotypes | #6 |
| systemic inflammation age | #6 |
| asthma authors | #6 |
| isaac programme | #6 |
| strategies disease | #6 |
| onset disease germany | #6 |
| genetic variants 17q12q21 | #6 |
| allergy tests children | #6 |
| allergic markers | #6 |
| 5 regions tao | #6 |
| bavarian preschool children | #6 |
| hypertonic skin tests | #6 |
| pair male nod2 | #6 |
| atopic europe | #7 |
| seasonal sensitivity allergic | #7 |
| bhr current asthma | #7 |
| fetal development allergic | #7 |
| strategies asthma | #7 |
| farm exposure | #7 |
| inverse association consumption | #7 |
| steiner school | #7 |
| functional phenotypes | #7 |
| viral infections development | #7 |
| grass rphl | #7 |
| chemokine cx3cl1 cx3cr1 | #7 |
| children regular contact | #7 |
| questionnaires allergic | #7 |
| immunologic receptors allergic | #7 |
| genetic predisposition role | #7 |
| influence neonatal | #7 |
| stat1 gene | #7 |
| endotoxin allergen | #7 |
| inhalant age | #7 |
| cells dust | #7 |
| exposure neu5gc | #7 |
| levels farm | #7 |
| infantis populations | #7 |
| pregnancy atopic dermatitis | #7 |
| large centres | #7 |
| log2fold | #7 |
| children breast | #7 |
| invading microorganism | #7 |
| indoor moisture | #7 |
| childrens bedrooms | #7 |
| 15245 | #7 |
| foxp3 blood | #7 |
| amish children | #7 |
| birth cohorts report | #7 |
| atopic dermatitis association | #7 |
| fieldworkers | #7 |
| perennial allergen | #7 |
| reference exposure | #7 |
| child dust | #7 |
| hypertonic sensitivity | #7 |
| preanalytix | #7 |
| allergy antibiotics | #7 |
| childhoodonset disease | #7 |
| european science | #7 |
| asthma environmental factors | #7 |
| highrisk occupations | #7 |
| polymorphisms il4 gene | #7 |
| fever atopic asthma | #7 |
| biomarker immune activation | #7 |
| aerosol bolus dispersion | #7 |
| environmental exposure endotoxin | #7 |
| lymphoid cells asthma | #7 |
| adult farmers | #7 |
| secretory receptors | #7 |
| exposure farms | #7 |
| infectious diseases phenotype | #7 |
| allergic atopic embryonic | #7 |
| hypersensitivity male | #7 |
| farm life | #7 |
| centers increase | #7 |
| lower risk asthma | #7 |
| diversity introduction | #7 |
| wheeze 12 months | #7 |
| 95 endotoxin | #7 |
| questionnaires phase | #7 |
| school age asthma | #7 |
| wheeze atopy | #7 |
| rhinitis early childhood | #7 |
| association cord blood | #7 |
| pasture study | #7 |
| pasture birth | #7 |
| interleukin4 sequence analysis | #7 |
| isaac eczema | #7 |
| pbmcs asthmatics | #7 |
| paracetamol year | #7 |
| children prognosis | #7 |
| nonfarm homes | #7 |
| lung sod3 | #7 |
| juvenile inflammatory | #7 |
| farm homes | #7 |
| hutterite children | #7 |
| level variety | #7 |
| steiner school children | #7 |
| 5 harmonization | #7 |
| asthma school age | #7 |
| children international study | #7 |
| murine offspring | #7 |
| symptoms adulthood | #7 |
| asthma fever | #7 |
| birth function | #7 |
| breastfeeding prevalence | #7 |
| environmental factors children | #7 |
| international variations | #8 |
| proteins dendritic cells | #8 |
| il15 snps | #8 |
| asthma atopic sensitisation | #8 |
| immunity gene expression | #8 |
| asthma 08 | #8 |
| il13 variants | #8 |
| indoor microbiota | #8 |
| surveyed children | #8 |
| 95 food allergy | #8 |
| early age exposure | #8 |
| age 911 years | #8 |
| fever atopic sensitisation | #8 |
| childhoodonset disease elevation | #8 |
| asthma analyses | #8 |
| repeats sequence homology | #8 |
| influence cytokine | #8 |
| inhalant europe | #8 |
| cows milk age | #8 |
| exposure dogs | #8 |
| children reference | #8 |
| crohns disease polymorphisms | #8 |
| hlx1 | #8 |
| atopic sensitization prevalence | #8 |
| asthma bias | #8 |
| bronchial histamine challenge | #8 |
| university work | #8 |
| association food diversity | #8 |
| childhood asthma atopy | #8 |
| p7×10−14 | #8 |
| chromosome childhoodonset disease | #8 |
| genetic risk asthma | #8 |
| association wheeze | #8 |
| c4ma3 | #8 |
| asthma physiciandiagnosed asthma | #8 |
| children anthroposophic families | #8 |
| hrqol questions | #8 |
| 3113 children | #8 |
| highthroughput sequencing data | #8 |
| agmr | #8 |
| amish child | #8 |
| gabriela study | #8 |
| igg1 galactosylation | #8 |
| eczema asthma child | #8 |
| p3×10−9 | #8 |
| ppg stimulation | #8 |
| factor analysis factor | #8 |
| finlande | #8 |
| amino acid asthma | #8 |
| allergy study | #8 |
| invertedu shape | #8 |
| asthma birth weight | #8 |
| asthmaprotective | #8 |
| asthma maternal smoking | #8 |
| study rural | #8 |
| current asthma data | #8 |
| p11×10−8 | #8 |
| sensitization patterns | #8 |
| 824 children | #8 |
| dogs risk factor | #8 |
| gabriela | #8 |
| children anthroposophic | #8 |
| austrian schoolchildren | #8 |
| lipid peptidoglycan | #8 |
| p4×10−9 | #8 |
| rs8076131 | #8 |
| th2 cells ilc2s | #8 |
| mice children | #8 |
| allergies childhood | #8 |
| allergy epidemiology | #8 |
| diversity year | #8 |
| chromosome 2q14 | #8 |
| diet year | #8 |
| 17q12q21 | #8 |
| asthma child conjunctivitis | #8 |
| sensitization mite | #8 |
| age positive spts | #8 |
| antibiotics year | #8 |
| airwayrelated symptoms | #8 |
| ige levels gwas | #9 |
| positive spts | #9 |
| 5 european | #9 |
| study asthma | #9 |
| gwas approaches | #9 |
| tbx21 promoter | #9 |
| 1314 children | #9 |
| n7498 | #9 |
| igg4 ige | #9 |
| chromosome ige levels | #9 |
| fcer1a susceptibility locus | #9 |
| asthma antibiotics | #9 |
| relation environment | #9 |
| random subsample | #9 |
| prevalence atopic | #9 |
| exposure farming environments | #9 |
| allergic seasonal risk | #9 |
| rad50 gene chromosome | #9 |
| association stat6 variation | #9 |
| life female germany | #9 |
| life ahr | #9 |
| rural farm | #9 |
| asthma child child | #9 |
| col29a1 variants | #9 |
| 1314yrolds | #9 |
| asthma symptoms baseline | #9 |
| symptoms 12 months | #9 |
| asthma early life | #9 |
| 1 npsr1 | #9 |
| clinical response score | #9 |
| autriche | #9 |
| 105 years age | #9 |
| cord blood cytokines | #9 |
| longitudinal follow‐up | #9 |
| allergic phenotypes | #9 |
| cytokines environmental | #9 |
| allergic preschool conjunctivitis | #9 |
| microbial substances | #9 |
| partial nonresponders | #9 |
| regular exposure | #9 |
| low levels hscrp | #9 |
| animals supplementation | #9 |
| asthma respiratory conditions | #9 |
| unprocessed milk | #9 |
| microbial exposure | #9 |
| subspecies bifidobacterium | #9 |
| atopic sensitization children | #9 |
| allergic inflammation patients | #9 |
| germany munich | #9 |
| ribosomal 16s risk | #9 |
| npsr1 snps | #9 |
| ausprägungen | #9 |
| factors sensitization | #9 |
| polymorphisms development | #9 |
| skinprick | #9 |
| dennd1b | #9 |
| regulatory th17 cells | #9 |
| asthma infant | #9 |
| farming environment | #9 |
| association wheezing | #9 |
| teenagers asthma | #9 |
| asthma allergy symptoms | #9 |
| conjunctivitis cross | #9 |
| kazal type | #9 |
| asthma risk | #9 |
| levels allergens | #9 |
| young german | #9 |
| role human asthma | #9 |
| relation asthma | #9 |
| asthma child | #9 |
| bronchial hyper‐responsiveness | #9 |
| drug development strategies | #9 |
| eczema weight | #9 |
| life prenatal exposure | #9 |
| ecuador eczema | #9 |
| ratio asthma | #10 |
| asthma nocturnal | #10 |
| production cord blood | #10 |
| predictors health utilization | #10 |
| missing values paper | #10 |
| mattress dust | #10 |
| substances development | #10 |
| atopic dermatitis 95 | #10 |
| bhr prevalence | #10 |
| infection allergic | #10 |
| 45 saline | #10 |
| consumption raw | #10 |
| urban rural area | #10 |
| phase protocol | #10 |
| adult cases controls | #10 |
| humans hypersensitivity | #10 |
| international study asthma | #10 |
| new onset rhinitis | #10 |
| bdnf gene variants | #10 |
| ige levels asthma | #10 |
| leipzig east germany | #10 |
| interrelations risk factors | #10 |
| farm children children | #10 |
| association new onset | #10 |
| countries centres | #10 |
| asthma chromosome | #10 |
| blood samples tubes | #10 |
| association atopic | #10 |
| receptors immunity | #10 |
| hormonal factors role | #10 |
| new zealand bhr | #10 |
| context eczema | #10 |
| reservoir method | #10 |
| house dust endotoxin | #10 |
| early life immunity | #10 |
| genetic probability receptors | #10 |
| farm exposures asthma | #10 |
| n1138 | #10 |
| endotoxin muramic acid | #10 |
| prevalence differences | #10 |
| indoor heating | #10 |
| 1992–2001 | #10 |
| ilt3 ilt4 | #10 |
| rural school children | #10 |
| study occupational | #10 |
| gabriel advanced studies | #10 |
| bias exposure | #10 |
| young german adults | #10 |
| latex children | #10 |
| centers prevalence rates | #10 |
| life allergen | #10 |
| mechanisms oral tolerance | #10 |
| airway hyperresponsiveness children | #10 |
| mothers contact | #10 |
| allergy risks | #11 |
| allergic disease children | #11 |
| factors agriculture | #11 |
| fetal ige | #11 |
| atopy | #11 |
| school beginners | #11 |
| cytokines allergic inflammation | #11 |
| german schoolchildren | #11 |
| asthma bacterial | #11 |
| pregnancy early life | #11 |
| allergic asthma conjunctivitis | #11 |
| association respiratory health | #11 |
| lebensbedingungen | #11 |
| samples persons | #11 |
| transient wheezing | #11 |
| asthma risk participants | #11 |
| health outcomes countries | #11 |
| farm buildings | #11 |
| wheeze year | #11 |
| active smoking association | #11 |
| reduced risk asthma | #11 |
| newborn male polymorphism | #11 |
| overweight body mass | #11 |
| occupational disinfectants | #11 |
| npsr1 polymorphisms | #11 |
| persistent uncontrolled asthma | #11 |
| asthma lower | #11 |
| subsequent development asthma | #11 |
| tbx21 polymorphisms | #11 |
| microbiome lung | #11 |
| wheeze aor | #11 |
| atopic dust | #11 |
| symptoms allergic rhinoconjunctivitis | #11 |
| blood foxp3 | #11 |
| early life development | #11 |
| ige measurements | #11 |
| protective development | #11 |
| children school entry | #11 |
| farm exposures | #11 |
| children rural | #11 |
| parsifal study | #11 |
| genotyped polymorphisms | #11 |
| tuberculosis notification rates | #11 |
| asthma candidate gene | #12 |
| symptoms atopic | #12 |
| child environmental | #12 |
| asthmatic cohort | #12 |
| transient wheeze | #12 |
| munich west germany | #12 |
| ige grass | #12 |
| increase prevalence | #12 |
| asthma parent | #12 |
| polymorphisms bdnf gene | #12 |
| current paracetamol | #12 |
| skin prick testing | #12 |
| infection analyses | #12 |
| children exposed children | #12 |
| age 105 years | #12 |
| asthma epidemic | #12 |
| female humans hypersensitivity | #12 |
| farm | #12 |
| pet contact | #12 |
| management childhood asthma | #12 |
| incident asthma 95 | #12 |
| dermatitis phenotypes | #12 |
| early priming | #12 |
| sensitization birth | #12 |
| male respiratory | #12 |
| validated questions | #12 |
| standard deviation skewness | #12 |
| doctor asthma | #12 |
| german multicentre | #12 |
| stepwise protocol | #12 |
| participants allergic rhinitis | #12 |
| young adults school | #12 |
| fever exposure | #12 |
| hypersensitivity immunity | #12 |
| birth cohorts asthma | #12 |
| east germany munich | #12 |
| 7 years data | #12 |
| polymorphism asthma | #12 |
| bhr wheeze | #12 |
| rural environments | #12 |
| backgroundasthma | #12 |
| 95 nox | #12 |
| damage mold | #12 |
| cattle child | #12 |
| asthma disease humans | #12 |
| overweight breast | #12 |
| healthy children asthma | #12 |
| children background | #12 |
| mattress dust samples | #12 |
| exposure asthma symptoms | #12 |
| multicentre allergy | #12 |
| association moisture | #12 |
| children low levels | #12 |
| farming exposures | #13 |
| sx1 | #13 |
| eastern western germany | #13 |
| asthma rhinoconjunctivitis | #13 |
| groups phenotype | #13 |
| n349 | #13 |
| cord adult blood | #13 |
| asthma outcomes patients | #13 |
| polymorphisms influence | #13 |
| ibd sle | #13 |
| switzerland children | #13 |
| northern indiana | #13 |
| developing microbiota | #13 |
| spt specific ige | #13 |
| dresden germany | #13 |
| children raised | #13 |
| subjects jobs | #13 |
| rural schoolchildren | #13 |
| asthma mental health | #13 |
| atopic eczema symptoms | #13 |
| wheezing ages | #13 |
| childhood isaac | #13 |
| local immunity | #13 |
| allergic sensitisation children | #13 |
| nod1 gene | #13 |
| rhinitis allergens | #13 |
| asthma nocturnal symptoms | #13 |
| occupational exposure disinfectants | #13 |
| children inhaled steroids | #13 |
| expression ormdl3 | #13 |
| hygiene hypersensitivity | #13 |
| npsr1 | #13 |
| childhood allergy | #13 |
| asthma snp | #13 |
| farm animal contact | #13 |
| th1cells | #13 |
| asthma community | #13 |
| children polymorphisms | #13 |
| antibiotic exposure pregnancy | #13 |
| farm dust | #13 |
| asthma bronchial | #13 |
| fx5 | #14 |
| asthma step | #14 |
| exacerbations fev1 | #14 |
| il15 gene | #14 |
| german children | #14 |
| farming lifestyle | #14 |
| burden prevalence | #14 |
| standardised questionnaires | #14 |
| th2 commitment | #14 |
| incidence rhinitis | #14 |
| diseases atopic | #14 |
| positive spts age | #14 |
| symptoms rhinoconjunctivitis | #14 |
| 7 polymorphisms | #14 |
| asthma1 | #14 |
| respiratory atopic | #14 |
| introduction complementary food | #14 |
| mrna expression vivo | #14 |
| detailed questionnaires | #14 |
| delayed introduction solids | #14 |
| air challenge | #14 |
| diabimmune study | #14 |
| cross environmental exposure | #14 |
| role lung microbiome | #14 |
| rhinitis conjunctivitis | #14 |
| increased risk age | #14 |
| nonaffluent countries | #14 |
| maternal sensitization | #14 |
| allergic sensitization age | #14 |
| asthma bronchial hyperresponsiveness | #14 |
| farm rural | #14 |
| 3099 | #14 |
| innate infant | #14 |
| untypical | #14 |
| 10‐year‐old children | #14 |
| breast feeding children | #14 |
| preventive development | #14 |
| upper respiratory symptoms | #14 |
| changing gender | #14 |
| atopic environmental | #14 |
| late introduction | #14 |
| polymorphisms ormdl3 | #14 |
| allele evidence | #15 |
| ahr male mice | #15 |
| mold problems | #15 |
| ω3 polyunsaturated | #15 |
| rhinitis puberty | #15 |
| bronchial responsiveness children | #15 |
| pregnancy protective | #15 |
| factors bronchial | #15 |
| 17q21 locus | #15 |
| sensitization indoor allergens | #15 |
| diabimmune | #15 |
| allele2 | #15 |
| unpasteurized | #15 |
| allergy risk | #15 |
| bronchial hyperreactivity | #15 |
| association asthma symptoms | #15 |
| immunity asthma | #15 |
| contact farm animals | #15 |
| street residence | #15 |
| skin prick tests | #15 |
| dogs children | #15 |
| puberty rhinitis | #15 |
| asthma allergy | #15 |
| epidemiological studies exposure | #15 |
| nocturnal symptoms | #15 |
| children allele | #15 |
| respective tlrs | #15 |
| children early | #15 |
| exposure atopic | #16 |
| wheeze trajectories | #16 |
| hutterite | #16 |
| 80 chromosomes | #16 |
| polymorphisms atopy | #16 |
| lung microbiome health | #16 |
| endotoxin house | #16 |
| newborn phenotype | #16 |
| asthma farm | #16 |
| asthma asthma risk | #16 |
| microbial exposures | #16 |
| multi‐centre study | #16 |
| increased food | #16 |
| diseases allergy | #16 |
| 7 year | #16 |
| allergic diseases childhood | #16 |
| childhood asthma asthma | #16 |
| burden childhood asthma | #16 |
| clinical response measures | #16 |
| nonatopic asthma children | #16 |
| association atopy | #16 |
| chronic asthma children | #16 |
| seasonal surveys questionnaires | #16 |
| bacteria respiratory tract | #16 |
| n1133 | #16 |
| protocadherin1 | #16 |
| 9 11 | #16 |
| sas institute | #16 |
| microbial environment | #16 |
| allergic asthma aa | #17 |
| humans preschool haemophilus | #17 |
| asthma biomarkers humans | #17 |
| dust extract | #17 |
| variants increase | #17 |
| munich | #17 |
| asthma environment | #17 |
| bavarian | #17 |
| neuropeptide receptor npsr1 | #17 |
| animals domestic | #17 |
| factors atopic | #17 |
| epidemiologic dermatitis | #17 |
| asthma associations | #17 |
| child allergic | #17 |
| function school | #17 |
| levels microbial | #17 |
| aerosol bolus | #17 |
| age 7 years | #17 |
| eczema exposure | #17 |
| single microbial | #17 |
| respiratory health children | #17 |
| munich germany | #17 |
| atopy childhood | #17 |
| rhinoconjunctivitis | #17 |
| persistent sensitization | #17 |
| ga2len skin | #17 |
| asthma immune responses | #17 |
| pregnancy gene expression | #17 |
| asthma 95 | #17 |
| mef75 | #18 |
| cb production | #18 |
| atopy rhinitis | #18 |
| german populations | #18 |
| preschool dna ribosomal | #18 |
| children german | #18 |
| edna concentrations | #18 |
| increase childhood | #18 |
| anthroposophic lifestyle | #18 |
| maternal contact | #18 |
| meat children | #18 |
| underlying responses | #18 |
| trajectories asthma | #18 |
| childrens mattresses | #18 |
| col29a1 | #18 |
| pregnancy 6 years | #18 |
| ormdl3 gene | #18 |
| measles infection | #18 |
| type employment | #18 |
| eczema 95 | #18 |
| asthma phenotyping | #18 |
| current wheezers | #18 |
| polymorphism genetic receptors | #18 |
| protective microbiota | #18 |
| asthma exposure | #18 |
| female humans asthma | #18 |
| 7 yrs | #18 |
| maternallyacquired mice mice | #18 |
| phenotypes children | #18 |
| cbmcs | #18 |
| wheeze | #18 |
| immune adaptation | #18 |
| asthma 6 years | #18 |
| atopic dermatitis studies | #19 |
| asthma report | #19 |
| hscrp age | #19 |
| life exposures | #19 |
| sounds risk | #19 |
| birth 13 years | #19 |
| receptors innate | #19 |
| linkage disequilibrium polymorphisms | #19 |
| asthma bronchiale | #19 |
| ilt4 | #19 |
| newonset symptoms | #19 |
| child crosssectional studies | #19 |
| regulatory tolllike receptor | #19 |
| poor symptom control | #19 |
| innate mice models | #19 |
| life asthma risk | #19 |
| susceptibility human | #19 |
| arg130gln | #19 |
| viable bacterial counts | #19 |
| microbial association networks | #19 |
| tcell phenotypes | #19 |
| seasonal risk | #19 |
| asthma | #19 |
| asthma allergy development | #19 |
| 3 years life | #19 |
| life diversity | #19 |
| developing asthma | #19 |
| expression treg | #19 |
| receptors innate immune | #19 |
| farming activities | #19 |
| disease atopic | #19 |
| german center | #19 |
| symptoms asthma | #19 |
| rural children | #19 |
| children current | #19 |
| crp levels age | #19 |
| atopy phenotypes | #19 |
| cary | #19 |
| higher levels endotoxin | #19 |
| atopy snps | #20 |
| asthma nonatopic asthma | #20 |
| infant colonization | #20 |
| npsr1 nps | #20 |
| pvalues patients | #20 |
| isaac | #20 |
| mice sod3 | #20 |
| breast feeding risk | #20 |
| stables | #20 |
| school university | #20 |
| adults childhood | #20 |
| farm environments | #20 |
| gene expression measurements | #20 |
| unboiled | #20 |
| allergic disease prevalence | #20 |
| life farm | #20 |
| inbred balb spores | #20 |
| persistent uncontrolled | #20 |
| specific ige food | #20 |
| westernized countries | #20 |
| dermatitis early | #20 |
| unhygienic | #20 |
| haplotype studies | #20 |
| children living | #20 |
| gender ratio | #20 |
| symptoms wheeze | #20 |
| 6 haplotype | #20 |
| animal exposure | #20 |
| dust female humans | #20 |
| disease germany | #20 |
| asthma trajectories | #20 |
| current asthma wheeze | #21 |
| network differences | #21 |
| rora | #21 |
| atopic asthma children | #21 |
| asthma review | #21 |
| bifidobacterium colonization | #21 |
| turkish children | #21 |
| patients degradation | #21 |
| prevalence rates symptoms | #21 |
| germany humans germany | #21 |
| plasma erythrocyte membranes | #21 |
| pseudocroup | #21 |
| development allergic diseases | #21 |
| eczema atopy | #21 |
| ige igg4 | #21 |
| farm environment | #21 |
| pregnancy production | #21 |
| environmental microbiome | #21 |
| tripeptidylpeptidases | #21 |
| children east | #21 |
| tlr2 receptor | #21 |
| childhood background | #21 |
| gstm1 deficiency | #21 |
| bhr 95 | #21 |
| unremitting | #21 |
| n1062 | #21 |
| markers early | #21 |
| c589t | #21 |
| studies eczema | #21 |
| environment lifestyle | #21 |
| children inhaled | #21 |
| hypersensitivity infant | #21 |
| β1→3glucans | #22 |
| crth2 th2 cells | #22 |
| respiratory diseases children | #22 |
| immune maturation | #22 |
| gabriel | #22 |
| muramic acid | #22 |
| feeding obesity | #22 |
| alleles asthma | #22 |
| 95 prenatal exposure | #22 |
| childhood atopy | #22 |
| chromosome asthma | #22 |
| r753q | #22 |
| lps risk | #22 |
| living germany | #22 |
| isaac childhood | #22 |
| effective airway | #22 |
| lower prevalences | #22 |
| 17q21 asthma | #22 |
| allergic rhinitis 95 | #22 |
| seasonal risk factors | #22 |
| samples dust | #22 |
| npsr1 gene | #22 |
| highschool | #22 |
| objective sought | #22 |
| asthmatic phenotypes | #22 |
| neonatal immune responses | #22 |
| endotoxin house dust | #22 |
| exposure germany | #22 |
| food diversity | #22 |
| fecal microbiota children | #23 |
| new onset | #23 |
| symptoms atopic eczema | #23 |
| childhood allergies | #23 |
| child cross | #23 |
| bronchial challenge tests | #23 |
| children adulthood | #23 |
| association atopic asthma | #23 |
| asthma 12 months | #23 |
| hillerød | #23 |
| traffic counts | #23 |
| nonlinear relations | #23 |
| breast feeding asthma | #23 |
| asthma cats | #23 |
| rapid alternative | #23 |
| single taxa | #23 |
| 7 prevalence | #23 |
| nonfarm | #23 |
| southern bavaria | #23 |
| gross national | #23 |
| isaac phase | #23 |
| farm childhood | #23 |
| microbiota respiratory | #23 |
| asthma agents | #23 |
| asthma prevention | #24 |
| 4 phenotypes | #24 |
| 2fold risk | #24 |
| children indoor | #24 |
| allergic dermatitis | #24 |
| asthma early | #24 |
| exposure road traffic | #24 |
| asthma bhr | #24 |
| bronchitis child | #24 |
| allergic respiratory symptoms | #24 |
| countrys | #24 |
| eczema susceptibility | #24 |
| asthma age | #24 |
| asthma aa | #24 |
| dust endotoxin | #24 |
| doctor diagnosed | #24 |
| phenotypes childhood | #24 |
| current symptoms | #24 |
| contact livestock | #24 |
| asthma cross | #24 |
| wheeze symptoms | #24 |
| tobit regression | #24 |
| gene expression immunity | #24 |
| asthma 5 years | #24 |
| haying | #24 |
| west german | #24 |
| differences asthma prevalence | #24 |
| farm animals | #25 |
| il13 pathway | #25 |
| prevention asthma | #25 |
| expression ige | #25 |
| car traffic | #25 |
| 5030 | #25 |
| igg1 ige | #25 |
| sensitization early | #25 |
| methods association | #25 |
| risk atopic diseases | #25 |
| exposure paracetamol | #25 |
| antibiotic year | #25 |
| cytokines children | #25 |
| 2 12 months | #25 |
| environmental determinants | #25 |
| early phenotypes | #26 |
| wheezing childhood | #26 |
| early atopic | #26 |
| 5 european countries | #26 |
| microbiota asthma | #26 |
| environmental asthma | #26 |
| farms humans | #26 |
| risk factors probability | #26 |
| levels mite | #26 |
| increased treg | #26 |
| asthma syndrome | #26 |
| 3rd year | #26 |
| blood samples children | #26 |
| sputum eosinophils feno | #26 |
| allergen sensitisation | #26 |
| child conjunctivitis | #26 |
| card4 | #26 |
| fev1 bhr | #26 |
| written questionnaire | #26 |
| clinical phenotypes children | #26 |
| risk allergic sensitization | #26 |
| trendwise | #26 |
| asthmatic participants | #27 |
| asthma child cross | #27 |
| prevention allergic diseases | #27 |
| children parental asthma | #27 |
| single snps | #27 |
| factors year | #27 |
| 035 iu | #27 |
| npsr1 asthma | #27 |
| prevalence atopic eczema | #27 |
| 9 11 years | #27 |
| children asthma symptoms | #27 |
| childhood origins | #27 |
| asthma childhood | #27 |
| ilt3 | #27 |
| visible mould | #27 |
| association childhood asthma | #27 |
| respiratory infections year | #27 |
| asthma environmental | #27 |
| specific ige levels | #27 |
| wheeze childhood | #27 |
| muramic | #27 |
| consumption raw milk | #27 |
| allergens europe | #27 |
| prevalence fever | #27 |
| analysis lca | #28 |
| host factors infection | #28 |
| higher hrqol | #28 |
| immune phenotypes | #28 |
| early identification children | #28 |
| dust children | #28 |
| gene asthma | #28 |
| weekly diaries | #28 |
| il13 polymorphisms | #28 |
| recurrence persistence | #28 |
| east germany | #28 |
| feno fev1 | #28 |
| pregnancy increase | #28 |
| childhood asthma risk | #28 |
| atopic phenotypes | #28 |
| levels sensitization | #28 |
| 10 years data | #28 |
| ige therapy | #28 |
| preschool environmental | #29 |
| pblc | #29 |
| farming | #29 |
| bioair | #29 |
| women males | #29 |
| acinetobacter lwoffii | #29 |
| primary prevention asthma | #29 |
| adult agriculture | #29 |
| mite sensitization | #29 |
| pediatric asthma patients | #29 |
| polymorphisms identified | #29 |
| dust indoor | #29 |
| centers prevalence | #29 |
| enhanced expression genes | #29 |
| anthroposophy | #29 |
| questionnaires urban | #29 |
| early years life | #29 |
| vivo age | #29 |
| rad50 gene | #29 |
| polymorphisms il13 | #29 |
| biodiversity child | #30 |
| asthma childhood asthma | #30 |
| il10 snps | #30 |
| dismutase 3 | #30 |
| incidence recurrence | #30 |
| boys asthma | #30 |
| affluent | #30 |
| effective ways | #30 |
| viral infections asthma | #30 |
| centres countries | #31 |
| questionnaires asthma | #31 |
| probability persistence | #31 |
| traditional farming | #31 |
| children diagnosed asthma | #31 |
| bronchial obstruction | #31 |
| childhood infectious | #31 |
| persons european ancestry | #31 |
| atopic food | #31 |
| moisture damage | #31 |
| ribosomal preschool dna | #31 |
| asthma atopic | #31 |
| il10 polymorphisms | #31 |
| enhancer marks | #31 |
| atopy children | #31 |
| card4 nod1 | #31 |
| germany leipzig | #32 |
| susceptibility asthma | #32 |
| atopic diseases | #32 |
| transferase deficiency | #32 |
| cohorts asthma | #32 |
| doctordiagnosed | #32 |
| rural regions | #32 |
| allergic diseases age | #32 |
| african ancestry asthma | #32 |
| epidemiology asthma | #32 |
| prick tests | #32 |
| infants countries | #32 |
| association paracetamol | #32 |
| gata3 gene | #32 |
| r2447x | #32 |
| microbial components | #32 |
| huge burden | #32 |
| microbial environments | #32 |
| symptoms childhood | #32 |
| européens | #32 |
| studies dermatitis | #32 |
| asthma odds ratio | #32 |
| linked polymorphisms | #32 |
| disease childhood | #32 |
| obese children age | #32 |
| preschool day | #32 |
| living environments | #32 |
| bhr fev1 | #33 |
| specificity skin tests | #33 |
| imputation data | #33 |
| immune cell enhancer | #33 |
| genetic epigenesis allergic | #33 |
| multiancestry association study | #33 |
| asthma associations loci | #33 |
| eczema prevalence | #33 |
| allergic genetic epigenesis | #33 |
| multiancestry association | #33 |
| new onset symptoms | #34 |
| tests surveys | #34 |
| bacterial farms | #34 |
| year life | #34 |
| pregnancy maternal health | #34 |
| clec4e | #34 |
| health utilization children | #34 |
| pattern frequency | #34 |
| mite allergen exposure | #34 |
| endotoxins environmental | #34 |
| infant contact | #34 |
| participants questionnaire | #34 |
| indoor mould | #34 |
| development atopy | #34 |
| dust microbiota | #34 |
| asthma atopic eczema | #34 |
| studies dust | #34 |
| participants childhood | #34 |
| fascinating | #34 |
| bradykinin receptor gene | #34 |
| asthma risk children | #34 |
| curve asthma | #34 |
| farms female | #35 |
| anthroposophic | #35 |
| endotoxin levels | #35 |
| wingedhelix | #35 |
| 95 atopic dermatitis | #35 |
| urbanrural differences | #35 |
| western lifestyle | #35 |
| asthma conjunctivitis | #35 |
| risk asthma | #35 |
| feno lung function | #35 |
| asthma asthma phenotypes | #35 |
| diseases rhinitis | #35 |
| western germany | #35 |
| tagging polymorphisms | #35 |
| germany haplotypes | #35 |
| prick testing | #35 |
| preschool fatty acids | #35 |
| nonatopic mothers | #35 |
| analysis steps | #35 |
| raw cows milk | #35 |
| children cross | #35 |
| exposure genetic | #36 |
| asthma dendritic cells | #36 |
| tolerance biomarkers | #36 |
| 1 stimulation | #36 |
| skin test reactivity | #36 |
| leipzig | #36 |
| maternal vitamin intake | #36 |
| chapter 1 epidemiology | #36 |
| maternal exposures | #36 |
| prevalence childhood asthma | #36 |
| 16s rrna data | #36 |
| earlylife exposures | #37 |
| asthma candidate | #37 |
| case status | #37 |
| nasal samples | #37 |
| incidence persistence | #37 |
| lifestyle environment | #37 |
| ril33 | #37 |
| allemagne | #37 |
| 8263 | #37 |
| native milk | #37 |
| life increased | #38 |
| mouse model asthma | #38 |
| asthma allergens | #38 |
| development allergic | #38 |
| nps npsr1 | #38 |
| ormdl3 expression | #38 |
| amish | #38 |
| endotoxin asthma | #38 |
| dust asthma | #38 |
| innate immunity genes | #38 |
| recurrence risk factors | #38 |
| wisc | #38 |
| foxp3 levels | #38 |
| association ndvi | #38 |
| allergy birth | #38 |
| reverse causation | #38 |
| asthma cough | #38 |
| itchy | #38 |
| atopy prevalence | #38 |
| eczema environmental | #38 |
| maximum expiratory flow | #38 |
| allergic symptoms children | #39 |
| wheezing phenotypes | #39 |
| degradation patients | #39 |
| maternal health pregnancy | #39 |
| haploview | #39 |
| levels house | #39 |
| igg nglycosylation | #39 |
| adulthood risk factors | #39 |
| genetic rhinitis | #39 |
| seasonal perennial | #39 |
| traffic asthma | #39 |
| c589 | #39 |
| diversity environmental | #39 |
| protect children | #39 |
| polymorphisms asthma | #39 |
| ige switching | #39 |
| eczema | #40 |
| 4606 | #40 |
| preschool conjunctivitis | #40 |
| symptoms allergic | #40 |
| crosssectional studies | #40 |
| biodiversity health | #40 |
| children bronchial | #40 |
| antibiotics development | #40 |
| transcription 6 | #40 |
| animal farms | #40 |
| mite exposure | #40 |
| isolated polysaccharides | #40 |
| farm residence | #41 |
| risk factors health | #41 |
| german cities | #41 |
| eczema phenotypes | #41 |
| allergic child | #41 |
| treg cells patients | #41 |
| effects asthma | #41 |
| discotheques | #41 |
| allergens age | #41 |
| asthma wheeze | #41 |
| small airway dysfunction | #41 |
| stress young | #41 |
| food questionnaire | #42 |
| dust female | #42 |
| international patterns | #42 |
| microbiome data | #42 |
| bronchiale | #42 |
| onset year | #42 |
| polymorphism single nucleotide | #42 |
| 95 antibiotics | #42 |
| pcdh1 | #42 |
| asthma food | #43 |
| increased regulatory | #43 |
| dermatitis food | #43 |
| time asthma | #43 |
| sensitized subjects | #43 |
| subspecies infantis | #43 |
| treg th17 cells | #43 |
| worldwide variations | #43 |
| asthma onset | #43 |
| gsdma | #44 |
| developing countries children | #44 |
| prevalence symptoms | #44 |
| work overload | #44 |
| facklamia | #44 |
| early childhood infections | #44 |
| asthma food allergy | #44 |
| sequential switching | #44 |
| atopic diseases asthma | #44 |
| microbiome asthma | #44 |
| wide variations | #44 |
| national institute allergy | #44 |
| diseases childhood | #44 |
| increased risk symptoms | #44 |
| cells cord | #44 |
| 97th | #44 |
| atp2a3 | #44 |
| asthma cystic fibrosis | #44 |
| followup physical activity | #44 |
| traffic exposure | #45 |
| antiasthma drugs | #45 |
| 7445 | #45 |
| questionnaire responses | #45 |
| birth 12 months | #45 |
| sensitization inhalant | #45 |
| dust endotoxins | #45 |
| animals pregnancy | #45 |
| severe atopic eczema | #45 |
| exposure early life | #45 |
| biodiversity hypothesis | #45 |
| phenotype respiratory | #45 |
| fever 95 | #45 |
| bamse | #45 |
| improvement reduction | #46 |
| prevalence bhr | #46 |
| farm animal | #46 |
| atopic diseases children | #46 |
| adolescence differences | #46 |
| asthma gwas | #46 |
| spt reactivity | #46 |
| evidence gene | #46 |
| prevalence diseases | #46 |
| humans hygiene | #46 |
| receptor tolllike receptors | #46 |
| control physical | #46 |
| asthma cluster | #46 |
| prevalence current wheeze | #46 |
| analysis step | #47 |
| efraim | #47 |
| germany east | #47 |
| international study | #47 |
| factors asthma | #47 |
| franche | #47 |
| 95 eczema | #47 |
| tirana | #47 |
| children atopic disease | #47 |
| prevalence rhinoconjunctivitis | #47 |
| wheeze phenotypes | #47 |
| halle | #48 |
| airways diseases | #48 |
| asthma adjusted | #48 |
| polymorphisms il4 | #48 |
| frequent wheeze | #48 |
| wheeze age | #48 |
| perennial allergens | #48 |
| breath volatile | #48 |
| asthma risk loci | #48 |
| parental interviews | #48 |
| fungal flora | #48 |
| doctordiagnosed asthma | #48 |
| lung function spirometry | #48 |
| asthma biological | #48 |
| prevalences asthma | #48 |
| cluster children | #48 |
| children female humans | #49 |
| milk farm | #49 |
| risk factors incidence | #49 |
| n228 | #49 |
| chromosome susceptibility | #49 |
| fcer1a | #49 |
| children paracetamol | #49 |
| exposures asthma | #50 |
| physiciandiagnosed | #50 |
| beta13glucans | #50 |
| background atopic | #50 |
| bacterial markers | #50 |
| diversity food | #50 |
| unpasteurized milk | #50 |
| longum subsp infantis | #50 |
| pcrsscp | #50 |
| microbial burden | #51 |
| lwoffii | #51 |
| allergy symptoms | #51 |
| populationattributable risk | #51 |
| identified polymorphisms | #51 |
| children cities | #51 |
| association atopic dermatitis | #51 |
| conjugated mice mice | #51 |
| maintenant | #51 |
| igg1 igg4 | #51 |
| asthma dust | #51 |
| association allergic | #51 |
| country prevalence | #51 |
| common chronic disease | #51 |
| asthma maternal | #51 |
| sensitization children | #52 |
| prevalence wheeze | #52 |
| gpra | #52 |
| itchy rash | #52 |
| bmi asthma | #52 |
| wheeze cough | #52 |
| epidemiologischen | #52 |
| 9357 | #52 |
| ige sige | #52 |
| geneenvironment interactions | #52 |
| doctor diagnosis | #52 |
| milk consumption | #52 |
| infant study | #52 |
| age wheezing | #52 |
| indoor endotoxin | #52 |
| eczema childhood | #52 |
| specific protective | #52 |
| atopic eczema children | #53 |
| early life exposure | #53 |
| il13 gene | #53 |
| adam33 asthma | #53 |
| outdoor pollution | #53 |
| 2q32 | #53 |
| life exposure | #53 |
| ige children | #53 |
| children current asthma | #53 |
| cross sectional studies | #54 |
| male prevalence | #54 |
| female germany life | #54 |
| animals asthma | #54 |
| asthma odds | #54 |
| nonmicrobial | #54 |
| prevalence wheezing | #54 |
| estonian children | #54 |
| stepwise procedure | #55 |
| cough wheeze | #55 |
| bacterial microbiota | #55 |
| prevalence association | #55 |
| year asthma | #55 |
| samples farm | #55 |
| asthma atopy | #56 |
| strong protective | #56 |
| immunoglobulin interleukin13 | #56 |
| adult asthma patients | #56 |
| alex study | #56 |
| cd14 tolllike receptor | #56 |
| atopy development | #56 |
| tuberculosis notification | #56 |
| random samples | #56 |
| maternal ige | #56 |
| visible mold | #56 |
| asthma allergic rhinoconjunctivitis | #57 |
| derp1 | #57 |
| prevention allergic | #57 |
| 3785 | #57 |
| diseases methods | #57 |
| adam33 polymorphisms | #57 |
| member 1 polymorphism | #57 |
| eczema flg | #57 |
| atopy wheeze | #57 |
| life atopic dermatitis | #57 |
| pollutant exposure | #57 |
| mononuclear lipid | #57 |
| mef50 | #57 |
| diseases children | #58 |
| reported parents | #58 |
| hypersensitivity immunoglobulin | #58 |
| eczema female | #58 |
| total serum | #58 |
| specificity asthma | #58 |
| early asthma | #58 |
| stat6 gene | #58 |
| 1q31 | #59 |
| milk cla | #59 |
| asthma morbidity children | #59 |
| 6 years age | #59 |
| finland estonia | #59 |
| german participants | #59 |
| th17 lineage | #59 |
| farm families | #59 |
| birth school age | #60 |
| development childhood | #60 |
| allergic surveys | #60 |
| preschool wheezing | #60 |
| iedap | #60 |
| predictors incidence | #60 |
| beta 2agonists | #60 |
| rna yield | #60 |
| atopy eczema | #61 |
| seasonal skin tests | #61 |
| breastfed children | #61 |
| implicated genes | #61 |
| species colonization | #61 |
| exposure asthma | #61 |
| immunoglobulin infant | #62 |
| life immune | #62 |
| childhoodonset asthma | #62 |
| asthma birth | #62 |
| persistence asthma | #62 |
| large german | #62 |
| respiratory sounds | #62 |
| development airway hyperresponsiveness | #62 |
| estonia finland | #62 |
| cystic fibrosis abpa | #63 |
| asthma breast | #63 |
| atopic | #63 |
| total quantity | #63 |
| children regions | #63 |
| children role | #63 |
| endotoxin level | #63 |
| hyperreactivity bronchial | #63 |
| indoor allergen exposure | #63 |
| dermatitis risk | #63 |
| exposure assessed | #63 |
| children centers | #64 |
| differential networks | #64 |
| allergenspecific ige | #64 |
| dust parameters | #64 |
| no2 benzene | #64 |
| newborn lymphocyte | #64 |
| helminth ascariasis ascaris | #64 |
| risk wheezing | #65 |
| animal contact | #65 |
| healthy controls children | #65 |
| childhood allergic diseases | #65 |
| preschool haemophilus humans | #66 |
| atopic symptoms | #66 |
| living area | #66 |
| ga²len | #66 |
| dust extracts | #66 |
| prevalence current asthma | #66 |
| umc | #66 |
| sensitization allergic | #66 |
| immunological data | #66 |
| allergic rhinitis age | #66 |
| ige expression | #67 |
| maternal atopy | #67 |
| 2 questionnaires | #67 |
| biomarkers predictors | #67 |
| respiratory allergies | #67 |
| pa obesity | #67 |
| early wheeze | #68 |
| mère | #68 |
| antibiotic sales | #68 |
| weight boys | #68 |
| ige allergens | #69 |
| hypersensitivity immunization | #70 |
| allergic disorders | #70 |
| atopic disease children | #70 |
| suisse | #70 |
| sod3 | #70 |
| gene gene interaction | #70 |
| asthma complex | #70 |
| atopic rhinitis | #71 |
| prenatal vitamin | #71 |
| occurrence progression | #71 |
| tlr2 tlr1 | #71 |
| small airway function | #71 |
| breathomics | #71 |
| barns | #71 |
| allergic sensitization children | #71 |
| unprocessed | #71 |
| factor asthma | #72 |
| association occupational exposure | #72 |
| molecular fingerprinting | #72 |
| children wheeze | #72 |
| 158 95 | #72 |
| infantis | #72 |
| persistent asthma children | #72 |
| european ancestry association | #73 |
| sounds respiratory | #73 |
| gni | #73 |
| onset allergic | #73 |
| ormdl3 | #73 |
| severe eczema | #74 |
| food allergy asthma | #74 |
| exposure europe | #74 |
| health services children | #74 |
| risk wheeze | #74 |
| west humans | #74 |
| asthmatic mothers | #75 |
| chromosome 17q21 | #75 |
| maternal immunity | #75 |
| standardized procedure | #75 |
| asthma genome | #75 |
| total serum ige | #75 |
| children hrqol | #75 |
| rfel | #75 |
| asthma case | #76 |
| eczema children | #76 |
| allergy childhood | #76 |
| food inhalant | #76 |
| rural differences | #76 |
| symptoms eczema | #76 |
| wheezing | #76 |
| microbial molecules | #76 |
| asthma healthy | #77 |
| diversity microbial | #77 |
| sexspecific association | #77 |
| 9 mmp9 | #77 |
| hyperresponsiveness bhr | #77 |
| 6399 | #78 |
| edta tubes | #78 |
| childhood | #78 |
| years odds | #78 |
| sensitisation children | #78 |
| findings prevalence | #78 |
| rhinitis atopic | #78 |
| turkish origin | #78 |
| blood cytokines | #78 |
| wheezing illnesses | #78 |
| mothers asthma | #78 |
| interactions snps | #79 |
| seasonal asthma | #79 |
| milk yoghurt | #79 |
| genes innate immunity | #79 |
| 95 protection | #79 |
| neuropeptide receptor | #79 |
| cats child | #80 |
| ige skin | #80 |
| dander | #80 |
| symptoms 12 | #81 |
| development atopic dermatitis | #81 |
| lower prevalence | #81 |
| prevalence respiratory | #81 |
| microbial agents | #81 |
| forkhead box protein | #81 |
| childhood wheeze | #81 |
| bacterial viral infections | #82 |
| laryngitis | #82 |
| 13 14 | #82 |
| age prevalence | #82 |
| ribosomal pcr | #82 |
| introduction solids | #82 |
| concentrations so2 | #82 |
| children european | #82 |
| age 45 | #82 |
| hypersensitivity risk | #83 |
| microbial stimulation | #83 |
| total fat content | #83 |
| gut commensals | #83 |
| current wheezing | #83 |
| study pcr | #83 |
| cleanliness | #83 |
| reporter genetic predisposition | #83 |
| children siblings | #83 |
| study population patients | #83 |
| specific exposures | #84 |
| 4732 | #84 |
| new asthma | #84 |
| oligoarticular juvenile | #84 |
| tests child | #84 |
| control pa | #84 |
| bronchial responsiveness | #85 |
| α1 antitrypsin | #85 |
| single nucleotide rna | #85 |
| atopy risk | #85 |
| européenne | #85 |
| n134 | #85 |
| infant inflammation | #86 |
| ige levels | #86 |
| comté | #86 |
| wheeze prevalence | #86 |
| children feeding | #86 |
| bifidobacterium species | #86 |
| arabinogalactan | #86 |
| truck traffic | #86 |
| hyper responsiveness | #86 |
| age asthma | #87 |
| genes asthma | #87 |
| analysis respiratory | #87 |
| visits asthma | #87 |
| 95 fever | #87 |
| exposure associations | #87 |
| influential factors | #87 |
| allergy tests | #88 |
| rhinitis risk | #88 |
| pollution allergens | #88 |
| asthma polymorphisms | #88 |
| tolllike receptors tlrs | #88 |
| exposure tobacco smoke | #88 |
| aged 6 | #89 |
| rphl | #89 |
| asthma children | #89 |
| bronchial hyper | #89 |
| asthma phenotypes | #89 |
| current exposure | #90 |
| critical time window | #90 |
| children area | #90 |
| allergic seasonal surveys | #90 |
| asthma school | #91 |
| development eczema | #91 |
| joint workshop | #91 |
| filaggrin mutations | #91 |
| newborn limit | #91 |
| newborn leukocytes | #91 |
| sensitisation | #92 |
| mononuclear polymorphism | #92 |
| geführt | #93 |
| rs2305480 | #93 |
| preschool haemophilus | #93 |
| east west germany | #93 |
| previous studies association | #93 |
| experimental asthma | #93 |
| allergic rhinitis symptoms | #93 |
| south germany | #93 |
| low levels exposure | #93 |
| tregulatory cells | #94 |
| pertussis infection | #94 |
| zpbp2 | #94 |
| fed children | #95 |
| eczema symptoms | #95 |
| asthma common | #95 |
| asthma loci | #95 |
| expression toll | #95 |
| international variation | #95 |
| university life | #95 |
| greater consumption | #95 |
| nickel allergy | #95 |
| 16q12 | #95 |
| trigger factors | #96 |
| anaphylaxie | #96 |
| lps recognition | #96 |
| nonfarmers | #96 |
| dust environmental | #96 |
| allergic sensitisation | #96 |
| airway dysfunction | #96 |
| dysbalance | #96 |
| expression th1 | #96 |
| onset wheeze | #96 |
| cumulative prevalence | #96 |
| schoolchildren aged | #97 |
| indoor factors | #97 |
| inhalant allergens | #97 |
| city air | #97 |
| 95 overweight | #97 |
| regulatory treg | #97 |
| childhood adulthood | #98 |
| children germany | #98 |
| background asthma | #98 |
| tlr1 tlr2 | #98 |
| seasonal sensitivity | #98 |
| factors school | #98 |
| age 3 years | #98 |
| earlyonset asthma | #99 |
| seasonal surveys | #99 |
| children atopic | #99 |
| rural school | #99 |
| current wheeze | #99 |
| asthma inflammation | #99 |
| eastern germany | #99 |
| comprehensive questionnaire | #99 |
| years aor | #99 |
| preschool crosssectional studies | #100 |
| childhood atopic dermatitis | #100 |
| isaac questionnaire | #100 |
| genetic factors susceptibility | #101 |
| summarised | #101 |
| raw cow | #101 |
| expression measurements | #101 |
| mef25 | #101 |
| weight girls | #101 |
| factors wheezing | #102 |
| risk factors persistence | #102 |
| tenascin tnc | #102 |
| retinoid acid | #102 |
| ige concentrations | #102 |
| effects respiratory | #102 |
| sensitization eczema | #103 |
| hdm exposure | #103 |
| irf1 gene | #103 |
| years early | #103 |
| 4264 | #103 |
| children increased risk | #103 |
| exposure milk | #104 |
| children relation | #104 |
| sensitization childhood | #104 |
| high‐sensitivity | #105 |
| hutterites | #105 |
| hyperreactivity | #105 |
| pollen concentration | #105 |
| arabinogalactans | #105 |
| animal dander | #106 |
| wheezing disorders | #106 |
| blood ige | #106 |
| physiciandiagnosed asthma | #106 |
| prevalence atopy | #106 |
| questionnaires switzerland | #106 |
| children contact | #106 |
| puberty age | #107 |
| socs4 | #107 |
| detailed questionnaire | #107 |
| underlying factor | #107 |
| fever episodes | #108 |
| inverse associations | #108 |
| overweight 95 | #108 |
| breast feeding | #108 |
| asthma wheezing | #109 |
| air pollution children | #109 |
| healthy children children | #109 |
| complex syndrome | #109 |
| moulds | #109 |
| publication air pollution | #109 |
| allergic perennial rhinitis | #109 |
| atopic eczema humans | #110 |
| genotype germany | #110 |
| folgenden | #110 |
| female germany | #110 |
| rs7216389 | #110 |
| p≤003 | #110 |
| parental questionnaire | #111 |
| il4ra | #111 |
| tbox transcription factor | #112 |
| olive pollen | #112 |
| 1314 | #112 |
| female histones | #112 |
| milk samples | #112 |
| environmental study | #112 |
| risk allergic | #113 |
| experimental allergic asthma | #113 |
| phenotypes asthma | #113 |
| indoor asthma | #113 |
| allergic | #113 |
| flg variants | #113 |
| occupational allergy | #114 |
| challenge data | #114 |
| asthma sensitization | #114 |
| mould exposure | #114 |
| tests bronchial | #114 |
| parent reported | #114 |
| allergic disease | #114 |
| igg4 responses | #115 |
| foxp3 locus | #115 |
| notification rates | #115 |
| cough children | #115 |
| cord blood ige | #115 |
| increased diversity | #115 |
| aged 9 | #116 |
| exclusive breast feeding | #116 |
| immune responsiveness | #116 |
| regulatory th17 | #116 |
| psychosocial characteristics | #117 |
| glutathione transferase gst | #117 |
| children underwent | #117 |
| germany humans | #118 |
| reference children | #118 |
| ratio prevalence | #118 |
| allergic sensitization | #118 |
| living rural | #118 |
| indoor microbial | #118 |
| west germany | #118 |
| skinprick tests | #118 |
| skin prick | #119 |
| delayed introduction | #119 |
| switching immunoglobulin | #119 |
| children wheezing | #119 |
| ancestry asthma | #119 |
| fibrolysis | #120 |
| levels endotoxin | #120 |
| childhood risk factors | #120 |
| association chromosome | #120 |
| environment children | #120 |
| aliments | #121 |
| symptom control | #121 |
| allergens asthma | #121 |
| common aeroallergens | #121 |
| lung function measurements | #121 |
| dampness | #121 |
| vitamin supplementation pregnancy | #121 |
| factors rural | #121 |
| tlr10 | #122 |
| preventive potential | #122 |
| 300 people | #122 |
| life early | #122 |
| urban traffic | #123 |
| hayfever | #123 |
| frequency pattern | #123 |
| germany prevalence | #124 |
| severe eosinophilic asthma | #124 |
| active asthma | #124 |
| passive smoke exposure | #124 |
| atopic manifestations | #124 |
| potted plants | #125 |
| immunologic tolllike receptor | #125 |
| common inhalant | #125 |
| il18r1 | #125 |
| eczema patients | #126 |
| prevalence allergic diseases | #126 |
| exposure pets | #126 |
| asthma background | #126 |
| sensitization development | #126 |
| await | #126 |
| paediatric studies | #126 |
| effects prevalence | #126 |
| 3 infections | #126 |
| environmental allergens | #127 |
| 95 ors | #127 |
| adaptive cells | #127 |
| prävalenz | #127 |
| allergens child | #127 |
| exposure endotoxin | #127 |
| caspase recruitment domain | #127 |
| test reactivity | #127 |
| parent questionnaire | #127 |
| bdnf polymorphisms | #128 |
| bdnf gene | #129 |
| microbial markers | #129 |
| receptors male | #129 |
| medall | #130 |
| sensitization allergens | #131 |
| test study | #131 |
| factors allergens | #131 |
| common allergens | #131 |
| protein allergy | #131 |
| severe eosinophilic | #131 |
| hypersensitivity respiratory | #131 |
| respiratory symptoms children | #131 |
| asthma objective | #131 |
| male occupational | #132 |
| effects development | #132 |
| expression receptors | #132 |
| diseases asthma | #132 |
| asthma adolescent | #132 |
| immunoglobulin inflammation | #132 |
| age 7 | #133 |
| bavaria | #133 |
| understanding natural | #133 |
| pollen prevalence | #133 |
| early age | #133 |
| 7 years age | #134 |
| dpp10 | #134 |
| allergy | #134 |
| crth2 | #135 |
| 95 ages | #135 |
| prevalence rhinitis | #135 |
| childhood risk | #135 |
| body composition bmi | #135 |
| asthma young | #136 |
| 60 iu | #136 |
| eczema risk | #136 |
| bronchial response | #136 |
| allergic phenotype | #136 |
| exposure children | #137 |
| 6 7 | #137 |
| ms4a2 | #137 |
| mechanisms asthma | #137 |
| actinomycetes | #137 |
| snps asthma | #137 |
| ga2len | #137 |
| sensitized children | #138 |
| asthma atopic dermatitis | #138 |
| régions | #138 |
| asthma development | #138 |
| mattress | #138 |
| snps interactions | #138 |
| pollutants allergens | #138 |
| reduced prevalence | #138 |
| sebacate | #139 |
| listeria spp | #139 |
| pollution asthma | #139 |
| 3 14 | #139 |
| serum ige | #139 |
| allergen levels | #139 |
| milk animals | #139 |
| duration type | #140 |
| tregs foxp3 | #140 |
| microbiota children | #140 |
| pasture | #140 |
| largest reduction | #140 |
| exposure symptoms | #140 |
| exposure indoor | #141 |
| asthma genes | #141 |
| age 6 years | #141 |
| n183 | #142 |
| indoor allergens | #142 |
| cla content | #142 |
| asthma bronchitis | #142 |
| susceptibility children | #142 |
| questionnaires illness surveys | #142 |
| factors difference | #142 |
| unifrac | #143 |
| pregnancy early | #143 |
| exposure year | #144 |
| pet exposure | #144 |
| replication association | #144 |
| asthma defined | #144 |
| incident asthma | #144 |
| snps chromosome | #144 |
| inconclusive | #144 |
| children allergy | #145 |
| expositions | #145 |
| onset menarche | #145 |
| dermatitis asthma | #145 |
| prematurely born children | #146 |
| allergy testing | #146 |
| interleukin13 interleukin4 | #146 |
| lower airways | #146 |
| health outcomes children | #146 |
| prevalence skin | #146 |
| airway mechanics | #146 |
| biomarkers child | #147 |
| study centers | #147 |
| original article | #147 |
| germany west | #148 |
| association early | #148 |
| children 6 | #148 |
| feno patients | #148 |
| atopic outcomes | #149 |
| early immune | #149 |
| indoor allergen | #149 |
| perennial rhinitis allergic | #150 |
| pregnancy respiratory | #150 |
| fall fev1 | #150 |
| confer protection | #151 |
| 105 years | #151 |
| prevalence childhood | #151 |
| profound differences | #151 |
| wheeze children | #151 |
| wheezing children | #151 |
| established asthma | #152 |
| bhr | #152 |
| exposure increased | #152 |
| immunomodulatory molecules | #152 |
| distribution asthma | #152 |
| consumption dairy products | #152 |
| children review | #152 |
| environmental exposure | #152 |
| tagging single | #153 |
| asthma dermatitis | #153 |
| common respiratory | #153 |
| function measurements | #153 |
| wheeze asthma | #153 |
| hens egg | #153 |
| cd28null | #154 |
| hormonal factors | #154 |
| neighboring countries | #155 |
| onset association | #155 |
| bronchial challenge | #155 |
| tests sex factors | #155 |
| atopic children | #156 |
| association asthma | #156 |
| positive spt | #157 |
| absolute levels | #157 |
| neu5gc | #157 |
| severity frequency | #157 |
| gene 3 | #157 |
| development allergy | #157 |
| lower diversity | #158 |
| paediatric asthma | #158 |
| bacterial lysates | #158 |
| asthma females | #158 |
| early environmental | #158 |
| children asthma | #159 |
| developing immune | #159 |
| patients controlled asthma | #159 |
| prevention allergy | #159 |
| microbiome diversity | #160 |
| children homes | #160 |
| spts | #160 |
| allergic seasonal | #160 |
| german adults | #160 |
| reported prevalence | #160 |
| children rhinitis | #160 |
| wheeze rhinitis | #161 |
| preventive measure | #161 |
| asthma presence | #161 |
| atopy asthma | #161 |
| newborn longitudinal | #161 |
| children lower | #162 |
| female humans allergic | #162 |
| parental asthma | #162 |
| immune pathways | #162 |
| perennial rhinitis | #163 |
| specific ige | #163 |
| environmental associations | #163 |
| exposure prevalence | #163 |
| sensitised | #164 |
| sscp | #164 |
| kindl | #164 |
| atopic dermatitis | #165 |
| children sensitized | #165 |
| atopic eczema | #165 |
| asthma ige | #165 |
| feeding child | #166 |
| illness surveys questionnaires | #166 |
| 5q31 | #166 |
| epidemiologie | #166 |
| infant respiratory | #166 |
| ige asthma | #166 |
| adolescent allergens | #167 |
| studies exposure | #167 |
| air pollutant concentrations | #167 |
| disease life | #167 |
| preadolescent children | #167 |
| preschool cross | #167 |
| years lung | #168 |
| year children | #168 |
| current asthma | #168 |
| regulatory treg cells | #169 |
| airway size | #169 |
| stratification patients | #169 |
| workplace young | #169 |
| 2688 | #169 |
| chronic inflammatory disease | #170 |
| nucleotide rna | #171 |
| inhalant | #171 |
| adolescent analysis | #171 |
| sensitization pollen | #171 |
| aged 13 | #171 |
| prevalence current | #172 |
| ifnγ levels | #172 |
| sheds | #172 |
| skin prick test | #172 |
| studien | #172 |
| endotoxins female | #172 |
| nucleotide pregnancy | #172 |
| risk score model | #173 |
| unifying concept | #173 |
| antipyretics | #174 |
| risk atopy | #174 |
| small airway | #175 |
| patients nocturnal | #175 |
| mice asthma | #175 |
| female humans questionnaires | #175 |
| school level | #176 |
| sensitization common | #176 |
| serine protease inhibitor | #176 |
| asthma attack | #176 |
| repeated infections | #176 |
| situ hybridization infant | #177 |
| life respiratory function | #177 |
| sensitization pattern | #177 |
| wheezers | #177 |
| genetic severity | #178 |
| sensitization asthma | #178 |
| aa patients | #178 |
| 9p24 | #178 |
| childhood infections | #178 |
| objective measurements | #179 |
| nocturnal asthma | #179 |
| childhood adolescence | #179 |
| sputum neutrophils | #179 |
| traffic characteristics | #179 |
| w12 | #179 |
| studies environmental | #179 |
| standardized methodology | #179 |
| asthma genetic | #180 |
| socks | #180 |
| breastfed infant | #180 |
| lung function testing | #181 |
| bacterial count | #181 |
| mattresses | #181 |
| children environmental | #181 |
| environmental predictors | #181 |
| differences hrqol | #182 |
| dermatitis children | #182 |
| immunemediated diseases | #182 |
| vitamin asthma | #182 |
| dust levels | #182 |
| mögliche | #183 |
| tlr signaling | #183 |
| children levels | #183 |
| exposure humans | #183 |
| german population | #183 |
| vocational training | #183 |
| environmental microbiology | #183 |
| school district | #185 |
| life prevalence | #185 |
| incidence allergic | #185 |
| work asthma | #186 |
| protein child | #187 |
| asthma body | #188 |
| tests children | #188 |
| qpcrs | #188 |
| childhood early adulthood | #188 |
| selfselection | #188 |
| development allergic disease | #188 |
| environmental exposures | #188 |
| jf1 | #189 |
| tlr genes | #189 |
| mother pregnancy | #190 |
| muscle mass patients | #190 |
| type duration | #190 |
| bacterial groups | #190 |
| wheezing age | #190 |
| inversely | #190 |
| early wheezing | #190 |
| association antibiotic | #190 |
| dry cough | #191 |
| cd14 gene | #191 |
| blood gene | #191 |
| atopic dermatitis children | #191 |
| longum subsp | #192 |
| pyroglyphidae | #192 |
| adjusted irr | #192 |
| adam33 | #193 |
| model allergic | #193 |
| cε | #193 |
| milk serum | #193 |
| prevalence severity | #195 |
| eosinophilic asthma | #195 |
| estonian | #195 |
| caspase recruitment | #196 |
| review asthma | #197 |
| enthusiasm | #197 |
| germany switzerland | #197 |
| questionnaire data | #198 |
| earlylife | #198 |
| representative population | #199 |
| rhinitis eczema | #199 |
| decreased prevalence | #199 |
| upper lower airways | #200 |
| bacteria role | #202 |
| complex interplay | #202 |
| allergy infectious diseases | #202 |
| patients europe | #203 |
| bronchial hyperresponsiveness bhr | #203 |
| paediatrician | #203 |
| phenotyped | #204 |
| difference prevalence | #204 |
| patients aa | #204 |
| amebocyte | #205 |
| new locus | #205 |
| 13 years age | #205 |
| dermatitis atopic | #205 |
| 3034 | #206 |
| allergen specific | #206 |
| asthma methods | #207 |
| factors atopy | #207 |
| asthma respiratory symptoms | #207 |
| allergic asthmatics | #208 |
| karelia | #208 |
| studies germany | #208 |
| male phenotype | #208 |
| diagnosed asthma | #208 |
| newborn logistic | #209 |
| innate adaptive immunity | #209 |
| glycolylneuraminic acid | #209 |
| higher diversity | #209 |
| col4a3 | #209 |
| sensitization age | #209 |
| prevalence obesity | #209 |
| studies cytokines | #209 |
| core microbiome | #210 |
| bhr asthma | #210 |
| symptoms children | #210 |
| bronchial provocation | #210 |
| epithelial barrier function | #210 |
| exposure sensitization | #211 |
| cats dogs | #211 |
| low prevalence | #211 |
| influence development | #211 |
| tlr4 cd14 | #212 |
| asthma animals | #212 |
| methodssubjects | #212 |
| birth 6 | #212 |
| asthma allergic | #212 |
| atopic dermatitis asthma | #212 |
| exposure allergens | #213 |
| 1872 | #213 |
| cohort methods | #213 |
| patients uncontrolled asthma | #213 |
| distinct clusters | #213 |
| workplace exposure | #214 |
| expression cd14 | #214 |
| asthma allergic diseases | #214 |
| prevalence allergic | #214 |
| 00035 | #214 |
| rural environment | #214 |
| reverse causality | #214 |
| life allergic | #215 |
| regulatory responses | #216 |
| obesity overweight | #216 |
| mast cell chymase | #216 |
| il2rb | #218 |
| atopic female | #218 |
| child dna | #219 |
| causation | #219 |
| microbial products | #219 |
| disinfectants | #219 |
| geneticist | #219 |
| pierced | #220 |
| steiner | #220 |
| variants asthma | #220 |
| allergy development | #220 |
| schistosoma schistosomiasis | #221 |
| homogenised | #221 |
| method participants | #221 |
| sensitization rates | #222 |
| 90 children | #222 |
| increased asthma | #222 |
| symptoms baseline | #223 |
| environmental epidemiology | #223 |
| groups asthma | #224 |
| sibship size | #225 |
| german study | #225 |
| sensitization allergen | #226 |
| conjunctivitis allergic | #226 |
| german | #226 |
| alpha1 antitrypsin | #226 |
| school age | #227 |
| provocative concentration | #227 |
| data asthma | #228 |
| test spt | #228 |
| specific stimulation | #228 |
| 95 obesity | #228 |
| lung health | #228 |
| allergic diseases asthma | #228 |
| road traffic | #229 |
| healthy worker | #229 |
| understanding asthma | #229 |
| wheezing asthma | #229 |
| tuberculosis prevalence | #229 |
| cord blood cells | #230 |
| butyryl | #230 |
| asthma phenotype | #230 |
| asthma allergic rhinitis | #230 |
| umwelt | #230 |
| allergy prevention | #231 |
| cord blood cb | #231 |
| health variables | #232 |
| living conditions | #232 |
| nonallergic asthma | #232 |
| discontent | #232 |
| subgroup children | #232 |
| 20 fall | #232 |
| innate leukocytes | #233 |
| lively | #233 |
| prevalence overweight | #233 |
| dermatophagoides pteronyssinus | #234 |
| complementary food | #234 |
| hyperreactive | #234 |
| fourth grade | #235 |
| n144 | #235 |
| exposure pregnancy | #236 |
| levels asthma | #236 |
| resequenced | #236 |
| specific allergen | #236 |
| puberty girls | #238 |
| finland france | #238 |
| incidence asthma | #239 |
| strategies prevention | #239 |
| neutrophilic asthma | #240 |
| preschool cytokines | #241 |
| regulatory th1 | #242 |
| immune development | #243 |
| age exposure | #243 |
| th2 immunity | #243 |
| adaptor protein polymorphism | #245 |
| adjusted odds ratio | #245 |
| receptor 1 | #245 |
| muropeptides | #246 |
| fungal dna ribosomal | #246 |
| nasal microbiota | #247 |
| fever asthma | #247 |
| role development | #247 |
| prick test | #247 |
| children analysis | #248 |
| patients healthcare | #248 |
| class analysis | #249 |
| factors allergic | #249 |
| baseline incidence | #249 |
| therapy severe | #250 |
| clinical science | #250 |
| biological therapy | #251 |
| tlr2 gene | #251 |
| communism | #252 |
| contact animals | #253 |
| asthma symptoms | #253 |
| cold air | #253 |
| china factors | #253 |
| hormonal influences | #254 |
| lowgrade inflammation | #255 |
| atopic disease | #255 |
| preschool dermatitis | #256 |
| low pa | #256 |
| h4 acetylation | #256 |
| human asthma | #257 |
| adolescent asthma | #257 |
| 454pyrosequencing | #257 |
| body mass children | #257 |
| niaid | #258 |
| association expression | #258 |
| prediction quality | #259 |
| epidemiological studies | #259 |
| airborne fungi | #259 |
| life symptoms | #260 |
| 2051 | #260 |
| rhinitis allergic | #260 |
| age 6 | #260 |
| exposure early | #260 |
| life asthma | #260 |
| discriminate | #261 |
| westernization | #261 |
| early life | #261 |
| eczema atopic | #261 |
| spink5 | #262 |
| interferon expression | #262 |
| utilization health services | #262 |
| milk pregnancy | #263 |
| development immune | #263 |
| physician diagnosed | #263 |
| protein 15 | #263 |
| alpha1antitrypsin | #263 |
| children associations | #264 |
| indoor exposures | #265 |
| tightly linked | #265 |
| latex sensitization | #265 |
| exposure traffic | #265 |
| nox concentrations | #266 |
| increase asthma | #266 |
| settled dust | #267 |
| age 13 years | #267 |
| early work | #267 |
| pollen sensitization | #268 |
| prick | #269 |
| rhinitis | #269 |
| fever children | #269 |
| allergen extracts | #270 |
| hypersensitivity immune | #270 |
| symptom prevalence | #270 |
| conditions asthma | #271 |
| relation body mass | #272 |
| child chromosomes | #272 |
| dipeptidyl peptidases | #273 |
| study centres | #273 |
| objective markers | #274 |
| asthma control patients | #274 |
| inflammatory properties | #275 |
| exposure female | #276 |
| host microbiome | #276 |
| extracellular polysaccharides | #277 |
| dust samples | #277 |
| future asthma | #277 |
| male microbiota | #277 |
| increased exposure | #278 |
| study birth | #279 |
| tests allergens | #280 |
| hire | #280 |
| remedy | #280 |
| questionnaires adolescent | #281 |
| allergies asthma | #282 |
| child dermatitis | #282 |
| 6 years | #282 |
| adolescent animals | #282 |
| randomeffects | #284 |
| collection methods | #284 |
| impulse oscillometry | #284 |
| 17 children | #285 |
| population burden | #285 |
| allergic symptoms | #286 |
| cells ilc2s | #287 |
| tests respiratory | #287 |
| differences asthma | #287 |
| gg 95 | #288 |
| geometric ratio | #288 |
| epidemiological surveys | #289 |
| pollution air | #289 |
| hdms | #289 |
| data normalization | #290 |
| role asthma | #290 |
| risk factors children | #290 |
| allergic manifestations | #291 |
| asthma increased | #291 |
| eczema food | #292 |
| asthma factors | #292 |
| cohort participants | #293 |
| longitudinal cohort study | #293 |
| environnement | #293 |
| answered | #293 |
| indoor exposure | #293 |
| recruitment domain | #293 |
| exposure environmental | #293 |
| allergic perennial | #293 |
| cbmc | #294 |
| asthma data | #294 |
| mucosal surfaces | #296 |
| smoke pollution | #297 |
| pollution respiratory | #297 |
| bifidobacterium | #298 |
| global synthesis | #298 |
| unification | #299 |
| obesity asthma | #299 |
| nonatopic | #299 |
| exposure benzene | #299 |
| exposure allergic | #299 |
| paxgene | #299 |
| infancy development | #300 |
| risk allergy | #303 |
| asthma drugs | #306 |
| analysis phase | #307 |
| reported association | #307 |
| lumbricoides | #307 |
| severe exacerbations | #308 |
| antigens dermatophagoides | #308 |
| messenger tlymphocytes | #309 |
| mucosal microbiota | #309 |
| 2623 | #309 |
| exposure childhood | #309 |
| ige sensitization | #309 |
| neonatal immune | #309 |
| controlled asthma | #311 |
| factors early | #311 |
| birth cohort studies | #312 |
| atopic march | #312 |
| midexpiratory | #312 |
| allergy age | #313 |
| asthma inflammatory | #313 |
| signal transducer activator | #314 |
| skin examination | #314 |
| variance animals antigens | #315 |
| jusqu | #315 |
| genotyping data | #315 |
| bacillus spores | #315 |
| independent study | #316 |
| 2 toll | #316 |
| older siblings | #317 |
| child comorbidity | #318 |
| adjustment covariates | #318 |
| pregnancy expression | #318 |
| compared children | #319 |
| fpr2 | #320 |
| bmi united states | #320 |
| il5 il13 | #320 |
| chronic airway inflammation | #321 |
| mfi20 | #321 |
| moisturizer | #323 |
| children birth | #324 |
| ige responses | #325 |
| maximal expiratory | #325 |
| 2 yrs | #326 |
| airway hyperresponsiveness ahr | #326 |
| stratified sample | #326 |
| flg mutations | #327 |
| ichthyosis vulgaris | #327 |
| recurrent wheeze | #328 |
| bedrooms | #328 |
| active smoking | #328 |
| selfadministered questionnaire | #328 |
| extracellular dna | #329 |
| glycolylneuraminic | #330 |
| male milk | #330 |
| demethylation | #331 |
| floor dust | #331 |
| pollutant levels | #331 |
| accuracy analysis | #331 |
| reference equations | #331 |
| dermatophagoides asthma | #331 |
| onset asthma | #333 |
| streptococcaceae | #333 |
| asthma biomarkers | #333 |
| upper respiratory | #334 |
| development sensitization | #334 |
| reduced lung function | #334 |
| children controls | #335 |
| boluses | #336 |
| asthma china | #336 |
| risk current | #337 |
| prevalence surveys | #337 |
| 1st year | #337 |
| predictive risk factors | #337 |
| childhood atopic | #338 |
| 3113 | #338 |
| risk eczema | #339 |
| respiratory outcomes | #339 |
| asthma parents | #340 |
| medical advice | #340 |
| exposure development | #341 |
| humans prevalence | #341 |
| adultonset asthma | #341 |
| filaggrin gene | #342 |
| kitchen | #342 |
| persistent wheeze | #342 |
| age introduction | #343 |
| nonatopic asthma | #343 |
| age 9 | #344 |
| breast fed | #345 |
| stat6 transcription | #346 |
| hypersensitivity | #346 |
| 90th | #348 |
| childhood onset | #349 |
| increasing prevalence | #350 |
| rates asthma | #350 |
| prevalence | #350 |
| exposed children | #350 |
| factors surveys | #351 |
| th1 th2 cells | #353 |
| activator transcription | #354 |
| repeated episodes | #356 |
| freeways | #358 |
| genetic interaction | #359 |
| purposepatients | #359 |
| subsequent asthma | #360 |
| regression approach | #360 |
| kazal | #360 |
| eurotium | #361 |
| asthma disease | #361 |
| strength association | #361 |
| children cohort | #361 |
| cord blood | #363 |
| expression asthma | #363 |
| age 3 | #363 |
| farming practices | #364 |
| allergic outcomes | #364 |
| food sensitization | #364 |
| annual concentrations | #365 |
| austria germany | #365 |
| children reported | #366 |
| chronic inflammatory disorders | #366 |
| lactadherin | #368 |
| atopic status | #369 |
| earlylife exposure | #370 |
| single snp | #370 |
| expression tlr2 | #370 |
| adolescent air | #370 |
| testing procedures | #371 |
| 1159 | #371 |
| austria switzerland | #371 |
| conclusionwe | #371 |
| obesity prevalence | #373 |
| east west | #373 |
| time activity | #373 |
| 22 countries | #374 |
| asthmatic symptoms | #374 |
| asthma current | #374 |
| performance accuracy | #374 |
| paragraphs | #374 |
| foxp3 tregs | #375 |
| smoking asthma | #375 |
| asthma cases | #376 |
| upper respiratory tract | #376 |
| statistical approaches | #377 |
| associations exposure | #377 |
| cows milk | #377 |
| positional cloning | #377 |
| mite allergens | #379 |
| parental reports | #379 |
| population studies | #379 |
| dietary strategies | #381 |
| pieces | #382 |
| inverse association | #383 |
| unifying | #384 |
| measles vaccination | #384 |
| preschool cohort studies | #384 |
| normal lung function | #385 |
| chronic asthma | #386 |
| latex | #386 |
| bronchial | #386 |
| impaired lung function | #386 |
| alliance | #388 |
| gene environment | #389 |
| allergie | #390 |
| haplotype analyses | #391 |
| immunological analysis | #391 |
| potential association | #391 |
| critical window | #391 |
| 11 year | #392 |
| cde | #393 |
| mmp9 gene | #394 |
| 14 year | #394 |
| early feeding | #394 |
| risk sensitization | #394 |
| linear regressions | #395 |
| polymorphism gene | #395 |
| increased risk asthma | #395 |
| immunological mechanisms | #396 |
| th2 th1 | #398 |
| respiratory health | #399 |
| study polymorphisms | #399 |
| salmeterol xinafoate | #399 |
| receptor cx3cr1 | #400 |
| antiviral responses | #401 |
| regions countries | #402 |
| receptor polymorphisms | #402 |
| 2033 | #402 |
| exposure animals | #403 |
| length time | #403 |
| analysis asthma | #403 |
| plea | #404 |
| timothy grass | #405 |
| study agreement | #405 |
| allergens | #405 |
| allergen exposure | #406 |
| cells asthma | #406 |
| production ifngamma | #406 |
| mugwort | #407 |
| childhood allergic | #407 |
| 071 | #407 |
| data cohort | #409 |
| geneenvironment interaction | #409 |
| mold exposure | #410 |
| living room | #411 |
| common occurrence | #411 |
| endotoxin exposure | #411 |
| blood rna | #413 |
| gene variations | #413 |
| blood cb | #413 |
| ige synthesis | #414 |
| germany | #415 |
| facemasks | #416 |
| mite allergen | #416 |
| childhood exposure | #416 |
| house dust | #417 |
| 7 years | #418 |
| bronchial hyperresponsiveness | #418 |
| illness asthma | #418 |
| extended haplotypes | #419 |
| age 2 years | #420 |
| population sample | #420 |
| alimentary | #420 |
| prenatal factors | #421 |
| halfwidth | #421 |
| confers protection | #424 |
| tnc | #424 |
| cytokine secretion | #426 |
| asthma eczema | #427 |
| parasitic infections | #427 |
| asthma treatment | #428 |
| childhood eczema | #429 |
| duration breastfeeding | #429 |
| tlr1 | #430 |
| childrens hospitals | #430 |
| allergic conditions | #431 |
| clinical examinations | #432 |
| risk overweight | #433 |
| 441 | #433 |
| specific sensitization | #434 |
| respiratory allergic | #434 |
| allergy diagnosis | #438 |
| decrements | #438 |
| age odds ratio | #438 |
| tobit | #438 |
| conundrum | #440 |
| asthma gene | #441 |
| annual prevalence | #441 |
| population asthma | #442 |
| chronic inflammatory diseases | #443 |
| male odds | #443 |
| fecal microbiota | #443 |
| inception | #443 |
| persisting | #444 |
| asthma effects | #444 |
| cell phenotypes | #444 |
| increase bmi | #445 |
| observed differences | #445 |
| asthma respiratory | #446 |
| specific serum | #446 |
| exposure respiratory | #448 |
| ethnic origin | #449 |
| allergic rhinoconjunctivitis | #449 |
| allergy food | #450 |
| 033 | #450 |
| adult asthmatics | #451 |
| associations asthma | #452 |
| n149 | #452 |
| including asthma | #455 |
| school entry | #456 |
| dermatophagoides farinae | #457 |
| pregnancy increased risk | #457 |
| germany health | #458 |
| provocation tests | #460 |
| mice role | #460 |
| allergic risk | #460 |
| external environment | #460 |
| airway hyper | #462 |
| westernized | #463 |
| rural health | #464 |
| asthma higher | #464 |
| asthma control test | #465 |
| environmental factors | #466 |
| postal questionnaire | #467 |
| cells innate | #467 |
| opposite effects | #467 |
| immunocap | #468 |
| severity asthma | #468 |
| alex | #468 |
| so2 concentrations | #469 |
| nod1 signaling | #470 |
| early identification | #470 |
| clinical asthma | #470 |
| emphasised | #471 |
| asthma rhinitis | #471 |
| exposure | #471 |
| microbial counts | #471 |
| birth cohorts | #473 |
| antibiotics children | #473 |
| fodder | #473 |
| yrs | #474 |
| 1133 | #474 |
| cross sectional survey | #476 |
| champ | #476 |
| exposure antibiotics | #477 |
| early exposure | #481 |
| risk severity | #482 |
| childhood environment | #483 |
| asthma association | #484 |
| total immunoglobulin | #484 |
| subphenotypes | #485 |
| children | #486 |
| immunity genes | #486 |
| atopic disorders | #486 |
| phenotypes | #487 |
| prospective birth cohort | #487 |
| exposure data | #489 |
| potential confounding | #489 |
| genes environment | #490 |
| studies rhinitis | #490 |
| multicenter cohort | #491 |
| snp association | #494 |
| uncontrolled asthma | #495 |
| polymorphisms association | #495 |
| lifestyles | #496 |
| age 10 | #496 |
| children jia | #497 |
| southern germany | #497 |
| housing animal | #497 |
| phenotype polymorphism | #498 |
| individual level | #498 |
| asthma severe | #498 |
| respiratory hypersensitivity | #500 |
| omega6 fatty acids | #500 |
| birth age | #501 |
| asthma susceptibility | #503 |
| lung function children | #503 |
| sensitizations | #504 |
| white children | #505 |
| diet diversity | #505 |
| tests specific | #505 |
| methods studies | #505 |
| ranks | #508 |
| allergy children | #508 |
| childhood respiratory | #509 |
| rna samples | #509 |
| prevalence rates | #509 |
| housing humans | #510 |
| stimulation lps | #511 |
| perennial | #511 |
| il15 | #513 |
| age 10 years | #514 |
| europe female | #514 |
| children exposed | #515 |
| asthma prevalence | #515 |
| infections asthma | #516 |
| cities china | #516 |
| asthma bronchiolitis | #516 |
| levels children | #516 |
| receptor tlr | #516 |
| cd4cd25high | #517 |
| dpps | #518 |
| atopic conditions | #519 |
| th2 immune | #519 |
| haplotype association | #520 |
| eczema asthma | #522 |
| neutrophils eosinophils | #522 |
| children maternal | #523 |
| risk factors asthma | #523 |
| age 1 year | #523 |
| polymorphisms snps | #523 |
| p0041 | #523 |
| rural areas | #524 |
| time window | #524 |
| adolescence age | #525 |
| maternal vitamin | #525 |
| trans fatty acids | #526 |
| baseline participants | #528 |
| bmi increased risk | #528 |
| obesity body mass | #528 |
| blood humans | #529 |
| c‐reactive protein | #529 |
| 117 95 | #529 |
| allergens animals | #529 |
| persistent asthma | #530 |
| edifice | #530 |
| obesity smoking | #531 |
| environmental bacteria | #531 |
| protect | #532 |
| samples children | #532 |
| oral tolerance | #533 |
| allergic airway inflammation | #534 |
| children methods | #535 |
| immune stimulation | #536 |
| topic rhinitis | #537 |
| il4r | #538 |
| blood eosinophil counts | #539 |
| industrialised | #540 |
| human microbiota | #541 |
| adolescence early adulthood | #541 |
| airway symptoms | #542 |
| rubella virus | #543 |
| immunological markers | #543 |
| pregnancy asthma | #543 |
| lipopolysaccharide receptors | #543 |
| cypress | #544 |
| pathomechanisms | #545 |
| regulatory cell | #546 |
| 17q12 | #547 |
| antitrypsin alpha | #547 |
| greenness | #548 |
| oligoarticular | #549 |
| floorcoverings | #549 |
| hypersensitivity humans | #550 |
| epidemic proportions | #553 |
| association children | #553 |
| isotype switching | #553 |
| multidisciplinary study | #554 |
| lung microbiome | #554 |
| children parental | #555 |
| mental health patients | #555 |
| asthma status | #556 |
| overweight prevalence | #556 |
| allergic rhinitis asthma | #558 |
| aqlq | #558 |
| 1129 | #559 |
| letzten | #560 |
| blood eosinophils | #560 |
| activity body | #561 |
| reduced exposure | #564 |
| 2 immunity | #566 |
| inhaled steroids | #566 |
| hormonal contraceptives | #566 |
| 077 | #567 |
| immune regulatory | #569 |
| initial observations | #570 |
| exposure matrix | #570 |
| tripeptidyl | #570 |
| asthma symptom | #571 |
| health urban | #571 |
| levels total | #575 |
| diseases prevalence | #575 |
| hcs patients | #575 |
| affluence | #575 |
| creactive protein levels | #579 |
| atopic asthma | #579 |
| followups | #580 |
| oro | #580 |
| age controls | #581 |
| association obesity | #581 |
| flanking regions | #582 |
| asthma population | #582 |
| fdr | #582 |
| tlr6 | #584 |
| uht | #584 |
| asthma severity | #584 |
| function asthma | #585 |
| bacterial microbiome | #588 |
| gsdmb | #589 |
| longum | #590 |
| n63 | #590 |
| skin test | #591 |
| 1 antitrypsin | #592 |
| holiday | #593 |
| endotoxin concentrations | #593 |
| il1rl1 | #596 |
| gasdermin | #596 |
| factors respiratory | #596 |
| model asthma | #597 |
| zeigen | #598 |
| total specific | #598 |
| pathogenesis asthma | #598 |
| advising | #598 |
| genetic environmental | #600 |
| galactosylation | #600 |
| active immunity | #601 |
| factors humans | #602 |
| 048 | #603 |
| pregnancy maternal | #603 |
| hladqa1 | #604 |
| statistical analyses | #604 |
| humans human | #604 |
| agents asthma | #606 |
| microbes | #606 |
| sensitization | #606 |
| microbiome studies | #607 |
| ige production | #608 |
| allergic rhinitis | #610 |
| 2 inflammation | #610 |
| infant feeding practices | #611 |
| bolus | #612 |
| 11–13 | #612 |
| work life | #612 |
| regulatory molecules | #612 |
| pollen allergens | #616 |
| aged allergens | #619 |
| chronic stress | #619 |
| albania | #619 |
| urban populations | #620 |
| life age | #621 |
| arthropod proteins | #621 |
| body plethysmography | #621 |
| deep phenotyping | #622 |
| unstimulated | #623 |
| radioallergosorbent | #623 |
| functional features | #625 |
| endotoxin | #627 |
| 779 | #627 |
| data prevalence | #627 |
| protective properties | #629 |
| crosssectional | #629 |
| school children | #632 |
| smoking surveys | #632 |
| models asthma | #633 |
| feeding patterns | #635 |
| exacerbating | #635 |
| settled | #635 |
| child asthma | #636 |
| children atopic dermatitis | #637 |
| standardized questionnaire | #637 |
| lifetime prevalence | #638 |
| european children | #639 |
| igg glycosylation | #639 |
| factors urban | #639 |
| clustering approach | #641 |
| grass pollen | #642 |
| innate immunity | #642 |
| humans microbiota | #643 |
| years increased | #645 |
| symptoms | #646 |
| innate lung | #647 |
| pollen concentrations | #648 |
| participation rates | #650 |
| life children | #650 |
| kindern | #650 |
| pets | #650 |
| health rural | #650 |
| glucocorticoid induced | #652 |
| helsinki | #653 |
| dermatitis allergic | #654 |
| comprehensive analysis | #654 |
| prospective studies association | #656 |
| 16 countries | #658 |
| common chronic | #659 |
| latent classes | #662 |
| age 1 | #662 |
| conclusion data | #663 |
| cd14 expression | #664 |
| hygiene | #665 |
| di2ethylhexyl | #665 |
| abpa | #665 |
| pvalues | #666 |
| hypertonic saline | #667 |
| chemokine cx3cl1 | #668 |
| adult lung | #669 |
| standardized questionnaires | #670 |
| birth cohort | #671 |
| susceptibility locus | #672 |
| central european | #672 |
| cellules | #673 |
| études | #674 |
| jobs | #676 |
| ilc2s | #677 |
| age 45 years | #679 |
| common infections | #680 |
| dairy farm | #681 |
| random sample | #681 |
| protective | #681 |
| female forced | #681 |
| egg allergy | #682 |
| cohorte | #683 |
| recurrent wheezing | #685 |
| dietary habits | #685 |
| childhood experiences | #686 |
| factors air | #688 |
| european community | #692 |
| major gene | #693 |
| doctor | #693 |
| turkish | #694 |
| factors skin | #695 |
| physical examination | #699 |
| rhinitis symptoms | #702 |
| hypersensitivity inflammation | #703 |
| sensitization food | #703 |
| microbial flora | #703 |
| risk obesity | #703 |
| tao | #707 |
| dramatic increase | #708 |
| 459 | #708 |
| microbial interactions | #708 |
| perpetuation | #709 |
| immune activation | #709 |
| population surveys | #712 |
| immunologic tlymphocytes | #712 |
| children time | #713 |
| pregnancy children | #718 |
| bacterial spores | #720 |
| mediated diseases | #721 |
| allergy asthma | #722 |
| ratio aor | #724 |
| function children | #727 |
| sensitized patients | #727 |
| alias | #734 |
| 95 males | #734 |
| il4 il13 | #738 |
| population adolescent | #741 |
| linkage chromosome | #741 |
| fractional exhaled | #742 |
| nonasthmatic | #742 |
| farms | #743 |
| treg cell | #745 |
| type 5 | #748 |
| traffic air | #748 |
| ifih1 | #749 |
| children low | #753 |
| earlier study | #754 |
| total lung | #755 |
| h20 | #758 |
| environment interactions | #758 |
| aeroallergens | #759 |
| moderate levels | #764 |
| indoor dust | #766 |
| edn1 | #768 |
| air trapping | #768 |
| pulmonary function tests | #769 |
| allergists | #769 |
| hscrp levels | #769 |
| blood leukocytes | #770 |
| hyperresponsiveness | #770 |
| pattern recognition receptors | #770 |
| asthma adults | #771 |
| strabismus surgery | #772 |
| nucleotide receptors | #773 |
| term impact | #773 |
| incidence longitudinal | #773 |
| volume humans | #777 |
| rhinitis children | #781 |
| new associations | #784 |
| studies asthma | #784 |
| children allergic | #785 |
| factors incidence | #785 |
| nonallergic | #788 |
| factors tobacco | #788 |
| shortness breath | #789 |
| asthma therapy | #791 |
| male metaanalysis | #793 |
| gis | #793 |
| children health | #794 |
| airway hyperresponsiveness | #795 |
| βdiversity | #795 |
| distinct trajectories | #796 |
| natural habitat | #796 |
| personalization | #798 |
| pc20 | #798 |
| card15 | #799 |
| protective effects | #799 |
| 45 years | #800 |
| pair 1 chromosomes | #801 |
| confer | #802 |
| allergen | #805 |
| age 4 years | #806 |
| infant food | #807 |
| dairy farms | #808 |
| tenascin | #810 |
| bifidobacterium longum | #810 |
| exposure age | #810 |
| subclinical inflammation | #811 |
| pteronyssinus | #811 |
| peak flow | #813 |
| bacillus licheniformis | #813 |
| initial data | #814 |
| boiled | #814 |
| onset age | #815 |
| foe | #816 |
| foxp3 | #817 |
| brevibacterium | #818 |
| positive skin | #819 |
| 0053 | #820 |
| food infant | #821 |
| skin tests | #822 |
| breastfeeding duration | #822 |
| spt | #827 |
| trier | #830 |
| studies respiratory | #830 |
| prevention strategies | #831 |
| asthma health | #832 |
| current analysis | #833 |
| rad50 | #833 |
| promoter polymorphisms | #834 |
| regularly | #835 |
| igg4 | #835 |
| farinae | #835 |
| snps haplotypes | #835 |
| adolescent age | #837 |
| cx3cr1 | #838 |
| exhaled breath | #838 |
| toll receptors | #839 |
| parental smoking | #839 |
| public health problem | #839 |
| asthma bronchi | #839 |
| subsequent development | #840 |
| cladosporium | #841 |
| chronification | #844 |
| fetal blood | #845 |
| modifies | #845 |
| innate | #849 |
| potted | #849 |
| bacterial endotoxin | #850 |
| maternal exposure | #850 |
| allergen sensitization | #852 |
| inspections | #854 |
| 17q | #855 |
| provocation | #856 |
| infant health | #856 |
| infant infant | #858 |
| repeatedly | #861 |
| age 5 | #861 |
| paracetamol | #862 |
| questionnaires young adult | #864 |
| receptors tlrs | #864 |
| asthma lung | #864 |
| volatile organic | #865 |
| airway eosinophilia | #866 |
| ige | #866 |
| birth cohort study | #866 |
| outdoor air pollution | #874 |
| cumulative incidence | #874 |
| latent class analysis | #875 |
| hmos | #878 |
| dermatitis | #878 |
| microbiome humans | #879 |
| 057 | #880 |
| 1940 | #880 |
| 12q | #884 |
| ifngamma tnfalpha | #886 |
| 856 | #888 |
| brink | #888 |
| oscillometry | #890 |
| european populations | #891 |
| bacterial counts | #892 |
| subsample | #895 |
| exposure study | #895 |
| esl | #896 |
| asthma incidence | #896 |
| impact asthma | #900 |
| immunoglobulin ige | #902 |
| inflammation airway | #902 |
| breastfed | #904 |
| respiration disorders | #905 |
| allergen induced | #907 |
| adult asthma | #908 |
| shortness | #908 |
| children overweight | #910 |
| microbiome composition | #910 |
| microbiota development | #912 |
| complex disease | #917 |
| cow milk | #917 |
| immunity innate | #919 |
| peripheral blood samples | #920 |
| methods cross | #920 |
| 710 | #920 |
| estonia | #923 |
| prospective birth | #927 |
| sectional population | #928 |
| sounds | #928 |
| biomérieux | #929 |
| ilcs | #929 |
| participants baseline | #932 |
| 026 | #939 |
| lactococcus lactis | #939 |
| potential confounders | #940 |
| dermatophagoides | #940 |
| 13 years | #940 |
| floors | #942 |
| life style | #944 |
| microbiome host | #949 |
| 055 | #950 |
| identification genes | #952 |
| environmental effects | #952 |
| 454 pyrosequencing | #953 |
| solids | #954 |
| polymorphisms | #954 |
| 1120 | #954 |
| genotyped | #954 |
| asthma exercise | #954 |
| human life | #955 |
| infections child | #957 |
| fever | #959 |
| children countries | #959 |
| domestic | #961 |
| exposures | #961 |
| rhinitis asthma | #961 |
| disease asthma | #964 |
| nasal secretions | #964 |
| immunoglobulin male | #965 |
| cytokines female | #965 |
| obesity children | #966 |
| innsbruck | #970 |
| readings | #971 |
| immunization immunoglobulin | #973 |
| fev | #973 |
| onset child child | #974 |
| teenagers | #975 |
| gondii infection | #976 |
| orphan receptor | #976 |
| bmi physical activity | #977 |
| nucleotide promoter | #978 |
| respiratory conditions | #979 |
| 682 | #981 |
| xinafoate | #981 |
| receptor gene | #981 |
| yearly | #982 |
| 1333 | #983 |
| small effects | #984 |
| child cohort | #986 |
| adolescents asthma | #987 |
| 12 months age | #990 |
| pasteurization | #991 |
| c3h hej | #991 |
| 068 | #991 |
| function development | #992 |
| hercules | #992 |
| asthma humans | #992 |
| sectional | #994 |
| design methods | #994 |
| immunoglobulin class | #995 |
| diagnosis asthma | #998 |
| respiratory symptoms | #1001 |
| bradykinin receptors | #1003 |
| yoghurt | #1005 |
| maternally | #1006 |
| rural population | #1006 |
| ppg | #1006 |
| linens | #1009 |
| preventive measures | #1010 |
| pt15 | #1012 |
| asthma outcomes | #1014 |
| timeframe | #1016 |
| phytohemagglutinin | #1017 |
| 039 | #1017 |
| association physical activity | #1018 |
| median levels | #1019 |
| strongest associations | #1020 |
| asthma medication | #1021 |
| western countries | #1022 |
| sought | #1024 |
| raw milk | #1027 |
| asthma adult | #1029 |
| outcome variables | #1030 |
| upper airways | #1031 |
| genomewide association | #1033 |
| 096 | #1033 |
| asthmatic children | #1035 |
| veillonella | #1037 |
| cell child | #1038 |
| breastmilk | #1039 |
| dairying | #1039 |
| nod1 | #1042 |
| milieu | #1046 |
| disease children | #1046 |
| missing values | #1047 |
| exposure conditions | #1048 |
| controls age | #1051 |
| severe allergic | #1057 |
| il5 | #1058 |
| infant gut | #1059 |
| hobbies | #1059 |
| metalloprotease | #1060 |
| pregnancy prospective | #1062 |
| class switching | #1064 |
| signaling adaptor | #1065 |
| predictor | #1066 |
| rural | #1066 |
| 8 12 | #1068 |
| skin sensitization | #1068 |
| gnp | #1069 |
| moraxella | #1070 |
| central europe | #1070 |
| margarine | #1070 |
| prevalence prospective | #1071 |
| expression humans | #1072 |
| interrelation | #1075 |
| cross sectional study | #1077 |
| large population | #1077 |
| west east | #1079 |
| box transcription | #1079 |
| trflp | #1080 |
| factors child | #1081 |
| risk development | #1081 |
| life respiratory | #1082 |
| study areas | #1083 |
| allergic airway | #1083 |
| cells tregs | #1083 |
| sufferers | #1086 |
| children prevalence | #1086 |
| maternal asthma | #1089 |
| gene expression data | #1090 |
| lca | #1090 |
| exposure delayed | #1091 |
| longduration | #1094 |
| disintegrin | #1095 |
| proteins polymorphism | #1096 |
| nationality | #1096 |
| 930 | #1097 |
| supplementary data | #1098 |
| overweight bmi | #1101 |
| enfants | #1103 |
| forkhead | #1103 |
| conjunctivitis | #1104 |
| studies evidence | #1104 |
| adolescence adulthood | #1105 |
| cd14 | #1106 |
| weight risk | #1116 |
| 248 | #1116 |
| risk gene | #1117 |
| characteristically | #1117 |
| associations observed | #1118 |
| meat consumption | #1119 |
| prevalences | #1122 |
| association exposure | #1123 |
| intermediate phenotypes | #1125 |
| newonset | #1126 |
| sscp analysis | #1127 |
| lung function decline | #1127 |
| il12b | #1127 |
| based clustering | #1128 |
| taxonomies | #1130 |
| endotoxins | #1130 |
| expiratory flow | #1132 |
| age birth | #1132 |
| 859 | #1134 |
| based birth | #1136 |
| pet ownership | #1144 |
| log2 | #1144 |
| gondii | #1145 |
| allergic asthma | #1145 |
| pediatric asthma | #1146 |
| patients severe asthma | #1146 |
| skewness | #1152 |
| 837 | #1152 |
| humans respiratory | #1153 |
| environmental tobacco | #1154 |
| regions china | #1154 |
| disease cohort | #1156 |
| dust mite | #1156 |
| 862 | #1158 |
| deciphering | #1159 |
| countries prevalence | #1160 |
| epidemiological evidence | #1164 |
| 027 | #1165 |
| anti ige | #1165 |
| rarer | #1168 |
| preschool cohort | #1169 |
| inbred balb receptors | #1172 |
| crowding | #1173 |
| genomewide | #1176 |
| receptors ige | #1178 |
| farmers | #1179 |
| phase behaviour | #1180 |
| croup | #1183 |
| serum immunoglobulin | #1184 |
| contre | #1184 |
| food allergens | #1186 |
| asthma bronchodilator | #1189 |
| new paradigm | #1189 |
| levels measured | #1190 |
| exhaled | #1194 |
| respiratory tract | #1196 |
| censored | #1197 |
| children association | #1200 |
| management children | #1206 |
| rorc | #1207 |
| bacterial taxa | #1208 |
| fungi humans | #1211 |
| sedentary lifestyle | #1211 |
| risk childhood | #1214 |
| flg | #1215 |
| regulatory cells tregs | #1216 |
| risk children | #1218 |
| food hypersensitivity | #1218 |
| orphan | #1219 |
| bradykinin | #1220 |
| eosinophilic inflammation | #1221 |
| day life | #1223 |
| factor activity | #1225 |
| 047 | #1229 |
| male pregnancy | #1233 |
| balb ovalbumin | #1234 |
| age menarche | #1236 |
| th1 th2 | #1236 |
| gene variants | #1236 |
| adult allergens | #1240 |
| european population | #1241 |
| antitrypsin | #1243 |
| small children | #1243 |
| ulm | #1247 |
| protective factors | #1250 |
| objective aim | #1251 |
| early years | #1252 |
| pertussis | #1252 |
| peripheral blood leukocytes | #1253 |
| food items | #1253 |
| airway hyperreactivity | #1253 |
| questionnaires | #1256 |
| shop | #1256 |
| debated | #1257 |
| telephone interviews | #1260 |
| lung function | #1260 |
| mite | #1262 |
| studies gene | #1263 |
| disease case | #1264 |
| yogurt | #1267 |
| temperature humidity | #1268 |
| overweight children | #1274 |
| occupational exposures | #1277 |
| pollution indoor | #1281 |
| fev1 forced | #1281 |
| children exposure | #1282 |
| shannon | #1284 |
| infections risk | #1284 |
| diseases occupational | #1289 |
| immunomodulating | #1289 |
| pollution exposure | #1292 |
| potential risk factors | #1293 |
| 182 | #1295 |
| body sites | #1296 |
| tests risk | #1299 |
| age baseline | #1301 |
| gme | #1302 |
| explain | #1303 |
| topic polymorphism | #1303 |
| venipuncture | #1306 |
| endotypes | #1309 |
| lymphocytes regulatory | #1312 |
| factor development | #1312 |
| th1 cytokines | #1314 |
| industrially | #1314 |
| 038 | #1318 |
| sought determine | #1320 |
| harmonization | #1322 |
| epidemiological survey | #1322 |
| cell numbers | #1322 |
| objective investigate | #1327 |
| neuraminic | #1329 |
| cleaning | #1329 |
| concerted | #1330 |
| lrti | #1330 |
| zusammenfassung | #1331 |
| prevalence rural | #1331 |
| gambia | #1332 |
| respiratory allergy | #1332 |
| induced sputum | #1335 |
| sponsorship | #1335 |
| loft | #1337 |
| passive smoking | #1340 |
| 897 | #1342 |
| mass breast | #1343 |
| multiple testing | #1346 |
| puberty | #1347 |
| airway function | #1349 |
| th2 cells | #1351 |
| irf1 | #1353 |
| expired | #1353 |
| oxide feno | #1353 |
| atopic humans | #1354 |
| toxoplasma gondii | #1355 |
| 267 | #1357 |
| reduction risk | #1358 |
| 16 18 | #1358 |
| asthmatics | #1359 |
| science foundation | #1359 |
| 2 innate | #1360 |
| lung microbiota | #1363 |
| france germany | #1366 |
| 279 | #1366 |
| maternal immune | #1367 |
| asthma female | #1369 |
| innate lymphoid | #1374 |
| whey proteins | #1378 |
| preventive strategies | #1381 |
| austria | #1382 |
| common forms | #1383 |
| total ige | #1383 |
| lactococcus | #1386 |
| studies lung | #1387 |
| management asthma | #1388 |
| environmental | #1389 |
| disagreement | #1389 |
| childhood adult | #1390 |
| early intervention | #1395 |
| milk proteins | #1403 |
| risk developing | #1404 |
| severe atopic | #1404 |
| q21 | #1404 |
| fef25 | #1406 |
| airway inflammation | #1407 |
| air samples | #1410 |
| indoor | #1412 |
| dust exposure | #1415 |
| baseline followup | #1417 |
| sige | #1417 |
| immune mechanisms | #1418 |
| bronchodilators | #1418 |
| microbial | #1419 |
| hapmap | #1421 |
| il13 | #1421 |
| bronchitis | #1422 |
| longitudinal cohort | #1422 |
| male multivariate | #1427 |
| pulmonary eosinophilia | #1429 |
| pair 17 | #1429 |
| timepoint | #1433 |
| asthmatic | #1433 |
| chronic inflammatory | #1435 |
| exhaled nitric | #1440 |
| irak4 | #1442 |
| induced airway | #1443 |
| centres | #1444 |
| inflammatory pathways | #1444 |
| overweight | #1445 |
| studies europe | #1445 |
| age 5 years | #1446 |
| bronchodilator response | #1448 |
| airway responses | #1451 |
| factors prevalence | #1454 |
| agricultural workers | #1460 |
| asthma clinical | #1460 |
| unique opportunity | #1461 |
| infancy | #1461 |
| immunizations | #1463 |
| barcelona | #1464 |
| 706 | #1464 |
| a20 | #1466 |
| hand eczema | #1468 |
| association polymorphism | #1468 |
| recognition receptors | #1470 |
| surveys questionnaires | #1470 |
| asthma compared | #1472 |
| immunity | #1473 |
| leur | #1474 |
| operating characteristics | #1474 |
| adolescence | #1475 |
| nod2 signaling | #1476 |
| 362 | #1477 |
| innate immune responses | #1478 |
| 1 levels | #1478 |
| meeting | #1479 |
| dgge | #1480 |
| otitis | #1482 |
| paediatricians | #1490 |
| immunologic mechanisms | #1493 |
| peptidases | #1494 |
| strongest predictor | #1494 |
| populationbased cohort | #1504 |
| ionomycin | #1505 |
| flexural | #1505 |
| tlr2 | #1506 |
| birch pollen | #1507 |
| structured interviews | #1508 |
| tlr2 tlr4 | #1509 |
| igg1 | #1511 |
| understood | #1512 |
| bacterial composition | #1514 |
| sulphur dioxide | #1514 |
| ergosterol | #1515 |
| epidemiological data | #1517 |
| living environment | #1517 |
| moderate asthma | #1517 |
| pasteurized | #1518 |
| latent class | #1520 |
| child welfare | #1521 |
| rôle | #1524 |
| pollution levels | #1524 |
| hladq | #1527 |
| 153 | #1527 |
| respiratory tract infections | #1530 |
| differences prevalence | #1533 |
| jia | #1536 |
| underlying mechanisms | #1536 |
| dust | #1542 |
| 245 | #1551 |
| factors development | #1552 |
| wisconsin | #1555 |
| birthday | #1558 |
| previous 12 months | #1558 |
| children aged | #1564 |
| children increased | #1566 |
| antibiotic exposure | #1567 |
| austrian | #1573 |
| born children | #1578 |
| china female humans | #1579 |
| children risk | #1584 |
| licheniformis | #1584 |
| current studies | #1588 |
| treatment asthma | #1595 |
| trans fatty | #1596 |
| explained | #1596 |
| breastfed infants | #1598 |
| study populations | #1599 |
| tract diseases | #1602 |
| development progression | #1603 |
| 775 | #1603 |
| air microbiology | #1604 |
| regulatory | #1605 |
| disease process | #1607 |
| ascariasis | #1610 |
| male prospective | #1611 |
| neuropeptide | #1612 |
| erythrocyte membranes | #1612 |
| peak expiratory | #1613 |
| cells1 | #1613 |
| familial aggregation | #1617 |
| candidate gene | #1622 |
| ige antibodies | #1624 |
| cells th2 | #1624 |
| early gene | #1626 |
| precision medicine | #1627 |
| short communication | #1627 |
| tolerogenic | #1628 |
| questionnaires young | #1632 |
| studies recurrence | #1634 |
| tcell responses | #1635 |
| newborn infants | #1641 |
| gata3 | #1641 |
| th2 cytokines | #1644 |
| th2 | #1645 |
| nutritional factors | #1647 |
| population based study | #1653 |
| topic surveys | #1653 |
| style male | #1653 |
| card | #1655 |
| microbial diversity | #1656 |
| 034 | #1656 |
| traffic volume | #1656 |
| smoke exposure | #1657 |
| northern europe | #1661 |
| cells transcription | #1661 |
| expiratory volume | #1664 |
| respiratory | #1666 |
| opportunity | #1667 |
| linear discriminant analysis | #1671 |
| followup study | #1677 |
| asthmatic agents | #1678 |
| epidemiologic evidence | #1688 |
| cheese | #1688 |
| employment | #1692 |
| microbiome | #1693 |
| innate immune | #1694 |
| early introduction | #1694 |
| obesity risk | #1694 |
| gitr | #1696 |
| health‐related quality | #1697 |
| aux | #1701 |
| th2 th17 | #1702 |
| phenotyping | #1704 |
| gene interaction | #1704 |
| adulthood | #1706 |
| 476 | #1710 |
| fungal diversity | #1712 |
| provocative | #1716 |
| singlenucleotide polymorphisms | #1717 |
| mere | #1718 |
| house dust mite | #1718 |
| 029 | #1723 |
| life hrqol | #1730 |
| airflow obstruction | #1732 |
| gabon | #1733 |
| asthma control | #1733 |
| genotyping | #1734 |
| anti asthmatic | #1735 |
| innate adaptive | #1739 |
| factors breast | #1742 |
| cytokine genes | #1746 |
| factors children | #1746 |
| 5 7 | #1748 |
| inverse relationship | #1749 |
| helminth parasites | #1749 |
| preschool clinical trials | #1751 |
| inconsistencies | #1753 |
| molds | #1754 |
| male polymorphism | #1756 |
| masks | #1756 |
| fivefold | #1760 |
| gstm1 gstt1 | #1760 |
| chronic airway | #1761 |
| refugees | #1761 |
| bacterial diversity | #1764 |
| susceptibility gene | #1767 |
| street | #1768 |
| environmental tobacco smoke | #1769 |
| association body mass | #1772 |
| soot | #1778 |
| cells airway | #1778 |
| helminth infections | #1779 |
| occupational exposure | #1782 |
| cd4cd25 | #1782 |
| peptidoglycan | #1782 |
| allergic reaction | #1788 |
| exposure assessment | #1789 |
| nucleotide polymorphisms | #1799 |
| generations | #1800 |
| helminths | #1801 |
| 054 | #1801 |
| key feature | #1801 |
| rubella | #1807 |
| life factors | #1809 |
| single nucleotide receptors | #1812 |
| treg cells | #1812 |
| feno | #1817 |
| censoring | #1821 |
| protein 3 | #1821 |
| factors health | #1822 |
| dna fingerprinting | #1823 |
| breastfeeding | #1825 |
| signal transducer | #1828 |
| asthma morbidity | #1828 |
| respiratory illnesses | #1831 |
| 112 | #1831 |
| leisure time | #1834 |
| generational | #1837 |
| vocational | #1838 |
| foxp3 expression | #1841 |
| regulatory cells | #1843 |
| il4 | #1843 |
| heterogeneous disease | #1843 |
| otus | #1845 |
| fetal growth | #1845 |
| forkhead transcription | #1849 |
| sampling methods | #1854 |
| causally | #1855 |
| idiopathic arthritis | #1857 |
| 95 risk factors | #1859 |
| disease incidence | #1878 |
| hypertonic | #1879 |
| friend | #1884 |
| unraveling | #1886 |
| diseases lung | #1886 |
| interleukin33 | #1891 |
| predispose | #1892 |
| age 4 | #1893 |
| aor | #1894 |
| age 2 | #1895 |
| life | #1898 |
| microbe | #1899 |
| lung male | #1900 |
| interleukin5 | #1901 |
| population level | #1901 |
| hrqol | #1903 |
| occupational stress | #1904 |
| jedoch | #1908 |
| brought | #1909 |
| vital capacity | #1909 |
| predictive models | #1914 |
| feeding practices | #1917 |
| coeliac disease | #1918 |
| confounded | #1924 |
| weight breast | #1929 |
| basics | #1932 |
| experimental models | #1932 |
| p0012 | #1933 |
| helminthiasis | #1934 |
| pregnancy prevalence | #1936 |
| child humans | #1938 |
| barrier function | #1941 |
| european commission | #1944 |
| aetiology | #1945 |
| percentiles | #1946 |
| juvenile idiopathic | #1946 |
| cell markers | #1949 |
| galactans | #1951 |
| moisture | #1959 |
| raised | #1959 |
| invading | #1960 |
| asthmatic subjects | #1960 |
| blood eosinophil | #1960 |
| immune mediated | #1960 |
| lps stimulation | #1966 |
| child female | #1966 |
| regulatory region | #1973 |
| 658 | #1975 |
| phenomena infant | #1977 |
| dwellings | #1985 |
| children severe | #1991 |
| dollar | #1994 |
| natural environments | #1997 |
| helper type | #1998 |
| studie | #1999 |
| agriculture | #2000 |
| descriptions | #2000 |
| 041 | #2004 |
| respiratory viral | #2010 |
| infectious agents | #2011 |
| richness | #2012 |
| physical activity pa | #2014 |
| lower frequencies | #2015 |
| life risk | #2018 |
| postnatal exposure | #2019 |
| children data | #2020 |
| diary | #2020 |
| regulation genetic | #2020 |
| physician diagnosis | #2021 |
| bedding | #2024 |
| underline | #2025 |
| relate | #2026 |
| age | #2027 |
| 939 | #2030 |
| bovine milk | #2038 |
| chymase | #2038 |
| ige mediated | #2040 |
| outdoor air | #2041 |
| subsamples | #2046 |
| mass child | #2047 |
| conflicting | #2056 |
| cx3c | #2057 |
| 858 | #2059 |
| schoolage children | #2063 |
| peanuts | #2068 |
| association snps | #2070 |
| standardize | #2072 |
| asthma diagnosis | #2073 |
| bronchial epithelial cells | #2075 |
| early childhood | #2075 |
| polarizing | #2076 |
| discrepant | #2080 |
| asthma quality | #2086 |
| women association | #2087 |
| gastrointestinal microbiome | #2095 |
| confounders | #2097 |
| clinical phenotypes | #2098 |
| abstracts | #2098 |
| dusts | #2099 |
| environment interaction | #2100 |
| symptoms age | #2101 |
| 19th century | #2103 |
| male maternal | #2103 |
| disequilibrium | #2104 |
| tregs | #2109 |
| reduced levels | #2111 |
| bacterial colonization | #2111 |
| dairy products | #2114 |
| permutation | #2116 |
| prevalence children | #2118 |
| alternata | #2118 |
| children higher | #2121 |
| 5q | #2125 |
| child preschool | #2128 |
| protection | #2128 |
| glucans | #2132 |
| year | #2133 |
| th2 cell | #2134 |
| common disease | #2139 |
| mild asthma | #2141 |
| dietary interventions | #2142 |
| animals child | #2145 |
| exhalation | #2145 |
| indoors | #2149 |
| sibling | #2153 |
| offspring mothers | #2154 |
| epigenetic regulation | #2155 |
| immune modulation | #2157 |
| schoolchildren | #2157 |
| ionization time | #2158 |
| studies food | #2161 |
| interleukin4 | #2163 |
| blood samples | #2166 |
| food allergy | #2173 |
| blood sampling | #2175 |
| west | #2178 |
| stat6 | #2178 |
| consumption | #2180 |
| spirometry | #2181 |
| forced expiratory | #2184 |
| utero exposure | #2186 |
| industrialized | #2190 |
| children age | #2192 |
| subsequent risk | #2193 |
| respiratory infections | #2196 |
| topic united states | #2207 |
| occupational diseases | #2208 |
| actinomycetales | #2210 |
| acinetobacter | #2212 |
| 146 | #2213 |
| communicable | #2213 |
| lung epithelial cells | #2215 |
| indoor outdoor | #2215 |
| early development | #2220 |
| onset disease | #2220 |
| female finland | #2221 |
| lung mice | #2229 |
| guardians | #2231 |
| preschool | #2232 |
| 079 | #2234 |
| 18 months | #2236 |
| diesel exhaust | #2242 |
| 12th | #2242 |
| childhood overweight | #2245 |
| th17 cell | #2246 |
| bacteria fungi | #2247 |
| spirometric | #2247 |
| immune regulation | #2248 |
| preventive | #2249 |
| whooping | #2249 |
| bacterial load | #2251 |
| functional relevance | #2252 |
| bmi risk | #2257 |
| christianity | #2258 |
| 108 | #2259 |
| specific immunoglobulin | #2259 |
| patients responders | #2267 |
| résultats | #2268 |
| environmental influences | #2271 |
| decanoic | #2274 |
| consistently | #2277 |
| preventative | #2280 |
| cla | #2282 |
| commensals | #2282 |
| 031 | #2286 |
| objective measures | #2287 |
| association childhood | #2292 |
| foxp3 cells | #2293 |
| avenues | #2296 |
| gene interactions | #2299 |
| 11 years | #2301 |
| asthma study | #2312 |
| normal children | #2318 |
| receptor 2 | #2322 |
| box protein | #2325 |
| 0042 | #2326 |
| limulus | #2329 |
| 056 | #2334 |
| studies children | #2336 |
| 064 | #2338 |
| methodsthe | #2338 |
| variation genotype | #2341 |
| ascaris | #2349 |
| omega3 fatty acids | #2352 |
| 922 | #2353 |
| prrs | #2353 |
| spss | #2354 |
| 035 | #2358 |
| treg | #2361 |
| strongest | #2364 |
| adaptive immune response | #2366 |
| regular | #2368 |
| throat | #2371 |
| microbial composition | #2376 |
| viral respiratory | #2377 |
| populationbased cohort study | #2379 |
| diseases respiratory | #2380 |
| immunologically | #2386 |
| expiratory | #2386 |
| breath | #2395 |
| genetic variation | #2396 |
| human immune | #2397 |
| urban environments | #2401 |
| blood institute | #2402 |
| diaries | #2405 |
| bronchodilator agents | #2405 |
| models male | #2413 |
| cord | #2416 |
| adequately | #2417 |
| ripk1 | #2419 |
| 7000 | #2422 |
| finnish | #2423 |
| gstt1 | #2428 |
| pathway genes | #2430 |
| early adulthood | #2435 |
| african ancestry | #2443 |
| partly | #2445 |
| toll receptor | #2457 |
| attributable | #2459 |
| motor vehicles | #2461 |
| questionnaires sweden | #2462 |
| luciferase reporter | #2464 |
| vitamin intake | #2468 |
| disease review | #2468 |
| enhancer elements | #2474 |
| genetic ancestry | #2477 |
| crosssectional survey | #2479 |
| 095 | #2496 |
| peers | #2497 |
| case control study | #2498 |
| questionnaire | #2500 |
| children adolescent | #2508 |
| cytokines humans | #2508 |
| forkhead box | #2509 |
| tolllike receptors | #2512 |
| tolllike receptor | #2525 |
| interleukin13 | #2525 |
| airway responsiveness | #2525 |
| 239 | #2527 |
| common cold | #2528 |
| style | #2528 |
| artemisia | #2530 |
| uncontrolled | #2540 |
| forced expiratory volume | #2541 |
| young adulthood | #2552 |
| switzerland | #2553 |
| inverse | #2553 |
| modify | #2556 |
| european countries | #2564 |
| pregnancy prenatal | #2568 |
| 060 | #2569 |
| siblings | #2572 |
| th2 response | #2576 |
| activator | #2584 |
| suggested | #2584 |
| myristate | #2585 |
| disease development | #2586 |
| sectional survey | #2586 |
| human microbiome | #2588 |
| ω3 | #2590 |
| 030 | #2590 |
| air pollutant | #2602 |
| immunoglobulin levels | #2603 |
| damp | #2605 |
| large sample | #2608 |
| health children | #2616 |
| viral infections | #2623 |
| humans immunoglobulin | #2624 |
| 241 | #2625 |
| mold | #2626 |
| adverse health effects | #2628 |
| polymorphism | #2633 |
| chronic respiratory diseases | #2637 |
| illness surveys | #2638 |
| prenatal exposure | #2638 |
| translate | #2640 |
| imputation | #2641 |
| molecular patterns | #2641 |
| 141 | #2643 |
| cb | #2643 |
| early | #2646 |
| evenness | #2647 |
| life illness | #2651 |
| stockholm | #2652 |
| virus diseases | #2657 |
| exhaled nitric oxide | #2657 |
| groups children | #2665 |
| 739 | #2668 |
| urban rural | #2672 |
| il4 il5 | #2673 |
| gene expression levels | #2678 |
| confounder | #2678 |
| urgently | #2684 |
| girls boys | #2684 |
| categorised | #2687 |
| onwards | #2687 |
| positive association | #2689 |
| 0048 | #2696 |
| 061 | #2699 |
| host factors | #2699 |
| effects prenatal | #2700 |
| 793 | #2703 |
| 063 | #2712 |
| leukocytes mononuclear | #2717 |
| il23r | #2721 |
| prenatally | #2721 |
| respiratory function | #2731 |
| progression disease | #2732 |
| interaction genetic | #2738 |
| risk allele | #2739 |
| worldwide | #2739 |
| reaction polymorphism | #2739 |
| contacted | #2742 |
| 95 children | #2754 |
| preschool chromosomes | #2755 |
| complete data | #2756 |
| female fetal | #2760 |
| modern | #2764 |
| milk | #2766 |
| effects air | #2770 |
| species level | #2770 |
| potential benefits | #2771 |
| rhinovirus | #2775 |
| urban health | #2778 |
| centile | #2786 |
| messenger receptors | #2787 |
| gstm1 | #2787 |
| questionnaire study | #2796 |
| prematurely | #2800 |
| emergency department visits | #2801 |
| 893 | #2802 |
| prospective longitudinal | #2809 |
| functional variants | #2810 |
| personalized treatment | #2812 |
| 812 | #2815 |
| detailed | #2816 |
| package | #2826 |
| stat1 | #2827 |
| standardized | #2829 |
| nocturnal | #2831 |
| toll | #2843 |
| dietary factors | #2848 |
| asthma patients | #2853 |
| alternaria | #2854 |
| infant formula | #2856 |
| children mothers | #2861 |
| antibiotic treatment | #2871 |
| deubiquitinating | #2878 |
| tobacco smoke | #2878 |
| lci | #2886 |
| living | #2887 |
| respondent | #2888 |
| human bronchial | #2894 |
| persistence | #2899 |
| east | #2902 |
| complement receptors | #2906 |
| male parents | #2911 |
| intrapulmonary | #2914 |
| life span | #2915 |
| 3 mm | #2916 |
| epidemiologic methods | #2917 |
| 645 | #2919 |
| 913 | #2923 |
| transitioning | #2925 |
| virtually | #2928 |
| male gender | #2928 |
| il33 | #2940 |
| listeria | #2942 |
| matrix assisted | #2944 |
| antibiotic | #2947 |
| clinical manifestation | #2956 |
| pollen | #2957 |
| visiting | #2958 |
| reduced risk | #2961 |
| written | #2965 |
| notification | #2966 |
| 074 | #2968 |
| asthma management | #2969 |
| birth | #2974 |
| study prevalence | #2975 |
| mould | #2979 |
| 073 | #2982 |
| 8th | #2983 |
| 804 | #2985 |
| patients asthma | #2985 |
| primary prevention | #2989 |
| 2 months | #2990 |
| critical period | #2996 |
| year age | #2996 |
| forced vital | #3004 |
| 293 | #3010 |
| allergic inflammation | #3011 |
| genetic receptor | #3013 |
| tlr5 | #3022 |
| forced | #3024 |
| confounding factors | #3040 |
| methodological issues | #3047 |
| polymorphism single | #3050 |
| fungal dna | #3054 |
| frequency genetic | #3059 |
| 3 years | #3060 |
| doubt | #3065 |
| epigenetic mechanisms | #3065 |
| tlrs | #3068 |
| findings studies | #3069 |
| dna extraction | #3069 |
| snps genes | #3071 |
| vaccinations | #3079 |
| economic development | #3082 |
| preschool children | #3087 |
| adaptive immune responses | #3087 |
| rapid increase | #3089 |
| rural area | #3089 |
| viewpoints | #3090 |
| overweight obesity | #3093 |
| 066 | #3096 |
| genetic variations | #3098 |
| homes | #3099 |
| analysed | #3103 |
| malditof | #3106 |
| invited | #3110 |
| delayed effects | #3119 |
| environment | #3123 |
| 0036 | #3125 |
| inhalation exposure | #3126 |
| europe humans | #3126 |
| menarche | #3129 |
| hdm | #3131 |
| 12 months | #3141 |
| filaggrin | #3142 |
| cow | #3143 |
| preschool dna | #3154 |
| vital | #3157 |
| pha | #3159 |
| baseline follow | #3182 |
| multifaceted | #3184 |
| clarified | #3188 |
| distinct | #3192 |
| bronchodilator | #3194 |
| pleiotropy | #3196 |
| monitoring female | #3197 |
| genetic receptors | #3197 |
| aor 95 | #3198 |
| 037 | #3201 |
| development disease | #3206 |
| disease genotype | #3207 |
| volume 1 | #3208 |
| 069 | #3209 |
| suburban | #3211 |
| bronchial asthma | #3213 |
| surveys | #3214 |
| messages | #3216 |
| university students | #3218 |
| housekeeping | #3227 |
| epidemiological | #3227 |
| catarrhalis | #3235 |
| functional effects | #3245 |
| 050 | #3251 |
| agents child | #3252 |
| health surveys | #3257 |
| beds | #3257 |
| 08 | #3258 |
| 360 | #3259 |
| genetic epigenesis | #3260 |
| systemic inflammation | #3261 |
| missing data | #3261 |
| prospective cohort | #3264 |
| eventually | #3266 |
| enhanced expression | #3270 |
| spores | #3271 |
| automobiles | #3272 |
| 3rd | #3275 |
| nested case | #3280 |
| premature birth | #3283 |
| 4th | #3289 |
| appreciation | #3296 |
| 19th | #3300 |
| european ancestry | #3301 |
| 098 | #3306 |
| lab | #3308 |
| cells toll | #3314 |
| influential | #3317 |
| corynebacterium | #3318 |
| surveys humans | #3318 |
| weight children | #3327 |
| child | #3332 |
| idiotypic | #3338 |
| subtle | #3341 |
| logistic regression models | #3343 |
| th17 cells | #3349 |
| age children | #3352 |
| noncommunicable diseases | #3354 |
| acid receptor | #3354 |
| influencing | #3358 |
| 509 | #3361 |
| 086 | #3367 |
| ifn γ | #3371 |
| 166 | #3372 |
| manifests | #3374 |
| polymorphisms genes | #3377 |
| 566 | #3377 |
| genetic variants | #3379 |
| rooms | #3380 |
| gut microbiome | #3384 |
| genetic background | #3388 |
| differed | #3397 |
| 0004 | #3398 |
| genetic protein structure | #3408 |
| benzene | #3408 |
| turn | #3409 |
| protecting | #3409 |
| alternaria alternata | #3418 |
| tlr | #3421 |
| gg | #3421 |
| occupational asthma | #3423 |
| maternal health | #3433 |
| sociodemographics | #3436 |
| 092 | #3443 |
| air pollution | #3445 |
| factors smoking | #3445 |
| guangzhou | #3448 |
| epithelial barrier | #3461 |
| disease genetic | #3465 |
| trends prevalence | #3467 |
| airflow limitation | #3468 |
| 049 | #3468 |
| cytokine responses | #3469 |
| th2 cytokine | #3470 |
| omega6 | #3470 |
| rye | #3480 |
| 043 | #3484 |
| humans linkage | #3484 |
| 089 | #3484 |
| 18s | #3488 |
| ambient air pollution | #3494 |
| counselling | #3496 |
| skin patients | #3497 |
| aged children | #3500 |
| total population | #3501 |
| evidences | #3507 |
| postal | #3507 |
| raw | #3512 |
| heating | #3515 |
| onset symptoms | #3519 |
| 95th | #3523 |
| 032 | #3525 |
| respiratory mucosa | #3525 |
| analysing | #3529 |
| schoolaged children | #3540 |
| innate immune response | #3541 |
| older children | #3542 |
| microbiota | #3544 |
| 059 | #3548 |
| bronchial epithelial | #3550 |
| seasonal | #3551 |
| parent | #3557 |
| 5p | #3565 |
| molecular biomarkers | #3566 |
| microbiota composition | #3568 |
| 042 | #3570 |
| coevolution | #3578 |
| tract humans | #3594 |
| minor allele | #3596 |
| plausibility | #3603 |
| children parents | #3604 |
| birch | #3605 |
| parents children | #3606 |
| linkage disequilibrium | #3610 |
| cough | #3612 |
| association polymorphisms | #3618 |
| objectively | #3623 |
| genotype humans | #3626 |
| cats | #3627 |
| claimed | #3628 |
| relating | #3629 |
| environment female | #3630 |
| pollution | #3634 |
| risk alleles | #3638 |
| broad spectrum | #3641 |
| hej | #3643 |
| odds | #3644 |
| 0011 | #3652 |
| lung volume | #3654 |
| skewed | #3670 |
| contact | #3674 |
| publication child child | #3677 |
| resides | #3679 |
| complex diseases | #3680 |
| 251 | #3681 |
| 1995 | #3684 |
| genetic control | #3686 |
| disequilibrium male | #3686 |
| toxoplasma | #3686 |
| 046 | #3688 |
| host immune | #3691 |
| monocytogenes | #3691 |
| adult blood | #3691 |
| 655 | #3695 |
| gene frequency | #3697 |
| il17 | #3701 |
| biological agents | #3703 |
| 456 | #3704 |
| gloves | #3704 |
| study gwas | #3705 |
| cette | #3725 |
| mice models | #3726 |
| 577 | #3727 |
| allocate | #3730 |
| genetic gene | #3735 |
| desorption ionization | #3735 |
| hyper | #3748 |
| ovalbumin ova | #3753 |
| glutathione transferase | #3755 |
| 094 | #3755 |
| vehicle emissions | #3759 |
| helperinducer | #3763 |
| adaptive immunity | #3764 |
| coeliac | #3765 |
| positive bacteria | #3766 |
| regressions | #3766 |
| function decline | #3771 |
| 824 | #3786 |
| housing | #3795 |
| gm csf | #3797 |
| time trends | #3798 |
| sympathomimetics | #3802 |
| multicenter studies | #3807 |
| nutrition examination | #3820 |
| weight child | #3825 |
| tcells | #3832 |
| girls | #3834 |
| bethesda | #3837 |
| health problem | #3838 |
| relation | #3838 |
| receptors immunologic | #3843 |
| 076 | #3846 |
| models immunological | #3854 |
| exposure risk | #3861 |
| epistasis | #3865 |
| tremendous | #3867 |
| loci genetic | #3869 |
| immunoglobulin | #3873 |
| utero | #3873 |
| berlin | #3876 |
| respiratory diseases | #3876 |
| maternal smoking | #3881 |
| lymphoid cells | #3891 |
| parental | #3899 |
| positively | #3912 |
| 319 | #3920 |
| 368 | #3920 |
| colonisation | #3922 |
| volatile organic compounds | #3934 |
| confounding | #3940 |
| arthropod | #3942 |
| 051 | #3943 |
| maternal serum | #3946 |
| airway resistance | #3947 |
| maternal fetal | #3948 |
| human milk | #3950 |
| denaturing | #3950 |
| asthma exacerbations | #3957 |
| progeny | #3957 |
| genetic predisposition | #3958 |
| faced | #3958 |
| exacerbations | #3960 |
| epigenetic modifications | #3970 |
| culturing | #3971 |
| viable | #3982 |
| ecuador | #3991 |
| congresses | #3995 |
| health utilization | #3999 |
| ndvi | #4004 |
| 381 | #4005 |
| r5 | #4019 |
| newborn infant premature | #4023 |
| messenger reverse | #4026 |
| variation humans | #4026 |
| capita | #4029 |
| infant nutritional | #4032 |
| pellucida | #4033 |
| phase 2 | #4035 |
| environments | #4036 |
| ema | #4036 |
| single nucleotide | #4050 |
| occupational | #4052 |
| dipeptidyl | #4055 |
| genetic risk | #4060 |
| positive associations | #4061 |
| tlr9 | #4064 |
| humans polymorphism | #4069 |
| reverse | #4070 |
| prevotella | #4081 |
| dairy | #4093 |
| 493 | #4094 |
| 023 | #4107 |
| unbalanced | #4109 |
| clarification | #4112 |
| coding region | #4113 |
| chronic disease | #4118 |
| 052 | #4118 |
| effects exposure | #4120 |
| ethnically | #4120 |
| children 2 | #4126 |
| 087 | #4136 |
| positional | #4136 |
| salmeterol | #4139 |
| urban population | #4151 |
| luminex | #4154 |
| th17 | #4162 |
| chronic respiratory | #4163 |
| researcher | #4163 |
| 011 | #4170 |
| mrna expression | #4180 |
| husbandry | #4180 |
| sulfur dioxide | #4182 |
| th1 cells | #4183 |
| 424 | #4185 |
| rgs | #4187 |
| ruled | #4189 |
| respiratory infection | #4193 |
| protected | #4194 |
| zealand | #4204 |
| lifestyle | #4210 |
| risk loci | #4212 |
| finland | #4213 |
| preterm delivery | #4220 |
| populationbased sample | #4221 |
| growing body | #4222 |
| whey | #4236 |
| androstadienes | #4237 |
| inflammatory disease | #4243 |
| disease genotype humans | #4247 |
| body height | #4248 |
| adult onset | #4250 |
| increasing trend | #4252 |
| inhaled | #4253 |
| indoor environments | #4256 |
| participated | #4256 |
| neonatal mice | #4262 |
| children born | #4269 |
| healthy individuals | #4289 |
| metagenome | #4300 |
| ordinal | #4303 |
| influenced | #4314 |
| ephedrine | #4318 |
| cx3cl1 | #4318 |
| immunologic receptors | #4322 |
| activity pa | #4324 |
| 1 gene | #4337 |
| male mothers | #4339 |
| male obesity | #4345 |
| years life | #4346 |
| phytohemagglutinins | #4349 |
| nucleotide | #4353 |
| children study | #4356 |
| 093 | #4358 |
| diagnostics | #4359 |
| healthy children | #4370 |
| 410 | #4375 |
| urban area | #4379 |
| rationale | #4393 |
| poaceae | #4397 |
| protects | #4404 |
| fluticasone | #4405 |
| age 12 | #4405 |
| stratified | #4414 |
| lpa | #4417 |
| cephalometry | #4418 |
| exposure levels | #4418 |
| percentile | #4421 |
| hypopharynx | #4424 |
| 95ci | #4425 |
| female sex | #4428 |
| 15 years | #4429 |
| onset | #4434 |
| crohn disease | #4437 |
| participating | #4439 |
| pupils | #4442 |
| secondary prevention | #4449 |
| dr3 | #4449 |
| receptors protein | #4451 |
| rash | #4457 |
| chances | #4457 |
| goblet | #4459 |
| confers | #4461 |
| patients cystic fibrosis | #4466 |
| respiratory viruses | #4468 |
| increased prevalence | #4468 |
| 457 | #4474 |
| 0022 | #4496 |
| severe asthma | #4499 |
| prevalence risk factors | #4499 |
| culture techniques | #4499 |
| microorganisms | #4511 |
| genetic effects | #4516 |
| infant | #4517 |
| trajectories | #4530 |
| no2 | #4538 |
| inflammatory diseases | #4542 |
| statistical | #4545 |
| butter | #4551 |
| assisted laser | #4555 |
| gramnegative bacteria | #4558 |
| structural equation modeling | #4559 |
| receptor alpha | #4564 |
| control children | #4572 |
| 49 | #4573 |
| population prevalence | #4583 |
| ahr | #4583 |
| prevalence estimates | #4588 |
| 080 | #4591 |
| neutrophilic | #4598 |
| adaptor protein | #4600 |
| haplotypes humans | #4600 |
| airway | #4601 |
| knowledge gaps | #4603 |
| strikingly | #4630 |
| daily practice | #4632 |
| lactis | #4634 |
| detectability | #4660 |
| str | #4661 |
| random | #4676 |
| aiming | #4676 |
| pef | #4683 |
| 299 | #4688 |
| accumulating | #4695 |
| measles | #4697 |
| 1014 | #4699 |
| hscrp | #4700 |
| gstp1 | #4725 |
| current evidence | #4730 |
| tlc | #4741 |
| associations | #4745 |
| bacterial communities | #4747 |
| immune | #4749 |
| obstructive lung | #4753 |
| lactic acid bacteria | #4754 |
| genetic risk factors | #4755 |
| transcriptomics | #4768 |
| lifestyle factors | #4772 |
| pathophysiologic | #4775 |
| lung development | #4777 |
| unclear | #4782 |
| exposure air | #4785 |
| immune responses | #4795 |
| quantity | #4804 |
| pulmonary function | #4809 |
| filament proteins | #4812 |
| plateau | #4814 |
| helminth | #4821 |
| albuterol | #4823 |
| respects | #4823 |
| adult air | #4837 |
| 399 | #4838 |
| female food | #4841 |
| implicating | #4844 |
| pointed | #4848 |
| feeding | #4851 |
| new cases | #4858 |
| haplotype analysis | #4874 |
| ont | #4886 |
| hcs | #4889 |
| occupations | #4896 |
| 624 | #4896 |
| respiratory illness | #4897 |
| newborn male | #4902 |
| studies effects | #4919 |
| hyperventilation | #4927 |
| asthma chronic | #4928 |
| dans | #4930 |
| contributors | #4940 |
| postnatal development | #4944 |
| respective | #4955 |
| starts | #4964 |
| tolerance induction | #4965 |
| blood mononuclear | #4969 |
| natal | #4973 |
| airway disease | #4975 |
| 322 | #4975 |
| predisposition disease | #4986 |
| eosinophils | #4994 |
| potential effects | #5005 |
| explore | #5011 |
| adaptor | #5012 |
| laser desorption | #5018 |
| epidemiology | #5018 |
| serine protease | #5020 |
| functionality | #5023 |
| inbred c57bl models | #5024 |
| inhalation | #5049 |
| livestock | #5058 |
| 95 | #5062 |
| paediatric | #5065 |
| manifestation | #5069 |
| milk human | #5071 |
| inflammatory markers | #5072 |
| grass | #5072 |
| 219 | #5083 |
| genetic analyses | #5084 |
| covariates | #5089 |
| hormonal | #5091 |
| held | #5091 |
| alpha1 | #5092 |
| urgent | #5094 |
| unexposed | #5099 |
| habits | #5099 |
| 097 | #5100 |
| genomewide significance | #5100 |
| il3 | #5102 |
| highrisk | #5105 |
| lysate | #5106 |
| gwas | #5119 |
| latent | #5125 |
| smoke | #5126 |
| 103 | #5130 |
| crucial | #5133 |
| 12 years | #5134 |
| regional differences | #5144 |
| mononuclear | #5153 |
| traffic | #5159 |
| decades | #5159 |
| dysbiosis | #5183 |
| 383 | #5186 |
| fingerprinting | #5191 |
| lung epithelial | #5191 |
| reflect | #5193 |
| p40 | #5196 |
| butyrates | #5200 |
| 070 | #5204 |
| age onset | #5209 |
| airways | #5210 |
| window | #5232 |
| hallmarks | #5241 |
| taxa | #5242 |
| recruited | #5243 |
| bronchopulmonary | #5247 |
| isotype | #5247 |
| crp levels | #5256 |
| psychosocial factors | #5267 |
| quartile | #5274 |
| inflammatory disorders | #5279 |
| dietary supplementation | #5280 |
| gprotein | #5283 |
| international | #5289 |
| early phase | #5305 |
| 123 | #5306 |
| environmental variables | #5314 |
| cutoff | #5318 |
| coupled receptor | #5329 |
| excessive | #5333 |
| 136 | #5336 |
| comprehensively | #5339 |
| suppressive | #5348 |
| gene expression | #5348 |
| immunology | #5348 |
| meat | #5350 |
| disease susceptibility | #5359 |
| supernatants | #5369 |
| new strategies | #5380 |
| illumina | #5384 |
| serum proteins | #5392 |
| 233 | #5406 |
| substantial | #5412 |
| discussions | #5423 |
| smad3 | #5429 |
| vitamin supplementation | #5436 |
| sensitized | #5441 |
| certainty | #5443 |
| 337 | #5450 |
| geometric | #5456 |
| 224 | #5465 |
| marks | #5470 |
| hypothesis | #5473 |
| growing evidence | #5475 |
| challenge | #5476 |
| epidemiologic | #5476 |
| phenotype | #5481 |
| healthy control subjects | #5495 |
| 373 | #5496 |
| cytokines disease | #5496 |
| floor | #5496 |
| road | #5504 |
| aged asthma | #5537 |
| alter | #5539 |
| 556 | #5544 |
| term exposure | #5547 |
| 454 | #5550 |
| coexpression | #5570 |
| predisposition | #5574 |
| 512 | #5578 |
| 45 | #5580 |
| lose | #5584 |
| 321 | #5595 |
| figures | #5602 |
| methacholine | #5602 |
| 2nd | #5610 |
| 258 | #5610 |
| 062 | #5630 |
| ld | #5634 |
| 14 years | #5637 |
| airflow | #5642 |
| contribute | #5645 |
| aa | #5661 |
| bacterial species | #5667 |
| protein coupled | #5668 |
| 081 | #5668 |
| notable | #5679 |
| contraceptives | #5682 |
| hints | #5688 |
| cytokine expression | #5693 |
| prebiotics | #5694 |
| commission | #5700 |
| 134 | #5704 |
| offspring | #5704 |
| cows | #5713 |
| cytokine production | #5722 |
| tlr7 | #5725 |
| presentations | #5727 |
| stepwise | #5729 |
| fecal samples | #5753 |
| animal humans | #5764 |
| 021 | #5770 |
| house | #5777 |
| rna expression | #5788 |
| cold | #5790 |
| maternal | #5797 |
| predominance | #5812 |
| persists | #5817 |
| humans immunity | #5824 |
| comprehensive | #5824 |
| cholecalciferol | #5831 |
| snps | #5833 |
| hen | #5848 |
| commensal | #5856 |
| 384 | #5863 |
| mites | #5878 |
| 078 | #5881 |
| bangladesh | #5887 |
| study genotype | #5888 |
| drug development | #5891 |
| sleeping | #5898 |
| workplace | #5900 |
| immunoglobulin igg | #5902 |
| paf | #5910 |
| study associations | #5924 |
| adjust | #5930 |
| encourage | #5930 |
| helper | #5938 |
| differ | #5944 |
| western europe | #5945 |
| questionnaire survey | #5947 |
| investigate association | #5947 |
| male risk | #5953 |
| 0017 | #5958 |
| 216 | #5963 |
| eastern europe | #5978 |
| promoter polymorphism | #5989 |
| disease prevalence | #5991 |
| longitudinal data | #5995 |
| interleukin15 | #5996 |
| adaptive immune | #5999 |
| calling | #6002 |
| 367 | #6008 |
| patients symptoms | #6008 |
| panels | #6009 |
| doseresponse relationship | #6012 |
| box | #6020 |
| pathogen interactions | #6022 |
| immune tolerance | #6023 |
| tract infections | #6029 |
| obese children | #6032 |
| adult population | #6032 |
| diversity | #6047 |
| existing methods | #6054 |
| risk variants | #6060 |
| prevalent | #6063 |
| eastern | #6064 |
| gmcsf | #6064 |
| modifier | #6066 |
| persisted | #6067 |
| restricted | #6068 |
| comparability | #6070 |
| 122 | #6072 |
| implication | #6077 |
| ors | #6082 |
| unselected | #6082 |
| ovalbumin | #6086 |
| microflora | #6091 |
| interleukin17 | #6094 |
| time flight | #6103 |
| 099 | #6113 |
| recruiting | #6117 |
| conferred | #6117 |
| genetic polymorphisms | #6122 |
| causality | #6128 |
| repeated | #6132 |
| fev1 | #6134 |
| fecal | #6135 |
| ahead | #6140 |
| 24 years | #6146 |
| programme | #6152 |
| 16 years | #6157 |
| town | #6158 |
| intermediate filament | #6161 |
| avec | #6163 |
| welfare | #6164 |
| gathered | #6166 |
| keeping | #6173 |
| constituent | #6182 |
| toluene | #6192 |
| determining | #6193 |
| genomewide association study | #6196 |
| narcotic | #6202 |
| conferring | #6205 |
| gross | #6216 |
| genuine | #6233 |
| populations | #6233 |
| illnesses | #6241 |
| institute | #6243 |
| prematurity | #6246 |
| administration inhalation | #6246 |
| protease inhibitor | #6252 |
| odds ratio 95 | #6262 |
| parents | #6266 |
| indoor environment | #6270 |
| study groups | #6270 |
| proposal | #6285 |
| offers | #6287 |
| irr | #6291 |
| communicable diseases | #6301 |
| nested | #6303 |
| alpha 1 | #6304 |
| tests | #6307 |
| young age | #6316 |
| outdoor | #6321 |
| infrequent | #6326 |
| allele frequencies | #6326 |
| interferons | #6343 |
| peptidase | #6346 |
| immunity mucosal | #6349 |
| 067 | #6355 |
| lymphocytes helper | #6360 |
| studies association | #6370 |
| 090 | #6375 |
| adjustments | #6385 |
| bivariate | #6388 |
| protective factor | #6390 |
| iu | #6394 |
| levels serum | #6400 |
| decreased risk | #6401 |
| immunological | #6409 |
| selection bias | #6410 |
| cell subsets | #6411 |
| genetic determinants | #6417 |
| infant premature | #6418 |
| 119 | #6439 |
| questions | #6448 |
| hypothesized | #6466 |
| mmp9 | #6467 |
| lower respiratory | #6475 |
| adverse health | #6475 |
| 287 | #6486 |
| 274 | #6490 |
| premature | #6493 |
| omalizumab | #6501 |
| sleep disturbance | #6507 |
| gst | #6507 |
| 238 | #6507 |
| links | #6512 |
| murine model | #6515 |
| infant feeding | #6523 |
| adam | #6524 |
| repeated measurements | #6527 |
| increased expression | #6529 |
| fev1 fvc | #6530 |
| diseases risk | #6548 |
| implied | #6555 |
| centers | #6567 |
| 1012 | #6571 |
| statements | #6572 |
| completion | #6598 |
| 283 | #6602 |
| disease onset | #6602 |
| children adults | #6604 |
| pollutant | #6605 |
| hospital admissions | #6617 |
| promoter region | #6624 |
| consumed | #6647 |
| host pathogen | #6653 |
| accessible | #6653 |
| adjusted 95 | #6654 |
| intervention studies | #6660 |
| playing | #6672 |
| 138 | #6684 |
| candidate genes | #6684 |
| bacterium | #6709 |
| cell responses | #6711 |
| systematic search | #6715 |
| cytokines dendritic | #6716 |
| washout | #6720 |
| nod2 | #6730 |
| impulse | #6732 |
| haplotypes | #6732 |
| cells disease | #6734 |
| 0009 | #6734 |
| ova | #6739 |
| focuses | #6745 |
| 126 | #6750 |
| n10 | #6757 |
| cities | #6761 |
| quartiles | #6763 |
| height weight | #6765 |
| mumps | #6769 |
| plethysmography | #6771 |
| eosinophilic | #6783 |
| disease mechanisms | #6787 |
| 065 | #6794 |
| developing | #6798 |
| 330 | #6807 |
| remained | #6813 |
| chronic exposure | #6823 |
| microbiology | #6831 |
| elucidated | #6846 |
| growing | #6846 |
| mz | #6852 |
| microorganism | #6861 |
| 305 | #6868 |
| cream | #6874 |
| lower incidence | #6887 |
| functional studies | #6890 |
| beef | #6896 |
| incidences | #6900 |
| inert | #6911 |
| academia | #6924 |
| supplementary | #6934 |
| zona | #6939 |
| multivariate logistic | #6941 |
| tertiles | #6948 |
| specific effects | #6949 |
| 1 diabetes | #6962 |
| 044 | #6965 |
| pathogenic bacteria | #6972 |
| lung | #6972 |
| maturation | #6975 |
| specialists | #6986 |
| infections | #6991 |
| transducer | #6998 |
| obesity bmi | #6999 |
| attendance | #7012 |
| summarizes | #7024 |
| infectious diseases | #7025 |
| shaping | #7027 |
| ribosomal 16s | #7033 |
| organic compounds | #7037 |
| 231 | #7041 |
| 028 | #7042 |
| confirming | #7043 |
| evidence association | #7046 |
| explaining | #7053 |
| amelioration | #7060 |
| concert | #7095 |
| 313 | #7102 |
| 019 | #7109 |
| type 1 diabetes | #7111 |
| linoleic acid | #7111 |
| triggering | #7114 |
| breath tests | #7117 |
| serum total | #7117 |
| 164 | #7122 |
| increased incidence | #7128 |
| th1 | #7132 |
| homeobox | #7134 |
| male membrane | #7135 |
| health humans | #7136 |
| homozygote | #7150 |
| consenting | #7153 |
| compare | #7155 |
| daily life | #7165 |
| increased risks | #7167 |
| likewise | #7184 |
| agents anti | #7184 |
| spatial variation | #7197 |
| develop | #7209 |
| health nutrition | #7223 |
| irritable bowel syndrome | #7227 |
| helper cell | #7228 |
| discusses | #7228 |
| spore | #7229 |
| cohort | #7231 |
| grow | #7238 |
| 163 | #7243 |
| beta1 | #7244 |
| influences | #7244 |
| analyses | #7255 |
| 0015 | #7268 |
| standardised | #7277 |
| 058 | #7278 |
| 053 | #7283 |
| handling | #7288 |
| urbanization | #7299 |
| herpesviridae | #7299 |
| 022 | #7309 |
| internationality | #7310 |
| single nucleotide polymorphisms | #7317 |
| personalized | #7355 |
| attending | #7374 |
| air pollutants | #7376 |
| 199 | #7387 |
| rome | #7392 |
| university | #7411 |
| linoleic | #7424 |
| potential risk | #7443 |
| histories | #7457 |
| 9 months | #7467 |
| human body | #7474 |
| boiling | #7486 |
| stratification | #7488 |
| bronchi | #7493 |
| spp | #7515 |
| alps | #7515 |
| enrollment | #7519 |
| intestinal diseases | #7523 |
| pediatrics | #7535 |
| toxoplasmosis | #7551 |
| bowel diseases | #7561 |
| allele | #7582 |
| eosinophil | #7586 |
| oropharyngeal | #7591 |
| considerably | #7612 |
| diseases animals | #7613 |
| overt | #7613 |
| worked | #7643 |
| school | #7649 |
| 316 | #7658 |
| haemophilus | #7669 |
| health conditions | #7671 |
| prenatal | #7684 |
| peanut | #7684 |
| rna ribosomal | #7700 |
| 161 | #7725 |
| nox | #7726 |
| europe | #7728 |
| leukocytes | #7731 |
| population | #7736 |
| characterised | #7744 |
| vehicles | #7748 |
| 308 | #7763 |
| single | #7777 |
| flora | #7792 |
| clinical examination | #7797 |
| infant male | #7799 |
| attended | #7802 |
| sputum | #7804 |
| reader | #7805 |
| lymphocyte subsets | #7808 |
| 66 | #7809 |
| 171 | #7839 |
| pyrosequencing | #7845 |
| conjunction | #7848 |
| m3 | #7856 |
| pa | #7859 |
| participation | #7865 |
| 1996 | #7881 |
| investigators | #7882 |
| specific | #7895 |
| deficiencies | #7898 |
| asked | #7899 |
| specificities | #7907 |
| months age | #7912 |
| parasitic | #7915 |
| epigenesis genetic | #7919 |
| neisseria | #7922 |
| 160 | #7928 |
| protective role | #7929 |
| egg | #7933 |
| therapeutic intervention | #7939 |
| listeria monocytogenes | #7941 |
| pbmcs | #7944 |
| fall | #7947 |
| unresolved | #7949 |
| prevalence incidence | #7950 |
| lockdown | #7950 |
| immune function | #7953 |
| altering | #7959 |
| human subjects | #7966 |
| collecting | #7980 |
| explanatory | #7997 |
| fatty acid composition | #8002 |
| lacking | #8024 |
| 264 | #8040 |
| bordetella | #8049 |
| phorbol | #8077 |
| separately | #8084 |
| rising | #8086 |
| 304 | #8087 |
| helper inducer | #8091 |
| weight infant | #8101 |
| 088 | #8109 |
| regarded | #8119 |
| determinants | #8119 |
| multiple logistic | #8132 |
| career | #8149 |
| factor binding | #8160 |
| polymorphism genetic | #8162 |
| gene regulation | #8172 |
| etiologies | #8201 |
| omega3 | #8202 |
| mutually | #8209 |
| initiative | #8212 |
| sophisticated | #8214 |
| 140 | #8224 |
| community based | #8228 |
| epigenesis | #8236 |
| emerged | #8237 |
| 266 | #8255 |
| hypotheses | #8257 |
| cars | #8265 |
| examination | #8283 |
| modifiable | #8285 |
| adolescent | #8294 |
| 242 | #8295 |
| hc | #8303 |
| belonged | #8306 |
| humans immunization | #8308 |
| based cohort | #8312 |
| nights | #8331 |
| objectives | #8337 |
| critical roles | #8342 |
| 111 | #8348 |
| nasal mucosa | #8351 |
| nineteen | #8357 |
| genera | #8357 |
| pylori infection | #8359 |
| normal weight | #8367 |
| instillation | #8385 |
| interleukin10 | #8388 |
| relative abundance | #8412 |
| latest | #8415 |
| author | #8420 |
| spearman | #8422 |
| infant low | #8429 |
| covariate | #8435 |
| authorities | #8438 |
| aspergillosis | #8440 |
| reduce risk | #8441 |
| 16s | #8447 |
| 113 | #8460 |
| multifactorial | #8460 |
| syncytial | #8462 |
| anhydride | #8462 |
| contrasting | #8463 |
| minor | #8478 |
| similarities | #8478 |
| profound | #8479 |
| investigate | #8497 |
| asthmatic patients | #8506 |
| resembles | #8511 |
| mass body | #8521 |
| genetic factors | #8538 |
| relations | #8543 |
| cytokines | #8544 |
| so2 | #8558 |
| prospective cohort study | #8565 |
| extract | #8568 |
| 4 years | #8590 |
| inclusion | #8598 |
| genetic loci | #8618 |
| humidity | #8633 |
| facilitates | #8642 |
| strong evidence | #8645 |
| logistic | #8648 |
| animal | #8656 |
| dendritic cells dcs | #8665 |
| adaptive | #8676 |
| 101 | #8677 |
| oropharynx | #8681 |
| defines | #8685 |
| histamine | #8716 |
| responsiveness | #8726 |
| increased odds | #8730 |
| choosing | #8732 |
| prevention | #8737 |
| 193 | #8776 |
| exploring | #8780 |
| 30 years | #8799 |
| airborne | #8805 |
| vdr | #8811 |
| incidence infant | #8815 |
| integrates | #8824 |
| unknown | #8840 |
| alveoli | #8852 |
| antibody levels | #8861 |
| traditional | #8865 |
| 155 | #8867 |
| association analysis | #8868 |
| humans logistic | #8879 |
| ears | #8884 |
| burden disease | #8884 |
| cesarean | #8884 |
| utilization | #8888 |
| residence | #8903 |
| bdnf | #8911 |
| pools | #8916 |
| 273 | #8926 |
| processed | #8935 |
| reactive protein | #8944 |
| pattern recognition | #8957 |
| lipopolysaccharide lps | #8958 |
| olive | #8963 |
| phase | #8966 |
| 177 | #8983 |
| 194 | #8996 |
| 0007 | #8998 |
| underlying | #9006 |
| 172 | #9017 |
| preschool humans | #9028 |
| surveyed | #9029 |
| humans lung | #9031 |
| sequelae | #9032 |
| receptor 4 | #9040 |
| population surveillance | #9046 |
| transferase | #9049 |
| cytokine | #9057 |
| boys girls | #9070 |
| london | #9088 |
| lower risk | #9095 |
| median duration | #9096 |
| parturition | #9101 |
| flanking | #9109 |
| nutritional physiological | #9139 |
| determinant | #9154 |
| statistical methods | #9170 |
| differing | #9175 |
| study selection | #9180 |
| butyrate | #9182 |
| secretions | #9187 |
| food | #9198 |
| exert | #9209 |
| dogs | #9217 |
| fungi | #9222 |
| 186 | #9234 |
| accompanying | #9239 |
| pattern | #9248 |
| human skin | #9259 |
| multivariate analyses | #9269 |
| popularity | #9269 |
| 04 | #9278 |
| 275 | #9282 |
| counts | #9296 |
| quintile | #9297 |
| controversial | #9299 |
| tract | #9302 |
| 95 women | #9304 |
| haplotype | #9306 |
| allele frequency | #9306 |
| outcome measures | #9309 |
| 345 | #9313 |
| anova | #9328 |
| prospectively | #9334 |
| eosinophilia | #9338 |
| vocs | #9351 |
| logistic regression analysis | #9353 |
| funded | #9360 |
| olds | #9364 |
| responders | #9364 |
| proteinase | #9366 |
| urban | #9376 |
| tlr4 | #9383 |
| infantile | #9386 |
| numerous | #9388 |
| 232 | #9392 |
| maldi | #9404 |
| ages | #9407 |
| newborn | #9409 |
| incidence | #9412 |
| 286 | #9422 |
| 5000 | #9432 |
| streptococcus | #9438 |
| extrinsic | #9445 |
| sick | #9460 |
| countries | #9478 |
| 016 | #9481 |
| anthropometric | #9495 |
| worker | #9498 |
| fatty acids | #9509 |
| longitudinally | #9512 |
| comprise | #9517 |
| markers | #9532 |
| antigen presenting | #9554 |
| 256 | #9559 |
| body composition | #9561 |
| airway obstruction | #9573 |
| 165 | #9574 |
| pharyngeal | #9579 |
| global health | #9583 |
| social class | #9585 |
| ifn gamma | #9589 |
| actinobacteria | #9597 |
| nutritive | #9598 |
| replicated | #9599 |
| occurrence | #9605 |
| lessons | #9617 |
| increases risk | #9627 |
| substances | #9659 |
| mucous | #9666 |
| adult mice | #9669 |
| dietary supplements | #9672 |
| crude | #9672 |
| child child | #9678 |
| reference | #9687 |
| obesity | #9698 |
| common genetic | #9743 |
| diagnoses | #9743 |
| populationbased study | #9744 |
| 9 | #9746 |
| p004 | #9752 |
| mothers | #9753 |
| mononuclear cells | #9760 |
| il10 | #9761 |
| proinflammatory | #9761 |
| directly | #9772 |
| publications | #9772 |
| 1 protein | #9773 |
| obstruction | #9774 |
| body mass bmi | #9788 |
| reliable | #9790 |
| 158 | #9800 |
| electrophoretic | #9807 |
| therapeutic strategies | #9818 |
| prove | #9826 |
| 20th | #9843 |
| random allocation | #9844 |
| cluster | #9849 |
| 102 | #9849 |
| modifying | #9850 |
| rrna | #9873 |
| nps | #9884 |
| restrictive | #9899 |
| altogether | #9903 |
| reality | #9904 |
| receptors | #9909 |
| immunomodulatory | #9920 |
| tagging | #9925 |
| intranasal | #9929 |
| century | #9933 |
| 39 | #9935 |
| southern | #9938 |
| bacterial infections | #9964 |
| 1991 | #9964 |
| tnf α | #9973 |
| 0002 | #9995 |
| exclusively | #10002 |
| 152 | #10006 |
| lavage fluid | #10012 |
| presenting cells | #10012 |
| particulate matter | #10015 |
| mass bmi | #10020 |
| health outcomes | #10050 |
| reproducible | #10052 |
| 57 | #10065 |
| disappeared | #10087 |
| 87 | #10096 |
| elucidation | #10099 |
| parts | #10121 |
| superoxide dismutase | #10123 |
| immune cell | #10127 |
| 072 | #10143 |
| nasal | #10159 |
| exist | #10160 |
| bias | #10162 |
| expression genes | #10164 |
| ascertained | #10166 |
| sedentary behavior | #10168 |
| exclusions | #10169 |
| 4 months | #10169 |
| timing | #10174 |
| incidence prevalence | #10175 |
| discover | #10203 |
| western | #10210 |
| microbial communities | #10218 |
| fungal | #10222 |
| adaptor proteins | #10226 |
| alpha subunit | #10236 |
| weaker | #10259 |
| influenzae | #10264 |
| 212 | #10290 |
| study children | #10303 |
| ghana | #10324 |
| aim | #10332 |
| analyze | #10356 |
| factorial | #10361 |
| interleukin12 | #10361 |
| 142 | #10364 |
| centrally | #10386 |
| concepts | #10386 |
| methodologies | #10387 |
| ulcerative colitis | #10399 |
| respiratory disease | #10403 |
| 17 | #10408 |
| polyunsaturated | #10422 |
| parasites | #10430 |
| scientific | #10436 |
| modelled | #10448 |
| nose | #10465 |
| flow rate | #10471 |
| bronchiolitis | #10473 |
| exposed | #10477 |
| 07 | #10499 |
| realtime pcr | #10503 |
| c3h | #10522 |
| twothirds | #10527 |
| interquartile range | #10528 |
| adjusted | #10532 |
| acetates | #10561 |
| 94 | #10565 |
| new zealand | #10576 |
| 010 | #10595 |
| biodiversity | #10595 |
| societal | #10603 |
| france | #10605 |
| priming | #10614 |
| homeodomain | #10623 |
| time pcr | #10638 |
| boys | #10643 |
| indirectly | #10650 |
| bacteriological | #10653 |
| 206 | #10664 |
| 004 | #10665 |
| ribosomal | #10691 |
| vitamins | #10703 |
| bidirectional | #10706 |
| positivity | #10711 |
| possibilities | #10723 |
| 008 | #10728 |
| items | #10729 |
| newborn infant | #10763 |
| ancestry female | #10768 |
| nitrous | #10770 |
| swabs | #10771 |
| entered | #10774 |
| female gastrointestinal | #10776 |
| regulation humans | #10776 |
| responses | #10786 |
| skin | #10787 |
| transferases | #10789 |
| increased production | #10799 |
| national institute | #10805 |
| suppressing | #10825 |
| workshop | #10850 |
| physical activity | #10855 |
| postnatal | #10859 |
| prevent | #10862 |
| bronchoalveolar | #10864 |
| fvc | #10873 |
| km2 | #10911 |
| functional role | #10915 |
| standardization | #10926 |
| 2002 | #10934 |
| 036 | #10944 |
| carriers | #10949 |
| subclinical | #10957 |
| microbiological | #10968 |
| subsequent | #10971 |
| 16s rrna | #10983 |
| immunoglobulins | #10986 |
| lps | #10988 |
| 217 | #10992 |
| roc | #10992 |
| 191 | #10993 |
| constituents | #10993 |
| harm | #10994 |
| 197 | #10996 |
| aerosol | #11002 |
| swiss | #11006 |
| inconsistent | #11009 |
| chance | #11022 |
| poland | #11028 |
| antibody responses | #11043 |
| amniotic | #11054 |
| 6 12 | #11055 |
| serology | #11092 |
| low birth | #11092 |
| passive | #11120 |
| chromosomes human | #11127 |
| ulcerative | #11134 |
| disturbed | #11159 |
| 235 | #11177 |
| crohn | #11187 |
| community | #11188 |
| 144 | #11222 |
| gut | #11232 |
| il12 | #11233 |
| confined | #11247 |
| environmental pollutants | #11258 |
| fourth | #11270 |
| 157 | #11286 |
| rna messenger | #11289 |
| duration | #11314 |
| regulatory mechanisms | #11327 |
| highest risk | #11328 |
| intron | #11330 |
| studies diet | #11351 |
| persistent | #11353 |
| chronic diseases | #11376 |
| 040 | #11389 |
| birth weight | #11397 |
| juvenile | #11415 |
| nitrogen dioxide | #11427 |
| cell function | #11428 |
| modulate | #11435 |
| supplements | #11440 |
| 18 years | #11446 |
| discuss | #11455 |
| female | #11457 |
| 105 | #11459 |
| epigenetics | #11463 |
| gut microbiota | #11475 |
| quinolines | #11485 |
| genetic susceptibility | #11493 |
| 128 | #11502 |
| factor1 | #11515 |
| 86 | #11521 |
| haemophilus influenzae | #11522 |
| late onset | #11524 |
| helicobacter | #11533 |
| biomarker | #11536 |
| 012 | #11542 |
| cd28 | #11550 |
| interact | #11564 |
| 78 | #11583 |
| proteases | #11587 |
| households | #11587 |
| variant | #11588 |
| physiological phenomena | #11594 |
| healthy control | #11597 |
| 130 | #11601 |
| celiac | #11633 |
| risk disease | #11636 |
| dispersion | #11666 |
| narrative | #11668 |
| interquartile | #11709 |
| gene polymorphisms | #11736 |
| introduction | #11752 |
| trimester pregnancy | #11755 |
| confirmation | #11758 |
| harmful | #11806 |
| lipopolysaccharides | #11813 |
| gram negative | #11824 |
| 222 | #11824 |
| irrespective | #11831 |
| 075 | #11858 |
| subtypes | #11860 |
| episodes | #11867 |
| incident | #11881 |
| insight | #11899 |
| fetal | #11900 |
| 230 | #11904 |
| air | #11924 |
| started | #11931 |
| genetic | #11936 |
| ifn | #11939 |
| 1990 | #11944 |
| autoantigens | #11967 |
| natural | #11982 |
| lowest | #11990 |
| genetic association | #11992 |
| protein levels | #11997 |
| finding | #12007 |
| initially | #12014 |
| 151 | #12047 |
| solely | #12055 |
| quantifying | #12075 |
| pcr | #12106 |
| case control | #12121 |
| ultimately | #12124 |
| upregulation | #12127 |
| immunologic factors | #12176 |
| subsets | #12179 |
| estimating | #12184 |
| country | #12201 |
| young children | #12219 |
| 149 | #12221 |
| inflammatory response | #12238 |
| leukocyte count | #12248 |
| fish oil | #12249 |
| december | #12256 |
| sle | #12270 |
| shifted | #12297 |
| began | #12327 |
| relapsing | #12330 |
| antibiotics | #12339 |
| 006 | #12341 |
| gm | #12351 |
| completed | #12354 |
| european continental | #12371 |
| minority | #12421 |
| linkage | #12422 |
| reasons | #12444 |
| ifngamma | #12445 |
| relevance | #12447 |
| lung tissue | #12462 |
| colonization | #12463 |
| 170 | #12467 |
| inflammatory cytokine | #12469 |
| european | #12469 |
| lymphocyte activation | #12520 |
| saline | #12546 |
| scarce | #12583 |
| 17 years | #12583 |
| 117 | #12590 |
| defense | #12609 |
| length polymorphism | #12616 |
| predictors | #12620 |
| tobacco | #12634 |
| crohns disease | #12638 |
| discriminating | #12641 |
| 203 | #12655 |
| residence characteristics | #12657 |
| tested | #12664 |
| collect | #12680 |
| detectable | #12682 |
| 156 | #12683 |
| cd3 | #12684 |
| total | #12687 |
| child development | #12695 |
| cystic fibrosis | #12696 |
| contributing | #12697 |
| residential | #12708 |
| multicentre | #12731 |
| beta2 | #12735 |
| aspect | #12741 |
| swedish | #12751 |
| enhancer | #12752 |
| 204 | #12773 |
| clinical manifestations | #12796 |
| 184 | #12815 |
| lung diseases | #12819 |
| combinations | #12856 |
| 104 | #12860 |
| pregnancy | #12873 |
| aspects | #12899 |
| sedentary | #12908 |
| translated | #12918 |
| elevated levels | #12943 |
| infants | #12943 |
| united kingdom | #12946 |
| debate | #12955 |
| human genome | #12959 |
| inflammatory bowel | #12963 |
| coded | #12998 |
| 154 | #13016 |
| 52 | #13056 |
| annually | #13056 |
| 220 | #13057 |
| elusive | #13067 |
| extracellular vesicles | #13082 |
| suffer | #13086 |
| future | #13086 |
| glucocorticoids humans | #13096 |
| genetic rna | #13096 |
| intrauterine | #13097 |
| measurable | #13120 |
| delayed | #13147 |
| conversely | #13160 |
| schistosomiasis | #13161 |
| differential effects | #13191 |
| strong association | #13209 |
| glucocorticoid | #13217 |
| methodological | #13236 |
| great | #13255 |
| developing countries | #13257 |
| 127 | #13262 |
| consultation | #13264 |
| 276 | #13267 |
| 018 | #13274 |
| proportions | #13279 |
| stimulated | #13297 |
| weaning | #13299 |
| hallmark | #13313 |
| 017 | #13323 |
| manifestations | #13333 |
| gene | #13338 |
| odds ratios | #13351 |
| nucleotide risk | #13354 |
| pediatric | #13397 |
| crp | #13407 |
| initiate | #13419 |
| 11 | #13424 |
| burden | #13446 |
| bowel | #13447 |
| kingdom | #13448 |
| auc | #13449 |
| mechanisms underlying | #13450 |
| 210 | #13457 |
| 20th century | #13476 |
| younger | #13480 |
| secretion | #13500 |
| 129 | #13518 |
| considerable | #13527 |
| 045 | #13543 |
| relevant | #13545 |
| confirm | #13567 |
| beijing | #13578 |
| visits | #13581 |
| 188 | #13602 |
| statistically | #13612 |
| respiratory syncytial | #13621 |
| 1989 | #13652 |
| inheritance | #13663 |
| 181 | #13690 |
| argue | #13695 |
| 020 | #13702 |
| depending | #13723 |
| lavage | #13735 |
| 014 | #13736 |
| pneumonia | #13774 |
| study association | #13782 |
| neighboring | #13790 |
| impairment | #13810 |
| sweden | #13833 |
| schistosoma | #13835 |
| severe | #13852 |
| concerns | #13856 |
| cohorts | #13856 |
| establishing | #13859 |
| genomics humans | #13875 |
| human pair | #13893 |
| ranged | #13900 |
| multiplex | #13937 |
| loci | #13953 |
| membrane glycoproteins | #14048 |
| mental health | #14054 |
| additionally | #14064 |
| chromosomes | #14069 |
| fat mass | #14090 |
| restore | #14107 |
| tendency | #14138 |
| nucleotide polymorphism | #14141 |
| establish | #14142 |
| subgroups | #14166 |
| immigrants | #14182 |
| randomly selected | #14189 |
| examples | #14202 |
| fetal development | #14226 |
| expand | #14234 |
| 183 | #14237 |
| concomitant | #14257 |
| socioeconomic status | #14258 |
| multigene | #14259 |
| disease genome | #14278 |
| refined | #14314 |
| breast | #14318 |
| unsaturated | #14320 |
| addresses | #14337 |
| independently | #14350 |
| health organization | #14355 |
| tightly | #14399 |
| amniotic fluid | #14424 |
| severity | #14432 |
| 121 | #14439 |
| penicillium | #14441 |
| epidemiologic studies | #14443 |
| tuberculosis | #14444 |
| 1 month | #14454 |
| 007 | #14492 |
| studying | #14492 |
| derivation | #14517 |
| tolerance | #14521 |
| contributed | #14529 |
| conclude | #14532 |
| systematically | #14533 |
| elevated | #14573 |
| humans | #14580 |
| factors socioeconomic | #14586 |
| cystic | #14593 |
| stranded | #14599 |
| food intake | #14600 |
| horse | #14606 |
| animals antigens | #14624 |
| 6 | #14638 |
| differentially expressed | #14641 |
| effector cells | #14675 |
| 205 | #14693 |
| striking | #14700 |
| lymphocyte count | #14703 |
| lipopolysaccharide | #14704 |
| filament | #14706 |
| transcription | #14707 |
| representative | #14726 |
| tetradecanoylphorbol | #14755 |
| classify | #14766 |
| trimester | #14772 |
| operate | #14777 |
| represents | #14788 |
| glycoproteins | #14799 |
| maximal | #14801 |
| cells patients | #14821 |
| determines | #14831 |
| 2 years | #14850 |
| seropositivity | #14866 |
| genetic analysis | #14890 |
| mice mice | #14912 |
| 002 | #14917 |
| ancestry | #14925 |
| maternal age | #14929 |
| clostridium | #14981 |
| marker | #14999 |
| ctla4 | #15005 |
| 162 | #15012 |
| ethnic | #15032 |
| male | #15042 |
| receptor | #15068 |
| compared healthy | #15084 |
| modulates | #15087 |
| disparities | #15118 |
| 00001 | #15123 |
| stronger | #15140 |
| p00001 | #15177 |
| luciferase | #15184 |
| gram | #15200 |
| longitudinal studies | #15223 |
| immune cells | #15233 |
| 131 | #15264 |
| hong kong | #15269 |
| cumulative | #15330 |
| copd | #15346 |
| nfkappab | #15356 |
| environmental monitoring | #15362 |
| socioeconomic | #15368 |
| gestational age | #15392 |
| curve | #15407 |
| physician | #15419 |
| integrate | #15467 |
| induce | #15469 |
| assessing | #15476 |
| modulated | #15501 |
| cells dcs | #15509 |
| perinatal | #15516 |
| pregnancy risk | #15527 |
| gonadal | #15550 |
| marked | #15553 |
| dysregulation | #15556 |
| feces | #15556 |
| 003 | #15556 |
| 110 | #15569 |
| built | #15581 |
| archaea | #15621 |
| tgfβ | #15667 |
| cytometry | #15669 |
| controlling | #15688 |
| inflammatory agents | #15708 |
| dietary fats | #15739 |
| cell surface receptors | #15743 |
| igg | #15765 |
| genotype | #15766 |
| il1 | #15772 |
| imply | #15830 |
| pregnant | #15831 |
| exclusive | #15843 |
| developed countries | #15863 |
| 47 | #15874 |
| cells animals | #15894 |
| 116 | #15895 |
| socioeconomic factors | #15901 |
| sensitivity specificity | #15922 |
| reflected | #15966 |
| humans inflammation | #15992 |
| agreement | #16016 |
| varies | #16017 |
| diagnosed | #16043 |
| unrelated | #16046 |
| casecontrol study | #16049 |
| filled | #16050 |
| transient | #16060 |
| conditional | #16084 |
| interleukin1beta | #16103 |
| major | #16105 |
| 12 | #16129 |
| located | #16168 |
| homozygous | #16182 |
| effector | #16208 |
| inducer | #16232 |
| anti inflammatory | #16238 |
| transducing | #16239 |
| psychosocial | #16242 |
| 93 | #16314 |
| born | #16347 |
| dendritic cells | #16365 |
| define | #16372 |
| causing | #16382 |
| bacterial | #16387 |
| 7 | #16394 |
| genome wide | #16420 |
| varied | #16428 |
| squared | #16431 |
| volatile | #16432 |
| 082 | #16433 |
| bacteria | #16447 |
| represented | #16476 |
| height | #16488 |
| ibd | #16518 |
| established | #16536 |
| identifying | #16549 |
| participants | #16561 |
| thought | #16634 |
| triggered | #16636 |
| areas | #16662 |
| broad | #16671 |
| academic | #16675 |
| functionally | #16694 |
| microsatellite | #16697 |
| genetic polymorphism | #16725 |
| characterizing | #16726 |
| 0006 | #16756 |
| dendritic | #16762 |
| centre | #16765 |
| 084 | #16783 |
| distributed | #16795 |
| agricultural | #16798 |
| dead | #16800 |
| nitric oxide | #16855 |
| chromosome | #16895 |
| bowel disease | #16898 |
| personal | #16912 |
| 09 | #16918 |
| 91 | #16918 |
| investigating | #16978 |
| utilize | #16980 |
| opportunities | #17033 |
| promoter | #17034 |
| steroid | #17056 |
| anti bacterial | #17061 |
| dna bacterial | #17074 |
| 81 | #17089 |
| mother | #17091 |
| epigenetic | #17095 |
| continuing | #17105 |
| messenger | #17106 |
| progression | #17115 |
| monocytes | #17130 |
| genotypes | #17190 |
| confirms | #17201 |
| individual | #17225 |
| seasons | #17244 |
| 53 | #17287 |
| untranslated | #17292 |
| denmark | #17301 |
| 137 | #17321 |
| retinoic | #17351 |
| drug therapy | #17361 |
| earlier | #17361 |
| cross | #17377 |
| encountered | #17387 |
| taxonomic | #17423 |
| visible | #17455 |
| strong | #17549 |
| excluding | #17551 |
| tnfalpha | #17598 |
| heterozygote | #17605 |
| alleles | #17619 |
| avoidance | #17647 |
| bronchoalveolar lavage | #17656 |
| bacterial agents | #17666 |
| introduced | #17690 |
| cd4 cells | #17717 |
| dcs | #17724 |
| initiating | #17727 |
| comparing | #17740 |
| newborns | #17784 |
| quantified | #17787 |
| regression | #17798 |
| lesser | #17810 |
| geographical | #17857 |
| interviewed | #17866 |
| 84 | #17903 |
| covering | #17927 |
| prospective | #17949 |
| bmi | #17963 |
| animals | #17994 |
| 009 | #18003 |
| drawn | #18014 |
| disease chronic | #18024 |
| longitudinal | #18047 |
| particulate | #18073 |
| monthly | #18086 |
| 77 | #18100 |
| altered | #18146 |
| 085 | #18150 |
| publication administration | #18171 |
| children adolescents | #18178 |
| snp | #18187 |
| neurotrophic | #18224 |
| systemic lupus erythematosus | #18235 |
| samples | #18263 |
| restriction fragment | #18268 |
| negative | #18269 |
| dismutase | #18321 |
| susceptibility | #18324 |
| demographics | #18339 |
| recognize | #18347 |
| inflammatory responses | #18460 |
| inflammatory bowel disease | #18499 |
| chemokines | #18511 |
| served | #18518 |
| difference | #18526 |
| mast cell | #18536 |
| 148 | #18545 |
| replication | #18548 |
| exists | #18580 |
| immunization | #18589 |
| remain | #18590 |
| intervals | #18593 |
| secretory | #18604 |
| carried | #18634 |
| fold | #18655 |
| provided | #18675 |
| 83 | #18683 |
| 36 | #18709 |
| symptom | #18710 |
| differentially | #18718 |
| variation genome | #18742 |
| rise | #18757 |
| weight | #18797 |
| epithelial cells | #18798 |
| sum | #18807 |
| candidate | #18807 |
| additional | #18812 |
| immunophenotyping | #18818 |
| families | #18838 |
| basis | #18843 |
| 1997 | #18843 |
| 28 | #18854 |
| maintain | #18856 |
| variants | #18858 |
| 13 | #18882 |
| fragment length | #18919 |
| missing | #18966 |
| lower | #18985 |
| sampling | #19004 |
| receptors cell | #19024 |
| intake | #19030 |
| vitamin | #19034 |
| experiencing | #19122 |
| susceptible | #19133 |
| fats | #19173 |
| balb mice | #19208 |
| crosssectional study | #19250 |
| c57bl mice | #19256 |
| promoter regions | #19283 |
| polymerase | #19291 |
| locus | #19302 |
| clinical presentation | #19308 |
| 1992 | #19352 |
| contributes | #19382 |
| termed | #19414 |
| mouse model | #19415 |
| trait loci | #19415 |
| clear | #19476 |
| partially | #19504 |
| completely | #19506 |
| elucidate | #19510 |
| socio | #19512 |
| × 10 | #19521 |
| pollutants | #19552 |
| validated | #19554 |
| necrosis | #19582 |
| illustrate | #19602 |
| lasting | #19718 |
| time polymerase | #19720 |
| healthrelated quality | #19789 |
| polymerase chain | #19797 |
| 1998 | #19855 |
| inbred balb mice | #19855 |
| chronic obstructive | #19868 |
| 5 years | #19869 |
| selecting | #19937 |
| carrying | #19967 |
| baseline | #19977 |
| context | #19977 |
| negatively | #19998 |
| 95 confidence interval | #20023 |
| inbred balb | #20051 |
| interferon gamma | #20056 |
| easy | #20065 |
| acetaminophen | #20066 |
| shared | #20130 |
| 74 | #20150 |
| 64 | #20157 |
| health | #20163 |
| activates | #20164 |
| summary | #20181 |
| reporter | #20212 |
| serological | #20244 |
| adjusting | #20271 |
| 1 year | #20289 |
| interacting | #20295 |
| autoimmune diseases | #20301 |
| 61 | #20339 |
| stimulation | #20363 |
| 14 | #20418 |
| identifies | #20457 |
| demonstrating | #20473 |
| 2003 | #20528 |
| humans longitudinal | #20557 |
| returned | #20566 |
| ratio | #20593 |
| 26 | #20613 |
| inflammatory | #20615 |
| interactions | #20618 |
| behavior female | #20629 |
| nitric | #20636 |
| chain reaction | #20655 |
| upregulated | #20694 |
| highest | #20707 |
| genetically | #20746 |
| immunologic | #20771 |
| recurrent | #20779 |
| cells female | #20794 |
| interleukin | #20806 |
| wide | #20813 |
| clarify | #20844 |
| blood | #20864 |
| 51 | #20870 |
| cd4 cell | #20884 |
| rodents | #20894 |
| infectious | #20895 |
| causal | #20898 |
| create | #20974 |
| mucosal | #20983 |
| named | #20988 |
| obstructive | #20991 |
| interval | #21015 |
| suggesting | #21054 |
| 59 | #21130 |
| hereditary | #21187 |
| identical | #21192 |
| followup | #21199 |
| regulation | #21207 |
| epithelial cell | #21236 |
| essentially | #21325 |
| kappab | #21354 |
| variety | #21563 |
| mast | #21565 |
| celiac disease | #21617 |
| infection | #21622 |
| endpoint | #21718 |
| tumor necrosis | #21799 |
| reduced | #21829 |
| 10 years | #21837 |
| measures | #21851 |
| stress psychological | #21874 |
| alterations | #22024 |
| definitive | #22102 |
| assess | #22118 |
| continued | #22161 |
| correlate | #22201 |
| familial | #22235 |
| ensure | #22257 |
| frequency | #22288 |
| abolished | #22332 |
| continental ancestry | #22431 |
| reflecting | #22432 |
| unchanged | #22438 |
| validation | #22455 |
| score | #22546 |
| frequent | #22558 |
| tumor necrosis factor | #22615 |
| 95 confidence | #22620 |
| balb | #22645 |
| closely | #22684 |
| genes | #22753 |
| coupled | #22803 |
| continuously | #22829 |
| reactive | #22841 |
| indicating | #22843 |
| comparable | #22875 |
| murine | #22957 |
| 22 | #22977 |
| neonatal | #22988 |
| supported | #23008 |
| introduce | #23009 |
| type 1 | #23013 |
| report | #23048 |
| ifnγ | #23104 |
| necrosis factor | #23137 |
| predict | #23148 |
| lived | #23179 |
| increasingly | #23205 |
| rich | #23217 |
| count | #23292 |
| smoking | #23305 |
| modulating | #23348 |
| late | #23357 |
| mechanisms | #23394 |
| confidence | #23438 |
| 1 | #23526 |
| young | #23528 |
| adjustment | #23611 |
| exclude | #23665 |
| endopeptidases | #23709 |
| adolescents | #23720 |
| factors united | #23849 |
| defined | #23927 |
| extensive | #23929 |
| body | #24002 |
| dietary | #24027 |
| intracellular | #24110 |
| 5 | #24167 |
| 3 | #24232 |
| lymphocytes | #24242 |
| aimed | #24342 |
| increasing | #24355 |
| symptomatic | #24455 |
| depend | #24530 |
| reduces | #24548 |
| interaction | #24609 |
| collected | #24626 |
| adults | #24658 |
| remains | #24734 |
| needed | #24798 |
| responsible | #24851 |
| rsv | #24888 |
| 15 | #24969 |
| putative | #25032 |
| identification | #25068 |
| enrolled | #25223 |
| representing | #25239 |
| yielded | #25263 |
| determine | #25273 |
| extracellular | #25281 |
| analysis performed | #25297 |
| sex factors | #25359 |
| documented | #25522 |
| anti | #25535 |
| describing | #25574 |
| comprised | #25660 |
| matter | #25795 |
| transcriptase polymerase | #25871 |
| continue | #25896 |
| lymphocyte | #25994 |
| decreased | #26047 |
| enabling | #26157 |
| diminished | #26261 |
| previous | #26271 |
| healthy | #26310 |
| 16 | #26319 |
| profiling gene | #26374 |
| implicated | #26377 |
| dioxide | #26380 |
| inflammation | #26386 |
| tended | #26519 |
| applied | #26644 |
| contained | #26780 |
| describes | #26787 |
| generally | #26891 |
| multivariate | #26969 |
| capable | #27003 |
| unaffected | #27064 |
| presenting | #27110 |
| moderate | #27144 |
| 18 | #27195 |
| heterozygous | #27203 |
| acquired | #27213 |
| oligonucleotide | #27226 |
| concluded | #27331 |
| undergone | #27359 |
| topic | #27376 |
| proteins signal | #27393 |
| reached | #27432 |
| large | #27637 |
| recognized | #27654 |
| positive lymphocytes | #27691 |
| 001 | #27802 |
| linked | #27832 |
| preschool female | #27932 |
| models genetic | #27987 |
| predicted | #28046 |
| 0005 | #28071 |
| subsequently | #28087 |
| quantitative | #28099 |
| respect | #28131 |
| represent | #28157 |
| impaired | #28234 |
| reverse transcriptase | #28434 |
| continental | #28581 |
| plays | #28633 |
| positive | #28648 |
| immunoenzyme | #28655 |
| occurring | #28707 |
| screened | #28708 |
| square distribution | #28750 |
| transcriptase | #29017 |
| quantitative trait | #29137 |
| versus | #29158 |
| allowed | #29194 |
| comparison | #29267 |
| affect | #29339 |
| administered | #29469 |
| easily | #29520 |
| human | #29690 |
| weak | #29736 |
| possess | #29786 |
| physical | #29792 |
| pair | #29885 |
| correlated | #29909 |
| chain | #29911 |
| characterize | #29984 |
| gastrointestinal | #30316 |
| providing | #30537 |
| 005 | #30590 |
| aims | #30608 |
| factual | #30658 |
| 2 | #30659 |
| confirmed | #30719 |
| markedly | #30761 |
| 4 | #30907 |
| eligible | #31311 |
| fatty | #31332 |
| upper | #31437 |
| frequently | #32564 |
| mice knockout | #32696 |
| predictive tests | #32836 |
| peripheral | #32944 |
| humanized | #33092 |
| expression | #33163 |
| registered | #33261 |
| functional | #33617 |
| dominated | #33759 |
| selected | #33999 |
| mediated | #34372 |
| independent | #34407 |
| activate | #34542 |
| acids | #34703 |
| occur | #34769 |
| mediate | #35225 |
| conducted | #35568 |
| national | #35610 |
| evaluate | #35821 |
| 0001 | #35859 |
| developed | #36145 |
| characterized | #36394 |
| measurements | #36573 |
| express | #37054 |
| measured | #37778 |
| follow studies | #37967 |
| appears | #37978 |
| biological | #38141 |
| examined | #38373 |
| include | #39853 |
| adult | #39859 |
| clinically | #40140 |
| united | #42200 |
| mice inbred | #42559 |
| consistent | #42590 |
| excluded | #42832 |
| expression regulation | #43143 |
| inbred | #45657 |
रिपोर्ट चलाएं | |
Prominent publications by Erika RM von Mutius
KOL-Index: 23349
BACKGROUND: Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma.
METHODS: As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, ...
| के लिए जाना जाता है Risk Asthma | 7 Years | Year Life | Children Aged | Rhinoconjunctivitis Eczema |
KOL-Index: 18397
BACKGROUND: Phase III of the International Study of Asthma and Allergies in Childhood measured the global prevalence of symptoms of asthma, rhinoconjunctivitis, and eczema in children.
OBJECTIVE: To investigate the associations between the use of antibiotics in the first year of life and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old.
METHODS: Parents or guardians of children 6 and 7 years old completed written questionnaires on current symptoms and ...
| के लिए जाना जाता है International Study | Rhinoconjunctivitis Eczema | Year Life | Symptoms Asthma | 95 Risk Factors |
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
[ PUBLICATION ]
Importance: Atopic dermatitis is an inflammatory, pruritic skin disease that often occurs in early infancy with a chronic course. However, a specific description of subtypes of atopic dermatitis depending on the timing of onset and progression of the disease in childhood is lacking.
Objective: To identify different phenotypes of atopic dermatitis using a definition based on symptoms before age 6 years and to determine whether some subtypes are more at risk for developing other allergic ...
| के लिए जाना जाता है Atopic Dermatitis | 6 Years | Age Children | Allergic Diseases | Food Allergy |
KOL-Index: 17686
BACKGROUND: Associations between exposure to cats and dogs and respiratory and allergic outcomes in children have been reported in affluent countries, but little is known about such associations in less-affluent countries.
METHODS: The International Study of Asthma and Allergies in Childhood, phase 3 was carried out in children aged 6-7 years and adolescents aged 13-14 years across the world. Questions about cats and dogs in the home were included in an additional questionnaire. Using ...
| के लिए जाना जाता है Cats Dogs | Asthma Rhinoconjunctivitis | Affluent Countries | Children Adolescents | International Study |
KOL-Index: 15451
BACKGROUND: There is increasing evidence that environmental exposures determining childhood illnesses operate early in life. Prenatal exposure to a farming environment through the mother might also play an important role.
OBJECTIVE: We sought to investigate the role of maternal exposures to environments rich in microbial compounds for the development of atopic sensitization, asthma, and corresponding alterations in the innate immune system in offspring.
METHODS: In the children of the ...
| के लिए जाना जाता है Atopic Sensitization | Innate Immunity | Farm Exposure | Microbial Compounds | Expression Receptors |
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
[ PUBLICATION ]
BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.
METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...
| के लिए जाना जाता है Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure |
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
[ PUBLICATION ]
OBJECTIVES: To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.
DESIGN: Prevalence surveys among school-children aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function ...
| के लिए जाना जाता है Allergic Disorders | Munich Leipzig | Prevalence Asthma | Seasonal Surveys | Living Conditions |
KOL-Index: 14833
BACKGROUND: Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
METHODS: We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an ...
| के लिए जाना जाता है European Ancestry | Association Asthma | Single Nucleotide Receptors | Tumor Necrosis Factor | Human Pair |
Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study
[ PUBLICATION ]
BACKGROUND: Associations between early life exposure to farm animals and respiratory symptoms and allergy in children have been reported in developed countries, but little is known about such associations in developing countries.
OBJECTIVE: To study the association between early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema in a worldwide study.
METHODS: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) was carried ...
| के लिए जाना जाता है Farm Animals | Asthma Rhinoconjunctivitis | Isaac Phase | Early Life | Affluent Countries |
KOL-Index: 14598
The German reunification offers a unique opportunity to study the impact of environmental factors on the development of childhood respiratory and allergic disorders in ethnically similar populations. We investigated the prevalence of asthma, hay fever, atopy, and bronchial hyperresponsiveness (BHR) in 9- to 11-year old children in West Germany (n = 5,030) and East Germany (n = 2,623). A self-administered questionnaire was distributed to the parents. Children underwent cold air challenge ...
| के लिए जाना जाता है East Germany | Asthma Fever | Prevalence Bhr | Environmental Factors | Atopic Sensitization |
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
[ PUBLICATION ]
International comparative studies, investigating whether disease incidence or prevalence rates differ between populations and, if so, which factors explain the observed differences, have made important contributions to the understanding of disease aetiology in many areas. In Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence rates of symptoms of asthma, allergic rhinitis and atopic eczema in 13-14-yr-olds, assessed by standardised ...
| के लिए जाना जाता है International Study | Asthma Allergies | Prevalence Rates | Atopic Eczema | Childhood Isaac |
KOL-Index: 13844
BACKGROUND: Mutations in the filaggrin gene (FLG) have been shown to play a significant role in ichthyosis vulgaris and eczema, 2 common chronic skin diseases. However, their role in the development of other atopic diseases such as asthma and rhinitis has not yet been clarified in large population-based studies.
OBJECTIVES: To study the effect of FLG mutations at the population level and their effect on other atopic phenotypes.
METHODS: Association analysis of the 2 common FLG-null ...
| के लिए जाना जाता है Filaggrin Mutations | Atopic Eczema | Allergic Rhinitis Asthma | Role Development | Disease Genotype Humans |
Increased food diversity in the first year of life is inversely associated with allergic diseases
[ PUBLICATION ]
BACKGROUND: The role of dietary factors in the development of allergies is a topic of debate, especially the potential associations between infant feeding practices and allergic diseases. Previously, we reported that increased food diversity introduced during the first year of life reduced the risk of atopic dermatitis.
OBJECTIVE: In this study we investigated the association between the introduction of food during the first year of life and the development of asthma, allergic rhinitis, ...
| के लिए जाना जाता है Food Diversity | Allergic Diseases | Year Life | Development Asthma | Atopic Sensitization |
के लिए प्रमुख लोग Atopic Dermatitis
दुनिया में शीर्ष kols
एक खोज वाक्यांश का चयन करें atopic dermatitis , atopic dermatitis patients , atopic dermatitis psoriasis , atopic dermatitis children , atopic dermatitis asthma
Erika RM von Mutius:विशेषज्ञ प्रभाव
जिसके लिए अवधारणाएंErika RM von Mutiusप्रत्यक्ष प्रभाव है:Atopic dermatitis, Childhood asthma, Allergic diseases, Atopic sensitization, Allergic rhinitis, International study, Farm milk, East germany.
Erika RM von Mutius:कोल इम्पैक्ट
अन्य लेखकों के काम से संबंधित अवधारणाएं जिनके लिएfor which Erika RM von Mutius प्रभाव है:Atopic dermatitis, Allergic rhinitis, Childhood asthma, Food allergy, Lung function, Air pollution, Early life.
Tools
क्या यह आपकी प्रोफ़ाइल है? अपनी प्रोफ़ाइल का दावा करें यूआरएल कॉपी करें अपनी प्रोफ़ाइल के लिए लिंक एम्बेड करें |